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Abstract
Specific hetero-oligosaccharides on glycoproteins and glycolipids play important 
roles in cell-cell and cell-matrix interactions, affect the stability and structure of proteins, 
and are epitopes for immune system recognition. Glycosyltransferases (GTs) are enzymes 
that catalyse the synthesis of these oligosaccharides. These enzymes are abundant in 
nature and represent one of the most widespread in the living world. They can be found in 
organisms as different as bacteria, yeast, plants and most of the living animals. Structural 
information on glycosyltransferases would facilitate in understanding and addressing the 
structural basis for the catalysis of specific glycoconjugates in the cell. Furthermore, 
structural data would be useful for the design of inhibitors and to assist the engineering of 
new catalysts for the enzymatic synthesis of natural and novel glycoconjugates for 
therapeutic use.
The bulk of this study is concentrated on structural studies of bovine a-1,3- 
Galactosyltransferase (a3GT) which is an enzyme that catalyzes the transfer of Galactose 
from UDP-a-D-galactose into an a-1,3 linkage with p-galactosyl groups in 
glycoconjugates. a3GT is a member of a family of metal-dependent retaining 
glycosyltransferases including the histo-blood group A and B synthases. The enzyme is 
expressed in many mammalian species but is absent from humans, apes and old world 
monkeys. This presents a barrier against xenotransplantation which is one of the major 
approaches to dealing with the limited supply of donor organs. Hence understanding the 
catalytic mechanism of this enzyme would have significant biological implications.
Chapter 1 of this thesis outlines the general principles of X-ray crystallography 
and gives an overview of the practice of this technique. Chapter 2 provides a general 
biological and structural background to glycosyltransferases, the metal retaining family 6 
glycosyltransferases and then move on to specifically describe a-1,3- 
Galactosyltransferase. Chapter 3 presents the majority of the work which is on structural 
studies of a-l,3-Galactosyltransferase. This chapter is divided into four sub chapters 
starting with the description of protein preparations and crystallisation of the wild type 
and mutant proteins. The second sub chapter discusses the conformational dynamics of 
the enzyme by structural studies of ‘apo’ forms of the enzyme and C-terminal mutants of
the enzyme. Subchapter three describes the structural studies carried out on active site 
mutants of a3GT in order to better understand the catalytic mechanism of the enzyme. 
Subchapter 4 discusses binding studies of wild type a3GT with an alternative acceptor 
substrate p-Nitrophenyl galactoside (pNPGal) and also discusses modelling studies of the 
enzyme with the inhibitor, U66. Chapter four of the thesis describes attempts to 
crystallise canine Forssman synthase which is an enzyme that also belongs to the metal 
retaining family 6 glycosyltransferases. This chapter presents the crystallisation trials 
which had been carried out in order to obtain a diffraction quality crystal. A brief final 
section comments on the status of, and future for, research in these areas.
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Chapter 1 Protein Crystallography
1. X-ray Crystallography
1.1 General Background
Crystallography provides the most direct way of visualizing the images of 
molecules. Through the method of X-ray crystallography thousands of 3- 
dimensional structures of proteins and nucleic acids have been elucidated. These 
give detailed information about their activity, their mechanism for recognizing and 
binding substrates and effectors, and the conformational changes they might undergo 
(Blow, 2002). Armed with this information we can design novel drugs that target a 
particular protein, or rationally engineer an enzyme for a specific industrial process. 
Over the years, with the advent of increasingly faster computers, crystallography 
software and improved X-ray technology has lead to many improvements in the 
speed and accuracy of structure solution (Helliwell, 1992). In turn, the information 
from many completed molecular structures has allowed us to further improve our 
interpretation of X-ray diffraction data. There are several steps towards the 
elucidation of a given protein structure through X-ray crystallography and they will 




> Data collection and processing
> Phase determination
> Electron density map calculation
> Model building and refinement
>  Structure validation and analysis
1.2 Protein preparation
The first step to obtaining a crystal structure of a given protein is acquiring pure 
protein for crystallisation. The availability of pure protein is usually detrimental 
towards obtaining diffraction quality crystals hence acquiring high quality
2
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diffraction for structure elucidation. The aim of protein purification ideally is to 
produce a pure (>99%), homogenous, correctly folded, monodisperse, active and 
stable protein sample. The protein sample should also be readily produced in large 
quantities for the means of crystallisation trials. There are several aspects which 
should be considered when purifying proteins for crystallography and they include 
the source of the protein (either wild type or recombinant), the expression system, 
fusion proteins and cleavage of tag, purification method and assessment of purity. 
Purity of a protein sample is essential in obtaining high quality diffraction data as 
low purity can be a barrier to crystal growth. Contaminating species can interfere 
with the bonding interactions needed to propagate the crystal lattice hence leading to 
a reduction in crystal formation. However, the protein samples available are not 
usually ideal for crystallisation as they could be difficult to purify and may only be 
produced in low concentration or have low stability. In order to overcome this, 
protein can be stored in buffers containing high concentration of glycerol (50%) and 
then it can be subjected to buffer exchange and concentrated to the appropriate 
concentration (5-20 mg/ml) prior to crystallisation.
1.3 Protein crystallisation
Crystals are regular, three-dimensional arrays of atoms, ions, molecules or molecular 
assemblies. The aim of a crystallisation experiment is to produce diffraction quality 
crystals which are the basis of X-ray structure determination. It is also sometimes the 
primary difficulty in the determination of a protein structure. The process involves 
controlled precipitation from aqueous solution under conditions that do not denature 
the protein (Rhodes, 2000). Proteins are structurally dynamic systems, often micro- 
heterogenous, whose properties are influenced by environmental conditions such as 
pH, temperature, ionic strength and a number of other factors. Protein purity and 
homogeneity is essential to the growth of single protein crystals. Crystallisation of 
macromolecules is a process involving three major stages: nucleation, growth and 
cessation of growth. It is of utmost importance for crystallisation to bring the protein
3
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to a supersaturated state (Figure 1.1), which will force the molecules to aggregate 






Concentration of precipitating agent
Figure 1.1: Solubility diagram. It represents the different steps occurring during crystal 
formation. The supersolubility curve separates the labile region, where nucleation occurs, 
from the metastable region, where crystals grow.
The precipitants normally used for crystallisation are salts, polyethylene 
glycols or organic solvents like ethanol, isopropanol or methylpentane diol. At low 
ionic strength (low ionic concentration), the solubility o f protein is higher if  the 
amount o f electrolytes is increased -term ed “salting in”. At high ionic strength the 
ions start to compete with each other for water molecules, resulting in a decrease in 
solubility. This process is known as “salting out” . The crystallographer can shift the 
equilibrium to supersaturation by increasing or reducing the ionic strength o f the 
protein solution. The most widely used precipitant is polyethylene glycol (PEG) 
because it is a powerful precipitant and a weak denaturant. PEG is often available in 
a variety o f average molecular masses such as PEG 4000 which has an average 
molecular mass o f 4000 daltons. As shown in Figure 1.1, crystal growth can be 
divided into two steps. First, a spontaneous nucleus formation occurs in the
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supersaturation area followed by formation of small aggregates. After the critical 
amount of aggregated molecules is surpassed, the crystal growth becomes an 
energetically privileged process. Crystal growth always needs a lower degree of 
supersaturation than nucleus formation. Crystals should grow slowly to achieve the 
maximum possible internal order. It is clear that crystal morphology is not a direct 
indication of crystal quality. “ Good looking” crystals can have disordered crystal 
packing limiting their diffraction properties. Contrary to this, some 
“ morphologically poor” crystals can give a positive surprise when they are 
measured. Different methods for growing crystals, as batch crystallisation, dialysis, 
liquid-liquid diffusion and vapour diffusion, have been established and developed in 
the direction of using less amounts of material. The technique most widely used is 
hanging drop method (Figure 1.2). The general role is that the sample must be pure 
and homogenous, it should be clean from small undesirable molecules and should 
contain a population with the same protein conformation. Microheterogenity of the 
sample can occur due to different reasons: variation in primary structure (genetic 
mutations), secondary structure (unfolding), tertiary structure (conformers), 
quaternary structure (oligomerization), partial oxidation of some groups, 
fragmentation by proteolysis or molecular dynamics of flexible parts(Bergfors, 
1999).
5
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Hanging drop containing protein 
solution and mother liquor
Siliconised c overslip 
High-vacuum grease
Reservoir containing mother 
liquor, i.e precipitant (Salt, 
PEG), Buffers
Figure 1.2: A few micro-litre of protein solution is mixed with an equal amount (normally a 
ratio of 1:1) of reservoir solution, which contains the precipitants and placed as a drop on 
the coverslip. A thin layer of grease seals the cover slip on the well containing the mother 
liquor. The most commonly used plates are 24 well linbro plates.
More often than not, waiting for a protein to crystallise can be a long and 
daunting process. Sometimes spontaneous nucleation needs a helping hand and this 
is where a technique known as seeding comes into practice. It is profitable to 
stimulate nucleation by seeding with crystals o f the same protein grown under other 
conditions. Energetically, it is more profitable to add to an already existing crystal 
plane than it is to create a new nucleus, so seeding increases the probability o f 
nucleation o f a new crystal form (Bergfors, 1999). There are three types o f seeding 
technique commonly used: microseeding which is the addition o f a very small piece 
o f crushed protein crystal to the crystallisation drop, macroseeding which is the 
addition o f  an intact, already grown crystal to the crystallisation drop and streak 
seeding which is similar to microseeding but involves the use o f a fine fibre (often a 
cat’s or rabbit’s whiskers are best) to pick up small protein crystal fragment and 
transfer it into a crystallisation drop. M icroseeding is the most reliable form o f 
seeding in which a few small crystals, or one large crystal is broken up to a fine
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powder using a needle. A small amount of mother liquor containing this fine powder 
is added to an aliquot of well solution and then serially diluted. A small quantity of 
the microseed solution is then added to a pre-equilibrated protein crystallisation 
drop. For streak seeding, an existing crystal is lightly touched with the fibre to 
dislodge a few seed and then introduce the seeds into a fresh pre-equilibrated drop 
by stroking the fibre in a straight line through the drop.
For data collection only best quality crystals should be used in order to 
obtain structural data. When different crystal forms are obtained, the best diffracting 
crystals with the highest symmetry should be chosen for further work.
1.4 Principles of X-ray crystallography
1.4.1 X-ray Diffraction of Crystals
X-rays are electromagnetic radiation which are diffracted by even the smallest 
molecules and X-ray crystallography is unique in its ability to provide a detailed, 
high resolution picture of molecular structures. In essence, X-rays are used to 
produce magnified images of protein molecules and the need for X-rays is due to the 
details of molecular structure being smaller than the wavelength of visible light 
which is between 400-700nm. If an atomic scale image is to be made, a ‘light’ of 
appropriate wavelength must be used. As atoms that are covalently bonded to each 
other have a bond length of 1-2 A apart, whilst hydrogen bonds are between 2.5-3.5 
A apart, it is therefore necessary to use wavelengths no larger than a couple of 
Angstrom (1 Angstrom= 10'8 cm) units (Blow, 2002). Electromagnetic waves of 
these wavelengths are known as X-rays.
Figure 1.3 depicts the collection of X-ray diffraction data. A crystal is 
mounted between an x-ray source and an X-ray detector. The crystal diffracts the 
source beam into many discrete beams which results in a diffraction pattern 
comprising many reflections. The greater the intensity of the X-ray beam that 
reaches a particular position, the darker the reflection (Rhodes, 2000). These 
reflections are measured using a detector such as CCD (charge coupled device), 
image plate or the area detector. The position and intensity of each reflection is
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measured precisely by the detector and is transmitted in digital form to the computer 
for analysis.
Figure 1.3: Schematic representation of a data collection set up
The position of a reflection can be used to obtain the direction at which a 
particular beam is diffracted by the crystal while the intensity of the reflection 
indicates the strength of the diffracted beam that produces a particular spot. The 
position of each reflection can be given a notation (hkl), where h, k and / are integers 
in which each component indicates into how many parts this set of planes splits each 
axis of the unit cell. The central beam position is taken as the origin and assigned the 
co-ordinates (h, k, 1) = (0, 0, 0) or hkl=000 with the rest of the reflections counted 
from this origin.
Even though there are many sets of planes throughout the crystal, coherent 
diffraction can only occur from sets of planes which have spacings that conform to 
Bragg’s Law (Figure 1.4). The Bragg’s Law states that for any angle of incident 
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planes which have spacings that allow a difference in path length between the waves 
to equal to an integral number of wavelengths (Blundell and Johnson, 1976). This 
keeps the resulting diffraction in phase hence producing a coherent signal:
2d sinO = nX
where d is the interplanar distance, 0 is the angle of the incident beam while n is the 
number of wavelength and X is the wavelength.
Incident radiation Diffracted radiation
Figure 1.4: Scheme that explains Bragg’s law. Two waves that are reflected by two adjacent 
lattice planes with distance d have a difference in path length that is equal to 2dsin0, as it 
can easily be derived from the scheme. A prerequisite for constructive interference is, that 
this difference in path is an integer multiple of the wavelength used: 2dsin0=nl.
The diffraction pattern for any given crystal is a coherent pattern of spots 
whose properties are related to the dimensions of the crystal. The waves which are 
diffracted from the real lattice of the crystal forms spots or reflections in the 
reciprocal lattice of the diffraction pattern. The inverse nature between the real
9
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lattice and the reciprocal lattice can be comprehended by observing Bragg’s Law. 
According to Bragg’s Law, the sets of planes which are closer together will only 
give coherent diffraction at larger angles of incidence. Leading to more dispersed 
spots on the diffraction pattern whereas the set of planes which are further apart will 
only give coherent diffraction at narrower angles of incidence resulting in spots 
closer to the center of the diffraction pattern. Therefore, information for the overall 
structure of a unit cell contents is concentrated at the center of the diffraction pattern 
which consists of the lower resolution reflections as these reflections originated from 
the wider spaced planes in the crystal. The finer details of the unit cell contents will 
be concentrated in the higher resolution reflections further out in the diffraction 
pattern as these reflections originated from the more narrowly spaced planes in the 
crystal. Further description on the concept of resolution is discussed in section 1.3.2. 
In order to obtain all the information about a given crystal, diffraction patterns from 
many angles of incident radiation must be recorded. This is achieved by rotating the 
crystal and this idea can be described best by a simple geometrical construction 
proposed by Paul Peter Ewald in 1921. Ewald sphere (Figure 1.5) shows that in 
reciprocal space, there is a sphere of possible reflections which occurs when the 
crystal and therefore the reciprocal lattice, rotates to bring them into view (Blundell 
and Johnson, 1976). The radius of this sphere is the inverse of the real space 
wavelength hence, the shorter the wavelength of the incident radiation, the larger the 
sphere of reflection will be thus allowing more of the potential reflections to be 
measured.
10
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1/X
Figure 1.5: The Ewald sphere is a sphere representation of the set of planes which obey the 
Bragg’s Law. A is the crystal center and O represents the point of exit for the non-difffacted 
beam, the origin of reciprocal space. Radius of the sphere is 1A and when the reciprocal 
lattice is rotated about O, point B in the reciprocal lattice intersects with the circle resulting 
in a reflection. This is due to the distance between the origin of the reciprocal space, O, and 
the diffracted beam being equivalent to 1/dhu in which d is the lattice spacing, hence OC is 
M2&hki which is equivalent to 1A sin0. Therefore, M2&hki = 1/ X sin0 which is equivalent to 
sin0 Idhki = K  is Bragg’s Law if n = 1. Adapted from (Rhodes, 2000)
1.4.2 The concept of resolution
Resolution o f a crystal structure refers to the minimum inter-planar spacing o f the 
reflections included in structure determination. The unit for resolution is represented 
in Angstrom (A= 10'8 cm). Resolution defines the quality o f  the structure o f a 
macromolecule. The main features o f a macromolecule that can be viewed at 
different resolutions are as follows (Acharya et al., 1995; Blundell and Johnson, 
1976):
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Resolution Features
6.0 A Outline of the molecule, secondary structure features such as
helices and strands, can be identified
3.0 A Course of the polypeptide chain can be traced and topology of the
folding can be established. With the aid of amino acid sequence, it 
is possible to place the side chains within the electron density map.
2.0 A Main chain conformations can be established with great accuracy.
Details of side chain conformations can be interpreted easily 
without amino acid sequence data. Bound water molecules, metal 
ions and cofactors can also be identified.
1.5 A Individual atoms are almost resolved. It is possible to make out the
solvent structure.
1.0 A Hydrogen atoms may be visible. It is also possible to see multiple
conformations for some side chains.
1.4.3 The unit cell and space group
Although individual atoms diffract X-rays, it is not possible to produce a focussed 
image of a molecule hence, unfocussed information needs to be collected and 
converted back to an image using a computational process. A further complication is 
that single molecules do not diffract X-rays strongly hence, to overcome this 
obstacle, crystals containing repeating arrays of the molecule are grown to amplify 
the signal. Crystals comprise a lattice of regularly repeated units known as the unit 
cells. The unit cell is defined as the minimal structural part that repeats in all three 
dimensions to build up the crystal. A unit cell is defined by the length of its three 
axes, a, b, c and the angles between them a, p and y (Figure 1.6). There are 7 crystal 
systems for describing unit cells based on their shape in which each of the unit cells 
can be built up in one of the 14 Bravais lattices to produce the crystal. Within the 
unit cell, a crystal can contain further symmetry elements, dividing it into several 
asymmetric units, which form the most basic structural element, which is related to 
all other identical objects in the unit cell by symmetry elements. The unit cell of a
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crystal can contain both rotational symmetry and screw axes, where the asymmetric 
unit is not only rotated around the axis, but also translated a fraction of the unit cell 
length. Screw axes are denoted as subscript numbers related to the fraction 
translation o f the unit cell, for example, 2 \ is a two-fold rotation axis with a 
translation corresponding to half the unit cell length. The geometry o f the unit cell 
together with the possible symmetry operations defines the space group o f the 
crystal. All these elements combined results in only 65 space groups that are feasible 
for chiral molecules such as proteins. Further details on symmetry and equivalent 
positions for these space groups, as well as other possible space groups for achiral 
objects can be found in Volume A o f the International Tables for Crystallography 
(Henry and Lonsdale, 1952).
Figure 1.6: The lengths of the unit cell edges are designated as a, b and c and the angle 
between the axes b and c is a, a and c is (3, a and b is y.
13





Angles (°) Point groups
Triclinic P a^b ^ c 1
Monoclinic P C a ^ b ^ c a = y = 90; 
P> 90
2
Hexagonal P a = b ^ c a = p = 90; 
Y= 120
6, 622
Trigonal P R a = b = c a = p = y ^ 90 3, 322
Cubic P I F a = b = c a = P = y = 90 23,432
Tetragonal P I a = b ^ c a = P = y = 90 4,422
orthorhombic P I C F a ^ b ^ c a = p = y = 90 222
Table 1.2: Seven crystal systems of primitive lattices.
1.5 Diffraction data collection
1.5.1 X-ray source
To perform an X-ray diffraction experiment, we need an X-ray source. The X-rays 
used for protein crystallography usually come from one of two sources. In 
crystallography laboratories, a rotating copper anode generator producing an X-ray 
beam of a characteristic wavelength is often used as a ‘home’ source. Electrons from 
a cathode are accelerated towards rotating, a water-cooled, copper anode, resulting 
in an emission of Cu-Ka radiation at a fixed wavelength of 1.54A. The X-ray 
produced is then filtered through a monochromator, made from either nickel or a 
single crystal. The monochromator functions to effectively remove absorbed 
radiation and have no contribution to the diffraction pattern. Curved mirrors are then 
used to deflect the focused X-rays through a low angle which increases the brilliance 
of the beam (Rhodes, 2000). However, home source radiation is often more suited 
for characterising crystals and collecting data for crystals that diffract well.
14
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The nature of most protein crystals make them better suited for synchrotron 
radiation. There are many advantages of using synchrotron sources such as shorter 
wavelength radiation, tuneable wavelength radiation, greater brilliance and greater 
flux (Helliwell, 1997). Synchrotron radiation is produced when electrons are 
accelerated near the speed of light by a magnetic field. During this acceleration, the 
electron’s path is forcibly curved around a large storage ring, in effect causing loss 
of energy thus resulting in the emission of electromagnetic waves. This 
electromagnetic radiation, emitted at a tangent to the ring, is then guided and 
focussed for use in experiments. There is a complete range of electromagnetic 
radiation produced hence allowing the experimental stations to be designed to offer a 
variety of wavelengths for diffraction experiments. Shorter wavelengths can be 
chosen for high resolution experiments and also the ability to choose wavelengths 
close to the absorption edge of heavy metal for anomalous scattering experiments.
1.5.2 Data collection
Ideally during data collection, we would like to collect the highest possible 
resolution data set for the crystal. Several factors need to be considered in order to 
achieve this goal. The diffraction limit depends on the order of the crystal and the 
wavelength of the X-ray radiation being used. The increasingly common use of 
synchrotron radiation at wavelengths beyond lA  has lead to more high resolution 
structures. The intensity of synchrotron radiation source allows a better signal to 
noise ratio. However, this same high intensity radiation is also the cause of radiation 
damage to the crystal. Radiation damage can be reduced by means of collecting data 
at cryogenic temperatures in the range of 80-100K. In this method, the crystal is 
picked directly from the drop with a loop of fine nylon or glass fibre and then frozen 
under a stream of cryogen such as nitrogen. However, not all crystals can be frozen 
without disruption of the crystal lattice. The crystals would usually need to be 
soaked in cryoprotectant which is often composed of both the crystallisation solution 
and a suitable cryoprotectant such as glycerol, polyethylene glycol or MPD (2,4- 
dimethyl pentane diol). The choice of cryoprotectant is of great importance and 
varies depending on the crystal. An ideal cryoprotectant should surround the crystal
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to prevent the formation of ice crystals that interferes with the diffraction pattern of 
the crystal. Data collection at cryogenic temperature can be considered as a 
relatively new method and has become an important tool in crystallography. 
Previously, data collection was carried out at room temperature in which the crystal 
is mounted in thin walled glass capillaries in a small amount of the crystallisation 
solution in order to stop the crystal from drying out. The capillary inner surface is 
carefully but quickly dried, and a few drops of liquid are placed at each end of the 
capillary which is then sealed with a high vacuum wax (Blundell and Johnson, 
1976). Some of the benefits of cryo-data collection can be summarized as follows:
(i) Reducing primary and secondary radiation damage and increasing the 
lifetime of the crystal, hence, enabling the collection of an entire dataset from a 
single crystal.
(ii) Manipulation of smaller, more fragile crystals is permitted due to a reduction 
of mechanical stress on the crystal.
(iii) The low temperatures minimize thermal motion and allow measurements at 
higher resolution. Furthermore the cryo method has brought about the establishment 
of new experimental technique for example; catalytic mechanisms can be deduced 
by solving the structure of enzymes in complex with reaction intermediates. The low 
temperature of data collection slows down the reaction mechanism enough to enable 
a sequence of events or ‘snapshots’ of catalysis to be observed (Garman, 1997; 
Rodgers, 1994).
Nevertheless, cryo-data collection is not ideal. During freezing unfavourable 
changes in the nature of the crystal can be observed. The freezing sometimes alters 
the alignment of each unit cell with its neighbour resulting in an increased amount of 
disorder which is reflected in increased mosaicity in the reflection pattern. Unit cell 
volume also changes at lower temperature causing non-isomorphism between 
crystals and this can be a problem when collecting native and derivative data sets. 
The cryoprotectant may also interact with the protein causing conformational 
changes and may also interfere with ligand binding studies.
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As mentioned before, increasing the lifetime of a crystal during data 
collection is a primary concern for many protein crystallographers and the effort to 
minimize radiation damage has led to the improvement of detector systems. The 
logic is that the quicker the data can be recorded for each orientation of the crystal, 
the less time the crystal will be exposed in the beam, hence, reducing radiation 
damage. Detectors most commonly used at synchrotrons are the charge-coupled 
device or CCD detector. This detector accumulates charge on the pixels of the 
detector where the radiation hits. These charges are systematically passed through 
fibers to an amplifier before reading. The CCD detector has the advantage of 
accurate recording of the position and magnitude of the reflections, which are 
continuously read making data collection fast and accurate.
Once the data collection method has been determined, the crystal must be 
mounted and aligned in the X-ray beam. The crystal is mounted on a goniometer 
which is a device that allows the orientation of the crystal to be set precisely. 
Alignment is usually carried out by rotating the crystal perpendicular to the beam 
and checking whether the crystal is centered in the beam path at 0°, 90°, 180° and 
270° of rotation. Initial orientation of the crystal is usually determined physically. 
Well-formed crystals usually exhibit distinct faces that are parallel to the unit cell 
edges and the initial diffraction pattern should be obtained by placing a crystal face 
perpendicular to the beam. Preliminary examination of the diffraction pattern allows 
determination of the unit cell dimensions and symmetry. The advancement of cryo 
data collection and fast detectors along with the automation of the data processing 
and scaling allows highly redundant, mostly complete datasets to be collected with 
ease from reasonably good crystals. Most data processing packages such as 
HKL2000 (Otwinowski and Minor, 1997) and MOSFLM (Leslie, 2001) allow 
simultaneous data processing with data collection. This provides an advantage as it 
allows immediate assessment of the quality of the data, allowing changes to be made 
to the data collection strategy if necessary. Completeness of datasets for very mosaic 
crystals can be monitored and rapid deterioration of a crystal can be identified 
immediately allowing the crystal to be changed. In the case of high mosaicity, high 
redundancy of the data is needed in order to be able to scale a complete data set.
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Even though the data collection process can be monitored, several factors 
should be taken into account before starting a data collection run. From the initial 
diffraction images, we can predict the exposure time by looking at the strength of the 
diffraction, the crystal to detector distance based on the diffraction limit of the 
crystal, the probable number of images to be collected based on the symmetry of the 
space group and the angle at which the crystal is rotated which depends on the size 
of the unit cell (Dauter, 1997). Hence, theoretically in order to collect most 
reflections for P222 space group, a 90° rotation would suffice. However, more 
images should be collected to achieve good redundancy in order to reduce errors. 
The higher the symmetry, the fewer degrees of rotation and therefore less number of 
images need to be collected in order to obtain a complete data set.
1.5.3 Data processing and scaling
After data collection, the raw intensities must be processed to improve their 
consistency and to maximize the number of measurements that are sufficiently 
accurate to be used. The procedure of processing the data involves the indexing of 
all of the reflections from planes in the chosen unit cell. This is followed by scaling 
of the data so that the backgrounds from different diffraction images match (Leslie, 
2001). There are several software packages that automate this process and the most 
commonly used packages are the HKL package (Otwinowski and Minor, 1997)and 
MOSFLM (Leslie, 2001). The HKL package consists of: (i) DENZO which carries 
out autoindexing, refinement and integration (ii) XdisplayF, which functions to 
visualize each image/diffraction pattern, (iii) SCALEPACK, which is used for data 
scaling. Autoindexing using DENZO involves the determination of the standard 
lattice. A complete search of all possible indices of all reflections is performed. 
When the program finds values (integers) of one index (for example, h) for all 
reflections, this is equivalent to having found one real-space direction of the crystal 
axis (for example, a) and this is carried out by Fast Fourier Transform (FFT). After 
the search for real space vectors is completed, the program finds the three linearly 
independent vectors with minimal determinant (unit cell volume) that would index
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all of the observed peaks and reduces the cell by conversion into a standard cell 
according to the Tables for X-ray Crystallography in the International Union of 
Crystallography, Vol I (Henry and Lonsdale, 1952), which contains an index for 
standard space group and symmetry classification. The space group of choice would 
usually be the one that has highest symmetry with least percentage of distortion and 
processing of the remainder of the data proceeds using the initial estimates as a 
reference. The next step to data processing involves averaging and merging the 
processed data by taking into account the errors which are caused by crystal decay 
and crystal absorption. The program SCALEPACK from the HKL package suite 
functions to serve this purpose. The output of this scaling process is a list of 
reflections with systematic absences characteristic of the space group that had been 
chosen during indexing (.sea file). The quality of the processed and scaled data is 
assessed by three values and can be viewed in the scalepack log file:
(i) Percentage completeness: Higher percentage completeness is favoured as this 
indicates that there is more information held in the processed data.
(ii) Rmerge’ The mean error of an intensity measurement, compared to the mean 
intensity, averaged over the chosen group of reflections (Blow, 2007).
Rmerge (I) = ^ ^ 1 (1 ^ )1 x 1 0 0
£/z 2 /1 hi
Where I/, is the weighted mean measured intensity of the observations I hi in 
which the intensities of the symmetry related reflections are compared, thus 
Rmerge is the measure of the disagreement (L-I/»).
(iii) I/al: ol is the uncertainty in the measurement of the intensity of a reflection. 
The acceptable resolution limit for scaling data is usually where the value of 
I/oI is more than 2.0.
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MOSFLM (Leslie, 2001) consists of a graphical user interface through which the 
process of data processing is carried out and MOSFLM is relatively more 
straightforward than DENZO as it does not use key word input. The end result of 
data processing with MOSFLM is a raw MTZ file of reflection indices with their 
intensities and standard deviations. The MTZ file is then put through the program 
SCALA of CCP4 program package to be scaled and merged. The HKL suite and 
MOSFLM use SCALEPACK and SCALA respectively to perform statistical 
assessment of scaled data.
1.6 Structure factor and the phase problem
1.6.1 Structure factor
The vector (amplitude and phase) which represents the overall scattering from a 
particular set of Bragg planes is termed the structure factor (F). The structure factors 
for the various points on the crystal lattice correspond to the fourier transform of the 
electron density within the unit cell and vice versa(Blundell and Johnson, 1976).
F(h,k,l) = Vjx-o J j= o  L=o p(x,y,z).exp[27ri(hx + ky + lz)] .dxdydz (1)
t t
A reflection Electron density
V represents the volume of the unit cell. It arises because p is a density expressed as 
electron per unit volume, while the structure factor F is normally expressed as 
electrons per unit cell. Three integrations are taken over 0 to 1 in each of x, y, z, in 
order to extend it over the whole unit cell. The phase factor is 27ii(hx + ky + lz)
The inverse fourier transform is,
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All reflections phase
I 1
p(x,y,z) = l/VXh£k£i I F (h,k,[)\ exp-[27ti(hx + ky + lz)- ia(h,k,[) (2)
t t
Electron density Amplitude 
at a point
The goal of a structural analysis is to obtain the distribution of atomic 
electron density in the unit cell (in practice the atomic positions) starting from the 
diffraction data. This is not a straightforward task because the experimental data 
only brings forward the amplitude, but not the phases of the structure factors. Fhid is 
a vector quantity that comprises of the amplitude, |F**/| and its phases, a(h,k,l) as 
shown in equation (1). From this equation, it is known that the frequency of the 
wave and the amplitude of the wave, which is the squared root of the measured 
intensity, Ihid of the reflection with indices hkl. The information which cannot be 
accessed from the experimental data, is the phase or the angle at which the X-ray is 
diffracted. This is known as the ‘phase problem’(Blundell and Johnson, 1976). This 
problem can be solved using several different methods: (i) Molecular replacement 
(MR), by determining the correct orientation and position of a molecule in the unit 
cell using a previously solved structure as a ‘search model’(Rossman, 1972) (ii) 
Isomorphous replacement (IR) provides indirect estimates of the protein phase 
angles by observing the interference effects of the intensities on scattered beams by 
a heavy atom marker (Blundell and Johnson, 1976). (iii) Anomalous scattering in 
which the scattering information of an atom whose absorption frequency is close to 
the wavelength of the source beam produces phase information Multi-wavelength 
anomalous dispersion, requires intensity measurements at several wavelengths, 
while resolved anomalous scattering requires intensity measurements at one 
wavelength (Hendrickson, 1991). Both methods (ii) and (iii) can be used to solve 
novel structures for which there are no homologous structures to be used for 
molecular replacement.
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1.6.2 Molecular replacement
A commonly used approach to solve the phase problem is Molecular Replacement 
(MR). Successful MR depends on the availability of a sufficiently homologous 
model structure. That is, if the structure of a protein (search molecule) is known that 
is homologous to the crystallized protein (target molecule) with unknown structure, 
the former can be used as a model to calculate a starting set of phases that can be 
interactively refined (Giacovazzo, 2002). For that, the search molecule must be 
oriented and positioned in the unit cell of the target molecule in a way that 
maximum overlap of the models calculated diffraction pattern with the observed 
diffraction pattern is achieved. Thus, the related structure (phasing model) is used to 
obtain phase information after orienting the model in the unit cell of the new protein. 
There are two major steps involved in MR, which are rotation and translation. In the 
rotation step, the spatial orientation of the known and unknown molecule with 
respect to each other is determined, while in the next step the translation needed to 
superimpose the now correctly oriented molecule onto the other is calculated (Figure 
1.7). Several factors can affect the success of this procedure. Firstly, the sequence 
identity between the search model and the actual molecule should be high. Secondly 
the quality and completeness of the data should be as high as possible. Other factors 
include the relative size of the search model compared to the unit cell and how the 
agreement between the model and experimental data are assessed.
Several programs for MR are available and they include, AMoRe 
(Automated Molecular Replacement) (Navaza, 1994), MOLREP (Vagin and 
Teplyakov, 1997) and Phaser (Read, 2001; Storoni et al., 2004) which are part of the 
CCP4 program suite(CCP4, 1994). Nevertheless finding the solutions to rotation and 
translation functions is not always a straightforward matter. In some cases it is 
necessary to modify the model, for instance, by ignoring the side chains and 
deletions/insertions in the model and by systematically varying the resolution range 
of the X-ray data used in the search. With the increasing number of protein structure 
determinations, MR has become an increasingly popular technique for protein phase 
angle determination.
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If more than one molecule is present in the asymmetric unit, molecular 
replacement would have to be repeated for each o f the molecules. The knowledge of 
the number o f molecules in the asymmetric unit can be determined from the 
Matthews coefficient (Matthews, 1968) which from the size o f  the protein and the 
unit cell estimates the solvent content o f the crystal for different numbers o f 
molecules in the unit cell. These solvent contents are then compared to the average 






Figure 1.7: A schematic illustration of the molecular replacement method. The search 
molecule is represented by the figure in red. The target molecule is represented in green
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1.6.3 Isomorphous replacement and anomalous scattering (Perutz, 1956).
The Isomorphous replacement method utilizes phase information from the 
comparison of structure factors from native and derivative crystals soaked in heavy 
metals. Because atoms contribute most strongly to structure factors from planes 
which intersect their positions, the uniform addition of heavy atoms, which have 
larger scattering factors, at certain points in the unit cell gives rise to an increase in 
the amplitude of those structure factors. If the native and the derivative crystals are 
isomorphous the resulting intensities can be compared to the native intensities to 
retrieve phase information for these atoms. This phase information can then be 
placed in the unit cell so that a rough framework for the model to be built into can be 
made. To determine the phases as accurately as possible, several derivatives are 
often necessary, requiring the production of many isomorphous derivative crystals. 
Anomalous scattering utilizes the absorption of X-rays by heavy atoms to derive 
information about phases (Hendrickson, 1991). All diffraction patterns are 
centrosymmetric as diffraction from each plane gives reflection, hkl and -h-k-l 
which are equal in intensity. This is known as Friedel’s law. All atoms absorb 
radiation at specific wavelengths which correspond to the required energy for 
electron excitation. For certain heavy atoms, these wavelengths correspond to X-ray 
wavelengths suitable for crystallography. If the X-rays used are tuned to this 
absorption edge, the absorption of the radiation results in an observable breakdown 
in Friedel’s law known as anomalous scattering, which can be used to retrieve phase 
information for these atoms. This technique has an advantage over isomorphous 
replacement methods as non-isomorphism of heavy atom soaks can be avoided by 
recording both native (at low absorbing wavelength) and anomalous datasets from 
the same crystal. Another advantage is with the option of using selenium that has an 
absorption edge of 0.98 A, which can be incorporated during expression of the 
protein. Bacterial cultures that are grown in seleno-methionine media can be used to 
produce recombinant protein with methionine uniformly replaced with seleno­
methionine, hence preventing the need for crystal soaking.
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The use of a combination of both these methods to estimate phases is also becoming 
increasingly common. Phase information from the increased scattering factor and the 
anomalous scattering of heavy atoms can be combined in a technique referred to as 
Single Isomorphous Replacement with Anomalous Scattering (SIRAS).
1.7 Model building, crystallographic refinement, structure validation, 
structure analysis and deposition
1.7.1 Model building
When a rotation and translation operation for MR, or the heavy atom positions have 
been found, the model phases can now be incorporated with the observed amplitudes 
from the diffraction pattern and the structure factors can then be refined against the 
model structure. If the model phases are correct, the R-factor which is the ratio of 
the difference between computed amplitudes for the model and the observed 
amplitudes should decrease. These structure factors can then be used to calculate an 
initial map which if the phase information is good enough should be interpretable. 
Crystallographic refinement is carried out in a cyclic process of gradual 
improvement of the model. During the refinement process the model is changed 
during model building at the graphics display in such a way that the structure factors 
calculated from the built model get closer to the observed amplitudes. Iterative 
cycles of refinement optimize the atomic model, allow for improved phases and thus 
help compute electron density maps (refer to equation (2), page 21) that show finer 
details of the molecular structure. The cyclic process of model building and 
refinement is usually repeated until ultimately a model which represents the 
observed data as closely as possible is generated.
Model building requires a certain degree of map interpretation skills. The 
electron density equation generates values for electron density for each point, 
p(x,y,z), in the unit cell, from the structure factors. These figures are then displayed 
as three dimensional contour maps on a graphic computer interface using programs 
such as 0(Jones et al., 1991) or COOT(Emsley, 2004). In order not to bias the map
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to the model structure-factor amplitudes, these are usually subtracted from a multiple 
of the observed amplitudes for example; a 2F0-FC map is the sum of twice the 
observed structure factor amplitudes, minus calculated amplitudes, multiplied by the 
phase term. This map is used to represent the positive continuous density of the 
model while F0-Fc maps are generated in order to provide positive peaks which, 
indicates that there is something in the data which is lacking in the model and it 
usually helps in identifying solvent molecule as well as ligands and ions that are 
either an integral part of the macromolecule or have been incorporated into the 
crystal lattice from the crystallisation buffer. Negative peaks in FoFc maps which 
indicate there is something in the model which is not present in the data. The 
respective maps are usually contoured to a set sigma level for viewing in the 
graphics although local adjustment of these levels is often necessary to assist in map 
interpretation. The quality of the map depends on the accuracy or inaccuracy of the 
phases and is also dependent on the resolution.
1.7.2 Refinement
As mentioned before, between rounds of model building, refinement is also carried 
out in order to improve the model. In general, refinement can be described as the 
optimization of a function, to find the global minimum, by changing the parameters 
of the model. The model parameters include the position, occupancy and thermal 
factors (B-factors) of the atoms. The algorithm used for refinement varies between 
refinement programs. There are several programs that are available for molecular 
refinement purposes. SHELX (Sheldrick et a l , 1993) utilizes the least squares (LS) 
function which minimise the sum of the weighted (Murshudov et a l, 
1997)difference between two sets of observations (the observed and the calculated 
amplitudes). An alternative to the least square algorithm is the Maximum likelihood 
(ML) function which is incorporated in REFMAC (Murshudov et al., 1997) and 
CNS (Brunger et al., 1998). The ML function finds the set of parameters which are 
the most probable to produce the experimental results seen. Another method which
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is also incorporated in CNS is energy minimization for which the target is the model 
with the lowest calculated energy.
In order to avoid model bias and entrapment in local minima, it is often 
advisable to initially start refinement at a lower resolution and then subsequently 
increase the resolution in one or more steps. This ensures that the gross features of 
the model are corrected first and the wrongly assigned details do not bias the model. 
Using restraints and constraints in refinement is also important especially at lower 
resolution. Adding restraints increases the observations to parameter ratio hence, a 
good technique is to restrain the geometry of the protein tightly so as the phases 
could become more accurate as distortions in local geometry cannot be assigned 
without good phases. Restraining of non-crystallographic symmetry partners 
together is also of particular use as it enables the averaging out of noise in the 
phases. Initial refinement is usually rigid body refinement in which the protein is 
refined as a whole followed by optimization of atom positions. If the data are of 
reasonably high resolution (better than 3 A), individual water molecule positions and 
protein atoms B factors can also be refined. B-factors are atomic displacement 
factors and are very closely associated with atomic coordinates of the model. B- 
factors represent the distribution of positions occupied by an atom over a period of 
time (dynamic disorder) as well as variations in the position of an atom between 
different unit cells (static disorder). Large B-factor values are usually indicative of 
errors in the model coordinates.
1.7.3 Structure validation
The measure of the success of a refinement process can be assessed by several 
means:
(i) R-factor: The primary measure of a refining structure is given by the 
residual index or the R-factor. As the model improves, the measured 
Structure Factors (F0) and the calculated (Fc) begin to converge and the 
value of the R-factor drops:
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R ^  = SIIFJ-|FJ|
S|F„|
Fo is derived from the measured reflection intensity and Fc is the corresponding 
structure factor obtained from the current model. This conventional parameter is 
known as the crystallographic reliability index (R^O-
(ii) Rfree: R ^e was first developed by Brunger and co-workers in 1997. 
Ryree(Brunger et al., 1998) is a more objective indicator of of model 
quality than Rcryst- Rfree is calculated as the Rcryst but for a randomly 
selected percentage of reflections known as the test set which are not 
used in the refinement. This acts as a cross validation tool to check that 
the refinement is not biasing the model away from the data
(iii) Ramachandran plot (Ramachandran et al., 1963): The plot
highlights the stereochemistry, conformation (planarity of the peptide 
bonds, bond lengths, bond angles etc.) and the backbone conformation 
angles (O,^) of the current model based on the expected values for 
simple organic molecules. The program PROCHECK (CCP4, 1994) is 
a useful program which can assist in the assessment of the quality of 
the structure at various stages of refinement.
(iv) Root mean square deviation (r.m.s.d): r.m.s.d value is another 
statistical method that helps assess the quality of a structure. The value 
measures the deviation from ideal geometry and a low value reflects on 
the success of refinement. Well refined structures would have a value 
between 0.005-0.010.
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1.7.4 Structure analysis and PDB deposition
Once the structure is complete, the next step is to deposit the coordinates with the 
Protein Data Bank (PDB) at either European Bioinformatics Institute (EBI; 
http://www.ebi.ac.uk/) or with the Research Collaboratory for Structural 
Bioinformatics (RCSB; http://www.rcsb.org/). The PDB helps in providing access to 
structural information (for proteins, nucleic acids, ligands and other biological 
macromolecules) to scientists all over the world. Studying the three-dimensional 
structure of a protein can bring insight into the functional aspects of the protein. 
Therefore, analytical observations should be carried out on the structural data 
obtained. The structure of a refined model does not only reveal the detailed 
architecture of the polypeptide chain folds but also gives an insight into how 
proteins evolved, the basis on which they interact with each other and how they bind 
with other molecules. Several programs are available to analyse structures and some 
of these are DSSP (Kabsch and Sander, 1983) which functions to assign secondary 
structure elements in the structure, CONTACT (CCP4, 1994) which is useful for 
analyzing hydrogen-bonding interactions, SC (CCP4, 1994) for analysis of the shape 
complimentarity between accessible area in a protein structure, CAVENV (CCP4, 
1994) to visualize cavities in the protein structure and PROSA (Sippl, 1993) which 








The study of the biosynthesis of complex carbohydrates and polysaccharides is 
becoming increasingly popular in the field of glycobiology. This is largely due to the 
important roles that complex carbohydrates play in cellular systems. These 
molecules govern a diverse range of cellular functions, including energy storage, cell 
wall structure, cell-cell interactions and signalling, host-pathogen interactions, and 
protein glycosylation (Bertozzi and Kiessling, 2001; Cautinho et al., 2003; Rudd, 
2001; Wells, 2001). In these functions especially where these carbohydrates act as a 
cellular language, they rely on the precise carbohydrate structures which display 
large chemical diversity. The biosynthesis of these carbohydrates may involve the 
action of a wide range of different and selective glycosyltransferases, enzymes 
which function to transfer sugar moieties from activated donor substrates to specific 
acceptor substrates. Even though many glycosyltransferases (GTs) catalyse 
chemically similar reactions, they display remarkable diversity in their donor, 
acceptor and product specificity hence, are able to generate a potentially infinite 
number of glycoconjugates, oligo- and polysaccharides.
Transfer of the sugar residue occurs with either the retention or the inversion 
of the configuration of the anomeric carbon (Figure 2.0) (Breton et al., 2006). These 
enzymes can be found in both eukaryotes and prokaryotes and in eukaryotes, most of 
the glycosylation reactions occur in the Golgi apparatus. These eukaryotic GTs 
(Gibson et al., 2002) belong to the type-II transmembrane proteins which have a 
large C-terminal globular catalytic domain facing the luminal side. The recent 
elucidation of several crystal structures of GTs, have brought about greater 
understanding of the molecular basis of mechanism and specificity for these 
enzymes creating tremendous possibility for inhibitor studies and facilitating the 
engineering of new catalysts for the enzymatic synthesis of natural and novel 
glycoconjugates for therapeutic purpose. Glycosyltransferases using nucleotide 
diphospho-sugars, nucleotide monophosphate sugars, sugar phosphates and related 
proteins are classified into families based on the amino-acid sequence similarities 
developed by Coutinho (Coutinho et al., 2003a). At the time of writing (May 2007),
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the Carbohydrate Active Enzymes (CAZy) database (http://afmb.cnrs-mrs.fr/CAZY) 
comprises more than 89 families of GTs. Large differences are observed in the 
number and function of families of GTs. Several families comprise of a huge 
number of sequences from various sources with diverse functions. This is best 
illustrated by the family 2 GT which contains more than 3000 sequences originating 
from various species of animal, plant, yeast and bacteria and for which 12 distinct 
functions have already been identified. Some of the members of this family include 
cellulose synthase, chitin synthase, mannosyltransferase, glucosyltransferase and 
galactosyltransferase. In the case of the polyspecific GT such as those from family 
GT2 and GT4, sequence similarities are restricted to only a portion of the catalytic 
domain while the monospecific family GT will generally display sequence similarity 
for the whole catalytic domain.
Inversion
Figure 2.0: Glycosyltransferases use sugar donors which typically have an activating group 
(substituted) phosphate such as a nucleotide (R=nucleoside monophosphate) or lipid 
phosphate (R=lipid). The acceptor is shown as R’OH where R can be varied, i.e, a sugar, 
lipid, protein, antibiotic or nucleic acid. Catalysis may occur with two possible outcomes; 
inversion or retention of the anomeric configuration of the donor (Coutinho et al., 2003b).
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These enzymes also display a range of diversity in their catalytic activity 
despite having remarkably high sequence identity or similarity making it difficult to 
predict the function of a putative GT of sequence similarity. This is reflected in the 
study of the A and B blood group enzymes, which showed different donor substrate 
specificity [A transferase, UDP-N-acetylgalactosamine (UDP-GalNAc) and B 
transferase, UDP-galactose (UDP-gal)] despite differing by only four amino acids 
(Yamamoto et al., 1990). The classification system which is currently being used for 
GT is based on sequence similarities, however this mode of classification may not 
apply to all GT families as distant similarities between inverting and retaining 
families have been identified which suggests that these families may share a 
common ancestor (Franco and Rigden, 2003; Liu and Mushegian, 2003). The recent 
elucidation of the crystal structure of mannosylglycerate synthase (MGS) from 
Rhodobacter marinus showed that although at the sequence level the protein showed 
similarity to the GT2 family, it is a retaining enzyme that has been classified into a 
new family (GT78) (Flint et al., 2005). This shows that the mechanism of GT cannot 
be predicted with reliability based on sequence similarities alone; hence the 
classification system should also integrate both structural and mechanistic features 
within each family.
The elucidation of the crystal structures of GT enzymes is slowed down by 
the difficulties in high-level expression, purification and crystallisation, however, 
even with this major hampering factor, more than 100 crystal structures representing 
39 different GT enzymes from both prokaryotes and eukaryotes have been 
elucidated thus far (Table 2.0). GT structures have been generally observed to adopt 
a a/p/a sandwich (Figure 2.1) which is very closely similar to the Rossman-type fold 
found in many nucleotide binding proteins (Lesk, 1995). Originally GTs could be 
structurally divided into 2 superfamilies, named GT-A and GT-B which were first 
observed in the SpsA and p-glucosyltransferase (BGT) structures (Chamock and 
Davies, 1999b; Vrielink et a l , 1994). The general characteristics of a GT-A 
structure comprises of a/p proteins with a single Rossman domain, conserved 
‘DXD’ motif and a conical active site cleft formed by two associated domains 
(Chamock and Davies, 1999a; Persson et a l , 2001; Unligil et a l , 2000) while the
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GT-B group consists of two Rossmann domains separated by a deep substrate- 
binding cleft (Gibson et al., 2002; Ha et al., 2000; Vrielink et a l, 1994). Recently, a 
novel fold which is closely similar to the GT-A fold but with some differences has 
been reported for the bacterial sialyltransferase (Cstll) which belongs to family 
GT42 (Chiu et a l, 2004) (Figure 2.1). This particular structure exhibits a single 
Rossman domain hence falls under the GT-A superfamily, however, marked 
differences from other member of the GT-A family are also noted in terms of the 
connectivity of the secondary structural elements and the absence of the conserved 
DXD motif. The GT-A and GT-B fold are not exclusively found only in GTs but 
they can also be found in non-GT enzymes such as nucleotidyltransferases and sugar 
epimerases. This chapter will discuss in further detail the structural classification of 










Phage T4 p-Glucosyltransferase BGT GT63 GT-B (Vrielink et a l ,  1994)
Phage T4 a-Glucosyltransferase AGT GT72 GT-B (Lariviere et al., 2005)
Prokaryotes
Agrobacterium tumefaciens Glycogen synthase I AtGS GT5 GT-B (Buschiazzo et al., 2004)
Amycolatopsis orientalis P-Epi-vancosaminyltransferase GtfA GT1 GT-B (Mulichak et al., 2003)
P-Glucosyltransferase GtfB GT1 GT-B (Mulichak et al., 2001)
P-Vancosaminyltransferase GtfD GT1 GT-B (Mulichak et al., 2004)
Bacillus subtilis Putative glycosyltransferase SpsA GT2 GT-A (Chamock and Davies, 
1999b)
Campylobacter jejuni a-2,3/2,8-Sialyltransferase Cstll GT42 Novel, similar 
to GT-A
(Chiu et al., 2004)
Escherichia coli P-l,4-GlcNAc transferase MurG GT28 GT-B (Ha et al., 2000)
Trehalose-6-phosphate synthase OtsA GT20 GT-B (Gibson et al., 2002)
Heptosyltransferase II RfaF GT9 GT-B PDB code: 1PSW
Neissseria meningitidis a-1,4-Galactosyltransferase LgtC GT8 GT-A (Persson et al., 2001)
Rhodothermus marinus Mannosylglycerate synthase MGS GT78 GT-A (Flint et a l ,  2005)
Streptomyces antibioticus UDP-Glucosyltransferase Olel/OleD GT1 GT-B (Bolam et al., 2007)
Pyrococcus abyssi glycogen synthase PaGS GT5 GT-B (Horcajada et al., 2006)
Clostridium difficile a-Glucosyltransferase Toxin B GT44 GT-A (Reinert et al., 2005)
Mycobacterium smegmatis Phosphatidylinositol Mannosyltransferase PimA GT4 GT-B (Guerin, 2007)
Streptococcus pneumoniae penicillin-binding protein IB Pbplb GT51 GT-A (Lovering et a l ,  2006)
Aquifex Aeolicus Peptidoglycan glycosyltransferase MrcA GT51 GT-A (Yuan etal., 2007)
Pasteurella multocida a-2,3-sialyltransferase PmSTl GT80 GT-B (Ni et al., 2006)
Streptomyces viridochromogenes Eurekanate-attachment enzyme AviGT4 GT4 GT-B (Martinez-Fleites et al., 
2006)
Eukaryotes
Yeast a-1,2-Mannosyltransferase Kre2p/MntlP GT15 GT-A (Lobsanov et al., 2004)




GT27 GT-A (Fritz et al., 2004)
P-l,3-N-Acetylglucosaminyltransferase GT31 GT-A (Jinek et a l ,  2006)
P-1,6-N-acetylglucosaminyltransferase C2GNT GT14 GT-A (Pak et a l ,  2006)
Rabbit a-Glucosyltransferase Glycogenin GT8 GT-A (Gibbons et al., 2002)
P-l,2-GlcNAc transferase I GnTI GT13 GT-A (Unligil et al., 2000)
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Mgatl GT13 GT-A (Gordon et al., 2006)
Bovine a-1,3-Galactosyltransferase a3GT GT6 GT-A (Gastinel et al., 2001)
P-l,4-Galactosyltransferase I P4Gal TI GT7 GT-A (Gastinel et al., 1999)
Human P-1,3-Glucuronyltransferase GlcAT-I GT43 GT-A (Pedersen et al., 2000)
P-l ,3-Glucuronyltransferase GlcAT-P GT43 GT-A (Kakuda et al., 2004)
a-l,3-GalNAc transferase A GTA GT6 GT-A (Patenaude et al., 2002)
a-l,3-Galactosyltransferase B GTB GT6 GT-A (Patenaude et al., 2002)
P-l ,4-Galactosyltransferase B4Gal-Tl GT7 GT-A (Ramakrishnan et al., 
2006)
Vitis vinifera Anthocyanidin-3-O-Glc transferase VvGTl GT1 GT-B (Offen et al., 2006)
Medicago truncatula P-Glucosyltransferase UGT71G1 GT1 GT-B (Shao et al., 2005)
Table 1: A list of crystal structures of different types of glycosyltransferases. All data are available from the 3D-Glycosyltransferase database 
(http://www.cermav.cnrs.ff/glvco3dA. Table adapted from (Breton et al, 2006)
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2.1.1 Structural classification of Glycosyltransferase
As previously mentioned, the GT-A fold resembles a Rossmann fold consisting of 
an a/p/a sandwich where the P-sheet is a seven stranded P-strand with strand 6 
running antiparallel to the rest. This central P-sheet is flanked by a smaller P-sheet 
which forms the active site of the enzyme. Another general feature of the GT-A 
enzymes is that they possess a common motif, the DXD motif which is associated 
with their dependence on a divalent cation for catalytic activity (Breton et al., 1998; 
Breton and Imberty, 1999; Breton et al., 2006). In the structures of GTs belonging to 
the GT-A family, this DXD motif has been shown to interact with the diphosphate 
region of the nucleotide donor through the coordination of a divalent metal cation, 
which in most cases is Manganese. The two aspartate amino acids in the DXD motif 
are not always conserved across the GT-A family but this particular motif or its 
variants can always be identified at the same location, in a short loop connecting the 
central P-sheet of the a/p/a sandwich to a smaller p-sheet (Figure 2.1 A). There are 
two regions which are structurally well conserved in all members of the GT-A 
family, including both inverting and retaining enzymes, which suggests that 
common structural elements are necessary for the glycosyl transfer reaction, 
irrespective of the stereochemistry of the reaction. The first region corresponds to 
the Rossmann-type nucleotide binding domain encompassing the first 100-120 
residues and terminating at the DXD motif. The key amino acids which interact with 
UDP are mainly located between pi to p5 strands. In some crystal structures, 
residues in the C-terminal region were also shown to make interactions with UDP 
(Boix et al., 2001) (Figure 2.3). Differences are also observed in the function of the 
DXD motif residues in retaining and inverting enzymes. In the retaining enzymes, 
the two aspartate residues can interact with the manganese ion, whereas only the last 
aspartate interacts with the metal cation in inverting enzymes (Breton et al., 2006; 
Persson et al., 2001; Tarbouriech et al., 2001). In both cases the DXD motif plays a 
crucial part in donor nucleotide binding by mediating the correct coordinating 
interactions for optimal binding of the donor molecule. The second structurally 
conserved region is the P-a-a region which has been shown in many crystal
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structures of GTs to interact with both the donor sugar and the sugar acceptor (Boix 
et a l , 2002; Breton et a l , 2006; Persson et al., 2001). Despite the similarity of their 
spatial folds, GT-A and GT-B enzymes appear to be unrelated. Both families have 
members in the three domains of life and in addition, some bifunctional enzymes are 





Figure 2.1: Structural representatives of the 3 different folds displayed by GTs thus far. 
Bound nucleotide is shown as sticks while manganese ion when present is shown as a 
sphere. (A) GT-A fold, mouse a-l,4-A-acetylhexosaminyltransferase (EXTL2) complexed 
with UDP-GalNAc. The conserved DXD motif is highlighted in green (PDB code: lOMZ) 
(Pedersen et a l ,  2003). (B) GT-B fold, Escherichia coli MurG complexed with UDP- 
GlcNAc (PDB code: 1NLM) (Hu et al., 2003). (C) Campylobacter jejuni sialytransferase 
Cstll complexed with cytidine monophospho 3-fluoro N-acetyl neuraminic acid (CMP- 


















































Figure 2.2: The hierarchical classification of glycosyltransferases from folds to clans, families and subfamilies, illustrated for some 
of the glycosyltransferases with a reported 3-D structure. SpsA, Bacillus subtilis glycosyltransferase (Chamock and Davies, 1999b) 
PGalT, bovine p-l,4 galactosyltransferase (Gastinel et al, 1999) pGlcNAcT, rabbit p-l,2-N-acetylglucosaminyltransferase I (Unligil 
et al., 2000)pGlcUAT, human p-l,3 glucuronyltransferase (Pedersen et al., 2000) aGalT, bovine a-l,3-galactosyltransferase 
(Gastinel et a l, 2001) LgtC, Neisseria meningitides a-galactosyltransferase (Persson et a l, 2001)glycogenin, rabbit glycogenin 
(Gibbons et al, 2002)GtfB, Amycolatopsis orientalis p-glucosyltransferase (Mulichak et al, 2001) MurG, Escherichia coli p-N 
acetylglucosaminyltransferase (Ha et al, 2000) T4-BGT, bacteriophage T4 DNA P-glucosyltransferase (Vrielink et al, 1994) 
glycogen phosphorylase, rabbit glycogen phosphorylase (Goldsmith et al, 1989) OtsA, E. coli trehalose-6-phosphate synthase 
(Gibson et al, 2002). Adapted from (Coutinho et al, 2003a).
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Figure 2.3: Typical GT-A fold shown here by the crystal structure of bovine a -1,3 
galactosyltransferase (a3GT) in complex with manganese ion and UDP. The bound ligand 
and ion identify the location of the active site. The manganese ion is shown as a purple 
sphere, UDP is in white, and helices are pink, while the strands are green [Adapted from 
(Boix et al., 2001)].
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Figure 2.4: The amino acid sequence of the catalytic domain of a3GT with all secondary 
structure elements highlighted. UDP binding residues are marked in yellow, while the 
manganese binding residues are shown by closed magenta spheres. [Adapted from (Boix et 
a l, 2001)]
A novel fold family has recently been reported with the determination o f  the 
crystal structure o f  sialyltransferase (Cstll) from Campylobacter jejuni (Chiu et al., 
2004). Although this enzyme showed structural similarities to the GT-A type fold it 
also displayed several differences as it has a different type o f  a /p /a  sandwich (a 
seven stranded parallel P-sheet) and does not have a DXD motif.
43
Chapter 2 Glycosyltransferases
2.1.2 Conformational dynamics of glycosyltransferases
The elucidation of several crystal structures of GTs in complex with substrates or 
analogues have shown that these enzymes undergo large conformational movements 
during the catalytic reaction of which a major part occurs due to the binding of the 
respective donor and acceptor sugars. The ratio of loops to secondary elements is 
high in GTs and many of the crystal structures which have been solved thus far do 
not describe the entire catalytic domain because some of the loops present in the 
enzyme are highly flexible and do not present distinct electron density. In GT, these 
flexible loops appear to play an important role in substrate binding as there have 
been demonstrations in some of these enzymes of an ordered binding of donor and 
acceptor substrates linked to a donor substrate conformational change (Boix et al., 
2002; Boix et al., 2001; Ramakrishnan and Qasba, 2002). In several of these 
structures, a disordered loop or the C-terminal region becomes ordered on binding of 
the nucleotide donor to create a lid which is folded over the donor substrate making 
direct contacts with the diphosphate region of the donor nucleotide. This 
conformational change results in the formation of a closed active site pocket that 
will serve as a binding site for the acceptor molecule. The structure of rabbit p-1,2- 
TV-acetylglucosaminyltransferase I (GnT I) contains a 13-residue internal stretch that 
undergoes loop ordering upon binding of the donor nucleotide, UDP-7V- 
acetylglucosamine (Unligil et al., 2000). This conformational change was postulated 
to result in the formation of one side of a pocket surrounding the active site, 
permitting catalysis to occur. The p-glucosyltransferase from the T4 phage is another 
enzyme which displays ordering of a disordered loop upon binding of a donor 
substrate. This enzyme in its resting state has two disordered loops in its N-terminal 
domain; however in the presence of UDP-glucose donor, both these loops become 
ordered (Vrielink et al., 1994) and similarly, the structure of LgtC
galactosyltransferase from Neisseria meningitidis also shows two loops that undergo 
stabilisation on binding of donor galactose. The stabilised loops were shown to form 
several intramolecular van der Waals contacts with the donor molecule (Persson et 
al., 2001). A series of amino acids in p-l,4-galactosyltransferase (p4Gal-Tl)
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undergoes a conformational change upon binding of the donor substrate (Gastinel et 
al., 1999; Ramakrishnan and Qasba, 2001). In the absence of a-Lactalbumin (LA), 
p4Gal-T transfers galactose to N-acetylglucosamine but in the presence of LA the 
acceptor specificity is changed to glucose. This combination of |34Gal-T and LA is 
called lactose synthase (LS). |34Gal-T on its own has a short loop of 8 amino acids 
but in presence of LA, a much larger loop of 21 amino acids that incorporates the 
smaller 8 amino acids loop is formed. The binding of the donor molecule to this LS 
complex results in the reorientation of the 21 amino acid loop such that 14 amino 
acids adopt a loop configuration whereas the remaining 7 residues form an a-helix 
(Yazer and Palcic, 2005). This results in the movement of His347 into position to 
coordinate with manganese and covers the bound substrate for catalysis to take place 
(Ramakrishnan and Qasba, 2001; Yazer and Palcic, 2005). This conformational 
change is thought to prevent water molecules from acting as an acceptor for sugar 
transfer hence, minimising hydrolysis of the energetically precious nucleotide sugar. 
The mouse p-l,3-N-acetylglucosaminyltransferase structure in complex with UDP 
showed disorder in two loop regions and based on mutational studies, one of the 
longer loop residues was predicted to be the putative site for acceptor molecule 
binding (Jinek et al., 2006). However, the human glycosyltransferases, GTA and 
GTB do not display reordering of their 26 amino acids disordered loop upon binding 
of their respective donor molecules, suggesting that these residues might already be 
in a catalytically active position independent of the binding of the donor or else are 
not involved in determining donor or acceptor specificity (Patenaude et al., 2002; 
Yazer and Palcic, 2005). Mutational studies of residues on the flexible loops of GTs 
serve to strengthen the hypothesis that these loops may play a part in catalysis or at 
the very least in the binding of both donor and acceptor molecules. A point mutation 
of Gly320Asp which is located on a disordered loop in the GnT 1 rendered the 
enzyme completely inactive (Unligil et al., 2000) while mutation of Arg365 on the 
C-terminus of a3GT to Lysine significantly decreased the catalytic activity of the 
enzyme by possibly compromising the stability of the transition state in the reaction 
(Boix et al., 2001). In addition, affinity studies using titration microcalorimetry on 
LgtC (GT8) demonstrated that the open state (free enzyme) has very little affinity
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for the oligosaccharide acceptor. Since both inverting and retaining 
glycosyltransferases undergo conformational changes during catalysis (Boix et a l , 
2002; Boix et al., 2001; Ramakrishnan and Qasba, 2001), there is an increasing 
interest towards the study of conformational dynamics in these enzymes both by 
structural means and also by means of molecular dynamic simulations (Gunasekaran 
and Nussinov, 2004; Snajdrova et a l , 2004).
2.1.3 Mechanism of glycosyltransferase
A specific feature of GTs is that they use an activated donor that can either be a 
nucleoside diphosphosugar, nucleoside monophosphosugar or lipid phosphosugar. 
Mechanistically, GTs can be divided into two groups, the inverting GTs and the 
retaining GTs. During GT catalysis, two stereochemical outcomes are possible for 
the hydrolysis of a glycosidic bond: the anomeric configuration of the product can 
either be retained or inverted with respect to the starting material. The mechanism 
for inverting GTs is believed to be similar to that of inverting glycosylhydrolases 
with the requirement of one acidic amino acid that activates the acceptor hydroxyl 
by deprotonation (Figure 2.5a). All structural data so far lend support to the Sn2 
mechanism first proposed by Murray et al for a3-FucT (Murray et al., 1996). 
Inverting GTs which have the GT-A fold use a divalent cation, generally manganese 
in catalysis where this ion plays a role of acid catalyst and also initiates a sequential 
ordered mechanism, in which nucleotide sugar binding is followed by restructuring 
of a loop region to form a closed active site hence, creating the binding site for the 
acceptor molecule (Boix et a l , 2002; Ramakrishnan et a l , 2004). GTs which 
possess the GT-B fold on the other hand do not need a divalent metal cation for their 
catalysis. T4 phage BGT which transfers glucose to modified DNA also uses an Sn2 
mechanism with the participation of one acidic amino acid from the protein 
(Lariviere et a l, 2005).
Thus far, the mechanism of retaining GTs has yet to be established. Direct 
comparison with glycosylhydrolases would suggest a double displacement 
mechanism which involves the formation of a short-lived glycosyl-enzyme
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intermediate (Figure 2.5b). If this mechanism is to take place, it demands the 
existence of an appropriately positioned nucleophile within the active site. As in the 
inverting enzyme mechanism, a divalent metal cation will play the role of a Lewis 
acid , with the leaving diphosphate group itself playing the role of a general base 
and activating the incoming acceptor hydroxyl group for nucleophilic attack 
(Lairson and Withers, 2004). Enzymatic characterisation of this class of enzyme has 
been a long and daunting task. Conclusive identification of a catalytic nucleophile 
and the observation of a covalent intermediate have yet to be reported for any 
retaining transferases. Despite numerous attempts on a variety of retaining GTs, the 
sole evidence for an intermediate formation was seen in the structure of a mutant a- 
1,4-Galactosyltransferase (Lairson et al., 2004). However, the result observed from 
this structure is quite confusing as the intermediate formation involved an amino 
acid located rather far, about 9 A away from the reaction centre of the enzyme. In 
the absence of any conclusive evidence to support the double displacement theory, 
an alternative mechanism for these retaining GTs has been put forth. This new 
proposed mechanism suggests that a direct attack by the acceptor takes place, as 
previously proposed for glycogen phosphorylase (Klein et al., 1986). This new 
mechanism termed Sni mechanism was first proposed by Persson et al. (2001) for 
bacterial LgtC. Retaining GTs which possess a GT-B fold that have distant structural 
similarities with glycogen phosphorylases, have been proposed to adopt the same 
mechanism (Gibson et al., 2002).
A common feature in all retaining GTs is that the nucleotide sugar adopts a 
distorted folded conformation in which the pyranose ring of the sugar is folded 
below the plane of the diphosphate moiety of the nucleotide. This conformation is 
thought to facilitate hydrolysis of the sugar at the Cl position and promote the 
transfer of the sugar to the acceptor molecule. This can be achieved by several 
means: the Cl carbon is spatially accessible for the reaction, the folded orientation 
causes stress and weakens the anomeric bond at the Cl position hence making it 
more vulnerable to nucleophilic attack and a hydrogen bond can be established 




2.1.4 Family 6 Glycosyltransferases: a-l,3-Galactosyltransferase and 
Forssman synthase
All the enzymes that are involved in the biosynthesis of the Gal(NAc)al- 
3Gal(NAc)-containing antigens display strong amino acid sequence similarities 
(Figure 2.6), suggesting a common goal and all belong to the same family, GT6, 
according to the classification in the CAZy database (Heissigerova et a l , 2003). 
Enzymes belonging to this a3-Gal(NAc)T family all share the same features. They 
all utilise a UDP-nucleotide sugar as donor, retain the configuration of the Gal (or 
GalNAc) transferred, and their catalytic activity is strictly dependent upon the 
presence of a divalent cation (generally manganese) (Heissigerova et al., 2003). 
These enzymes differ by their specificity: a-Galactosyltransferase (a3GT), blood 
group B transferase and iGb3-S only use UDP-Gal as donor, while blood group A 
transferase and Forssman synthase (FS) use UDP-GalNAc. In addition to this the 
mouse AB glycosyltransferase can transfer sugar from both donors (Heissigerova et 
al, 2003; Yamamoto et a l, 2001). The sequence and structural basis for Gal versus 
GalNAc specificity has been well reported for the blood group A and B transferases, 
which differ by only 4 amino acids (Persson et a l, 2007; Yamamoto and McNeill, 
1996). However, there is limited information on the basis for acceptor substrate 
specificity in which a3GT and iGb3-S utilise N-acetyllactosamine and lactose 
respectively while blood group enzymes require substitution by a L-fucose on 
position 2 of the acceptor galactose, whereas FS requires a N-acetyl group at the 
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Figure 2.5: Established and proposed mechanisms for glycosidases/transglycosidases and 
glycosyltransferases, respectively. For glycosidases, R = a carbohydrate derivative and 
R’OH = H20  or phosphate (phosphorylases classified as glycosidases). For
transglycosidases, R=a carbohydrate derivative and R’OH = another sugar. For 
glycosyltransferases, R = a nucleoside diphosphate (e.g. UDP, GDP), a lipid phosphate, or 
phosphate (phosphorylases classified as glycosyltransferases) and R’OH = an acceptor 
group (e.g. another sugar or a protein), (a) A direct displacement SN2-like reaction results in 
inverted anomeric configuration via a single oxocarbenium ion-like transition state, (b) The 
double displacement mechanism proceeds via two oxocarbenium ion-like transition states 
with the intermediate formation of a discrete covalently bound glycosyl-enzyme species, 
resulting in overall retention of anomeric configuration, (c) SNi-like mechanism proposed 
for retaining glycosyltransferases and glycogen phosphorylase involving a direct frontside 
displacement resulting in retention of anomeric configuration. (Lairson and Withers, 2004).
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Enzyme Donor Acceptor Product
a3GT UDP-Gal PGall,4pGlcNAc-R aGall,3 pGall,4pGlcNAc-R
GTB UDP-Gal aFuc 1,2pGal 1,4pGlcN Ac-R aGal 1,3 [aFucl,2]pGal 1,4pGlcNAc-R
iGb3-S UDP-Gal PGal 1,4pGlcP-ceramide aGall,3 PGall,4pGlcP-ceramide
GTA UDP-GalNAc aFucl ,2pGall,4pGlcNAc-R aGalNAc 1,3 [aFuc 1,2] pGal 1,4pGlcNAc-R
FS UDP-GalNAc PGalNAcl ,3aGal-R aGalNAcl,3 pGalNAcl,3aGal-R
Table 2.1: Donor substrates, acceptor substrates and reaction products of GT6 family 
enzymes. The monosaccharides that carry the acceptor hydroxyl are indicated in bold 
(Heissigerova et al., 2003).
The crystal structures of 3 members of the family 6 glycosyltransferases have 
been elucidated thus far: bovine a-1,3 galactosyltransferase and human A and B 
transferases. These structural determinations allow the understanding at the atomic 
level of the interactions of individual amino acid residues with donor and acceptor 
carbohydrate hence facilitating the understanding of the mechanism of these 
enzymes. This thesis will move on to discuss in more detail 2 members from this 
family: Bovine a-1,3-galactosyltransferase (a3GT) and canine Forssman synthase.
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Figure 2.6: Amino acid sequence alignment of bovine a3GT and related enzymes of the 
GT6 family. Conserved amino acids have a red background and preserved ones a green 





a-1,3-Galactosyltransferase (a3GT) is an enzyme that catalyzes the transfer of 
galactose from UDP-a-D-Galactose (donor substrate) to N-acetylglucosamine 
(acceptor substrate) to form an a-1,3 linkage with P-galactosyl groups in 
glycoconjugates, also termed as a-Gal epitopes. The enzyme is expressed in many 
mammalian species but is absent from humans, apes and old world monkeys. Most 
of the genes expressed in other mammals have counterparts in humans. The a3GT 
gene however is an exception. Only partial sequences, similar to a3GT gene of non­
primate mammals have been detected in the human genome and are considered to 
correspond to pseudo genes, due to multiple deletions leading to premature 
translation stops (Lanteri et al., 2002). Attempts to detect human a3GT transcripts 
have remained unsuccessful thus far (Galili, 1999). Complete loss of expression of 
this gene in old world primates, enables the production of significant amounts of 
natural antibodies towards a-Gal (Galili et a l , 1987). These antibodies are strongly 
active in the presence of complement. This is thought to be advantageous as it 
permits the production of antibodies to provide a barrier against infection of 
pathogenic microorganisms that carry the galactoconjugate epitope. However, this 
presents a barrier against xenotransplantation which is one of the major approaches 
to dealing with the limited supply of donor organs. Transfer of organs from 
organisms which produce a3GT to organisms that lack its activity will cause 
hyperacute rejection and in particular, prevent projects of transplantation of pig 
organs to humans (Kobayashi and Cooper, 1999). Studies by Kuwaki and co­
workers showed that elimination of a3GT activity in baboons prevented hyperacute 
rejection and extended survival of pig hearts in baboons for 2-6 months (Kuwaki et 
a l , 2005). Another study by Yamada and co-workers further supported these results 
in which they reported that by using a3GT knockout donors and a tolerance 
induction approach, they had successfully achieved life-supporting pig-to-baboon 
renal xenograft survivals of up to 83 days (Kuwaki et a l , 2005). Intravenous 
administration of a-Gal epitopes as oligosaccharides have been shown to result in
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neutralisation of anti-Gal and concomitantly in a temporary delay of hyperacute 
rejection of pig organs (Simon et a l, 1998). Recent studies also showed that a3GT- 
expressing allogeneic tumour cell vaccine can be used for treatment of cancer cells. 
This cancer vaccine comprised irradiated allogeneic cancer cells transfected to 
express a3GT with antitumour activity. Vaccination results in a3GT-mediated 
expression of foreign a-Gal carbohydrate residues on cell membrane glycoproteins 
and glycolipids of the vaccine cancer cell "xenograft”; these foreign a-Gal epitopes, 
not present on human cells, then induce a hyperacute rejection of the vaccine 
pancreatic cancer cell xenograft. The hyperacute rejection involves pre-existing 
human anti-Gal antibodies (naturally occur against gut flora) that bind the foreign a- 
Gal epitopes, resulting in the rapid activation of complement and antibody- 
dependent cell-mediated cytotoxicity (ADCC). The host immune system then attacks 
pancreatic cancer cells, existant prior to vaccination and with cell membrane 
epitopes unmodified by a-Gal, resulting in ADCC and tumor growth inhibition or 
reduction (Chen et al., 2001; Deriy et al., 2005; Galili, 2005; Manches et a l, 2005). 
The limited information currently available regarding the structural basis of 
molecular recognition and catalysis by this enzyme prevents a clear understanding of 
the molecular basis of its biological functions in cellular interactions and regulation. 
Hence, high resolution structural data are needed for better understanding of the 
mechanism of this enzyme in order to facilitate the design of inhibitors and also for 
the enzymatic synthesis of glycoconjugates for therapeutic use in diseases.
Structural studies of a3GT
The crystal structure of the catalytic domain (residues 80-368) of a3GT was first 
published by Gastinel and co-workers in the tetragonal form (form I), P4i2i2 space 
group at 2.3- and 2.5 A resolution in UMP- and Hg-UDP-Galactose-bound forms, 
respectively (Gastinel et a l, 2001). The overall structure of the enzyme consists of 
10 p-strands, 6 a-helices and 6 3io helices. The folding of the protein is that of the 
typical a/p protein often observed in GTs with a central core of twisted P-sheet of 8 
p-strands surrounded by 4 long a-helices. The central P-sheet can be divided into
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two main regions. The first region runs from Vail29 to Met224, defining the N- 
terminal subdomain and is made up of a P-sheet formed by 4 parallel p-strands and 
surrounded by two long a-helices. This N-terminal subdomain is the site for the 
binding of the nucleotide moiety of the nucleotide-sugar donor substrate. The second 
portion of the central P-sheet consists of 2 parallel p-strands flanked by 2 anti­
parallel P-strands and with 2 long helices on one side. A second small p-sheet 
running almost parallel to the central P-sheet consists of 2 short antiparallel p- 
strands (Gastinel et al., 2001). These structures identified binding sites for UDP and 
the manganese ion co-factor. A region of electron density in the Hg-UDP-Galactose- 
bound structure was interpreted as a p-galactosyl moiety covalently attached to 
residue Glu317 suggesting that a covalent catalytic mechanism takes place in the 
enzyme. However no direct evidence was obtained for a glycosyl-enzyme covalent 
bond, and the limited resolution of the structure raises questions about this 
interpretation (Boix et al., 2001). This structure also exhibited disorder in the C- 
terminal region (residues 358-368), with this region having high B-factors of about 
90 A2, suggesting that there is more than one conformation (Figure 2.1 A).
In order to answer some of the questions that arose from the structure by 
Gastinel and co-workers, Boix and co-workers reported the structure of a3GT in 
complex with donor and acceptor substrates at 1.53 A in the monoclinic space 
group P2i (form II) (Boix et al., 2002; Boix et al., 2001). This structure exhibited an 
ordered C-terminus and gave further insight into the catalytic mechanism of a3GT 
by revealing that there is a significant conformational change in the catalytically 
important C terminus during substrate binding (Figure 2.7B). The overall structure is 
almost identical to the form I structure reported by Gastinel and co-workers, 
however, the C-terminal region comprising residues 358-368, which is slightly 
disordered in the form I structure has undergone a large conformational change. This 
stretch of molecule is also highly ordered in form II as evidenced by the much lower 
5-factors reflecting the high resolution and much lower mobility for all residues. In 
the form II structure the C-terminus forms a lid over the active site of the molecule 
minimising the active site accessibility. In this structure the C-terminus forms a short
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P-strand, and residues 361-364 adopt a definite a-helical structure and are well 
defined. Some of the residues in this form II structure, especially Arg365 make 
direct interactions with the UDP molecule in the active site (Figure 2.8).
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Form I  (Tetragonal) structure (Gastinel et al., 2001)
DP
Form II (Monoclinic) structure (Boix et al., 2001)
Figure 2.7: Comparison between the Form I and Form II structures of a3GT. Root-mean -square-deviation of 0.17 A for the form I and form II 
structures. The marked difference is in the conformation of the C-terminal region (circled in blue). In the form I structure (A), the C-terminal 
region is disordered and is shown to face away from the active site cleft whereas in the for II structure (B) the C-terminal region is ordered and is 
observed to fold over the active site cleft to form a pocket. Also shown in the form I structure is the bound mercury ion shown in a grey sphere and 
the galactose (shown in pink sticks) which is thought to make covalent interactions with the putative catalytic nucleophile Glu317 (Boix et a l,  
2001;Gastinel et al., 2001).
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Mutational and biophysical studies showed that the C terminal region of 
a3GT is important for catalysis, possibly reflecting its role in a donor-substrate 
induced conformational change. Arg365 is a key residue on the C-terminus that 
interacts directly with the oxygen atom of the a-Phosphate of UDP (Figure 2.8). 
Mutation of this residue to lysine which is expected to perturb the conformational 
change of the C-terminus, showed that the enthalpy of binding for UDP is greatly 
reduced, in keeping with the role of Arg365 in UDP binding, while &cat for UDP- 
Galactose hydrolysis and galactosyl transfer to lactose are reduced 12- and 40-fold, 
respectively (Zhang et al., 2003). These results suggest that the conformational 
change in the C-terminal region of a3GT has a role in the rate-limiting step for these 
reactions.
Subsequent structural and calorimetric binding studies suggest an obligatory 
ordered binding of donor and acceptor substrates, linked to a donor substrate- 
induced conformational change, and the direct participation of UDP in acceptor 
binding (Boix et al., 2002). The crystal structures and molecular modeling suggest 
that binding of a distorted conformation of UDP-Gal may be important in the 
catalytic mechanism of a3GT.
Several other mutational studies have been carried out in order to study the 
catalytic mechanism of a3GT (Boix et a l , 2002; Zhang et al., 2004; Zhang et al., 
2003). One of the hypothesis that was put forth with the elucidation of the form I 
structure of a3GT is that the mechanism of the enzyme involves the formation of 
glycosyl-enzyme intermediate characteristic of a double displacement mechanism. 
However due to the low resolution of the structure as well as the lack of any direct 
evidence supporting this, the hypothesis has been cast in doubt. Subsequent 
mutational and structural studies that were carried out were designed in order to 
better understand that catalytic mechanism of the enzyme and to determine the exact 
role of Glu317 which was previously purported to be the catalytic nucleophile in the 
double displacement mechanism. In a study by Zhang et. al (2003) mutation of 
Glu317 to Gin was observed to weaken lactose binding and reduces the &cat for 
galactosyltransfer to lactose and water by 2400-fold and 120-fold, respectively. The 
structure is not perturbed by this substitution, but the orientation of the bound lactose
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molecule is changed. However, the magnitude o f  these changes does not support a 
previous proposal that Glu317 is the catalytic nucleophile in a double displacement 
mechanism and suggests it acts in acceptor substrate binding and in stabilizing a 
cationic transition state for cleavage o f  the bond between UDP and C l o f  the 
galactose (Zhang et al., 2003). Several other mutations were carried out on 
tryptophan residues which line the acceptor binding region o f  a3G T  and this study 
showed that the mutations reduced both hydrolase and transferase activity and 
reduces affinity for the acceptor substrate (Zhang et a l,  2004). Crystal structures o f  
some o f  these mutants did not show any changes in the overall structure o f the 
enzyme however, localised changes that occur in the interactions o f  the mutated 
residues with substrates affect the catalytic activity and substrate binding o f  a3G T. 
Both mutational studies highlighted the importance o f  hydrogen bonds and 
hydrophobic interactions between enzyme and substrates in a3G T. These 
interactions play a pivotal role in arranging substrates in appropriate conformations 
and orientation for efficient catalysis.
Figure 2.8: The figure shows the mutation sites of the mutants initially studied. Subsequent 
mutants that were produced, structurally studied and discussed in this thesis were based on 
the complex structures of these initial mutants. The UDP is shown in cyan and the 
manganese ion as a purple sphere. The individual residues are represented in sticks with the 
green residues representing the mutation sites for the 5-site mutant: Trp249, Ala248, 
Gln247, Cys338 and also includes a mutation of His280. The reason for studying the 5-site 
mutant is to determine the importance of the conserved cys338 and also to study the affect 
that mutation has on donor substrate and acceptor substrate binding.
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2.2 Aim of studies
The main goal of this study is to carry out structural studies of C-terminal and active 
site mutants of a3GT in order to understand the significance of the conformational 
flexibility of some regions in the enzyme especially the C-terminal region. The aims 
are to determine the actual role of the C-terminus in the catalytic activity of the 
enzyme as well as determining the mechanism of a3GT. The other aim of this study 
is to determine the crystal structure of .a3GT in complex with the inhibitor, U66. 
This study also extends to determine the crystal structure of Forssman synthase 
enzyme which is another enzyme from the glycosyltransferase 6 family, in complex 
with its substrates.
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3.1 Methodology
3.1.1 a3GT sample preparation
All a3GT protein samples (wild type and mutants) and the U66 inhibitor were kindly 
provided to us by our collaborator Professor Keith Brew from Florida Atlantic 
University, USA. The purification process for a3GT has been published (Zhang et 
a l, 2001). Both proteins are unstable and at extended period of storage would 
precipitate out of solution, hence, the proteins are stored in a stable buffer containing 
50% glycerol and 20 mM MES-NaOH, pH 6.5. Due to high concentration of 
glycerol in the buffer, the protein samples need to undergo a preparation process 
which involves buffer exchange and concentration prior to crystallisation. The 
protein sample is buffer exchanged into a buffer containing significantly less 
glycerol but still high enough to keep the protein stable in solution for 
crystallisation. The protein preparation described here is based on a previous method 
carried out by Boix and co-workers for the crystallisation of wild type a3GT 
(unpublished data). The protocol described is for the preparation of 250 pi of protein 
at concentration of 2-5 mg/ml. The buffer measurements are altered accordingly 
according to the volume of the starting protein material being used. All protein 
samples both for the wild type and mutants of a3GT were prepared using this 
protocol unless otherwise stated:
Buffer exchange and concentration
Concentrators:
15 ml volume concentrators: Millipore UFV2BGC10 Ultrafree-15 centrifugal filter 
device; Biomax 10K (Ref. Z36,463-0 from SIGMA)
Eppendorf 0.5 ml volume concentrators: IVSS vivaspin 500 centrifugal concentrator 
filter device, 10K (Ref. Z614025-25E, VS0101 from SIGMA)
Buffer preparation:
Buffer 1: 375 pi 20mM MES, pH6
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Buffer 2 (for 10 ml): 0.2 ml MES 1M, pH6, 1 ml Glycerol 100%, 8.8 ml Analar H2 O 
(keep on ice)
12000 x g, 4 min (Eppendorf centrifuge 5415 D)
12000 x g, 4 min (Eppendorf centrifuge 5415D)
5000 x g, 40 min (Heraeus Biofuge Stratos)
5000 x g, 40 min (Heraeus Biofuge Stratos)
5000 x g, 40 min (Heraeus Biofuge Stratos)
5000 x g, 40 min (Heraeus Biofuge Stratos)
Transfer supernatant to 15 ml 
concentrator
Transfer supernatant to a new eppendorf 
tube and add 375 ul buffer 1
250 pL (5 mg/ml) of protein 
sample in 1.5 ml eppendorf tube
Concentrate down to 250-500 pi 
and add 1ml cold buffer 2
Concentrate down to 250-500 pi 
and add 1ml cold buffer 2
Concentrate down to 250-500 pi 
and add 0.5 ml cold buffer 2
Concentrate down to 250-500 pi 
and add 0.5 ml cold buffer 2
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5000 x g, 40 min (Heraeus Biofuge stratos)
12000 x g, 15 min (Eppendorf centrifuge 5415D)
12000 x g, 30 min (Eppendorf centrifuge 5415D)
Concentrate again to 250 pi
Protein is ready for crystallisation
Concentrate to about 200 pi and 
add another 200 pi of buffer 2
Transfer protein into 0.5 ml 
concentrator and add 200 pi of cold 
buffer 2
Transfer retentate into new 
eppendorf tube and leave on ice in 
cold room overnight
Concentrate again to about 5 0 -  100 pi. At this point, a protein assay is 
carried out in order to determine the protein concentration more 
accurately. Protein concentration should be within the range of 4-8 mg/ml
Figure 3.0: Flow chart describing the steps involved in the buffer exchange 
process o f a3GT.
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Protein estimation with Bradford Assay:
Protein estimation was carried out using a method based on Bradford (1976) 
(Bradford, 1976). The final volume o f each assay is 1 ml. Bovine serum albumin 
(BSA) was used as a standard and a series o f concentration in the range o f 0.01 to 
0.1 pg/pl was prepared to a final volume o f 50 pi with analar water. Aliquots o f 0.5, 
1 and 2 pi o f the a3G T  sample were also used and diluted to 50 pi. 950 pi o f 
Bradford reagent was added to the BSA standards and a3G T  samples. Both 
standards and samples were left at room temperature for 10 minutes before the 
absorbance was recorded spectrophotometerically (Pharmacia Biotech, Ultrospec 
2000 UV/Vis spectrophotometer) at 562 nm. A standard graph o f absorbance versus 
the concentration o f  protein was plotted (Figure 3.1). The amount o f protein present 
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Figure 3.1: Protein assay calibration curve using known concentration of BSA
y = 1.6475X 
R2 = 0.9918
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3.1.2 Crystallisation of a3GT mutants
Crystals were grown at 16°C by the vapour diffusion hanging drop method, lpl of 
the protein in 20mM MES-NaOH buffer, pH 6 and 10% glycerol, lOmM donor 
substrates (UDP or UDP-Gal Sigma®) and lOmM manganese chloride was mixed 
with lul of reservoir solution. Crystallisation was also carried out in the presence of 
acceptor substrate N-acetyllactosamine (LacNAc) (Sigma®).
> Streak seeding:
Crystallisation drops were set up as described above. The drops were then pre­
equilibrated at 16°C for about 1 hour. A fine fibre (Cat whisker) was used to pick up 
microscopic crystal seeds from an existing crystal. The fibre was then used to seed 
the pre-equilibrated drop by stroking the fibre in a straight line through the drop.
> Crystallisation conditions and screens
Known a3GT crystallisation conditions:
Monoclinic form(Boix et al., 2002; Boix et a l , 2001): 5-10% PEG 6000 (Sigma®), 
0.1M Tris-HCl, pH 8.0 (form II)
Tetragonal form (Zhang et a l, 2003): 1.4-2.0M (NID 2 SO4, Tris-HCl, pH 8.0 (form
I)
Crystallisation screens:
Structure Screen I and II from Molecular Dimensions Limited, UK and PEG/Ion 
screen from Hampton Research Corp., USA.
Self designed crystallisation screen:
Crystallisation screen designed based on the monoclinic (form II) crystallisation 
condition (Boix et a l, 2002; Boix et a l, 2001):
Several changes were carried out according to the results obtained after setting up 
crystallisation based on the known a3GT conditions and also the conditions from 
the standard crystallisation screens.
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Main variables that were changed:
>  Drop size (protein to reservoir ratio of: 1:1, 2:1, 1:2 etc.)
>  Type of PEG (PEG 3350, 4000, 6000, 8000)
> Concentration of PEG (concentration range of 1 % to 35%)
> pH of buffer (pH range 7.0-9.0)
> Additives, e.g: Salt (i.e: Sodium citrate, Sodium acetate etc.), organic 
solvents (i.e: MPD, Jeffamine, Ethanol etc.)
3.1.3 Results of Crystallisation experiments
Crystallisation experiments often go through two distinguishable phases: a screening 
step, which is frequently followed by optimisation. Screening establishes which 
conditions produce promising crystals -  or at least, some leads -  and optimisation 
refers to the fine tuning of those initial conditions to obtain well diffracting crystals 
which are suitable for data collection.
Wild type a3GT
One of our objectives is to co-crystallise wild type a3GT with the inhibitor U66, 
however, initial attempts to co-crystallise wild type a3GT with the inhibitor U66 
were unsuccessful. On addition of U66, a3GT precipitates and it is concluded that 
the best way to overcome this problem was to grow a3GT crystals without 
substrates or co-factor (apo form) and then carry out soaking experiments with U66 
(Results for experiments with U66 are discussed in section 3.4).
(x3GT mutant complexes
Apart from carrying out co-crystallisation attempts of wild type a3GT with the 
inhibitor U66, another aim of this research was to obtain the crystal structures of 
mutants of a3GT in complex with donor substrates and donor substrate analogues 
for the purpose of understanding the mode of binding of these substrates hence
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shedding light into the catalytic mechanism of a3GT. Previously, crystallisation of 
a3GT mutants primarily the Glu317Gln and the active site tryptophan mutants were 
carried out in the presence of UDP (Zhang et al., 2004; Zhang et al., 2003) hence 
often resulting in the structures of the mutants in complex with UDP which is a dead 
end inhibitor of the enzyme. As co-crystals of the a3GT mutants in complex with 
UDP-Gal did not grow in the original crystallisation condition reported by Boix and 
co-workers (Boix et al., 2001), a new crystallisation condition which promotes the 
formation of co-crystals of the mutants in complex with the donor substrate UDP- 
Gal was sought.
Attempts were carried out to co-crystallise the a3GT mutants with UDP-Gal 
and manganese ions. Preliminary crystallisation screens with commercial screens 
from Molecular Dimensions and Hampton research resulted in the identification of a 
few new conditions which produced crystals. These conditions in general produced 
bypyramidal looking crystals which are usually associated with the tetragonal crystal 
form. Unfortunately, these bipyramidal crystals did not diffract very well and did not 
show any ligand binding in the active site. This result is in agreement with the 
tetragonal structure reported by Boix and co-workers (Zhang et al., 2003) which 
suggested that the tetragonal crystal form of a3GT is the open inactive form of the 
protein. This result indicated that a different crystallisation condition should be 
pursued especially a condition which favours crystal formation in the active form or 
at the very least, a condition which produced crystals in a space group other than 
tetragonal. It was observed that crystallisation conditions that utilised high salt 
concentration will often produce a3GT crystals in the tetragonal space group.
At this point, conventional commercial screens were abandoned and a new 
screen was formulated based on crystallisation condition for the monoclinic crystal 
form reported by Boix and co-workers (Boix et al., 2002; Boix et al., 2001). This 
condition utilised PEG 6000 as the precipitant and Tris as buffer. A crystallisation 
screen with different types of PEG and incorporation of additives listed in table 3.0 
was formulated.
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Additive Concentration Results
Salts (chloride, sulphate, acetate and citrate) 0.05M-0.3M Several conditions containing acetate and 





DMSO 2-15% Heavy precipitate
DTT 2-15% Heavy precipitate
Dioxane 2-15% Light precipitate
MPD 2-30% Crystal plates of reasonable size
1,6-hexanediol 2-15% Precipitates
1,2,3-heptane diol 2-15% Precipitates
xylitol 5-30% Precipitate
Ethylene glycol 5-20% Precipitates
1,2,3-butanediol 2-15% Precipitate
Jeffamine 2-15% Light precipitate and small crystals
PEG 200-600 2-15% Precipitates
Table 3.0: The list of additives used to screen for a co-crystallisation condition for the a3GT mutants. The concentrations shown are 
the final concentrations in the crystallisation well containing 5-15% PEG 6000 and 0.1M Tris-HCl, pH 8, hence the concentration of 
the additives in a 2 micro-liter drop is half of the concentration shown.
68
Chapter 3 Structural Studies on Bovine a-1,3 Galactosyltransferase (a3GT)
The addition of additives especially salt was vital as salt assists the solubility 
of the protein as previous attempts had shown that the a3GT mutants precipitated 
immediately when crystallised in the presence of just PEG and Tris buffer. The new 
screen gave more promising results as co-crystals of the mutants with UDP-Gal were 
obtained in conditions containing 5-10% PEG 6000, Tris pH 8 and 5-20% MPD. 
Interestingly for most of the mutants, MPD seemed to be a common and perhaps an 
important factor for crystal growth as the original condition without MPD did not 
produce any crystals, in fact co-crystallisation attempts of the mutants with UDP-Gal 
in the original condition would usually result in precipitation. MPD seemed to be 
very important for crystal contacts as a result of adding which all the crystallisation 
conditions, despite varying the concentration of PEG 6000 and even the pH of the 
Tris buffer, will produce diffraction quality crystals. In general subsequent 
crystallisation of a3GT mutants unless otherwise stated were carried out using this 
condition with variations in the concentration of PEG 6000 and MPD.
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3.2 Conformational dynamics of a-1,3 Galactosyltransferase (a3GT)
3.2.1 Introduction
To understand the structural basis of catalysis and substrate specificity in a3GT, our 
goal is to elucidate the interactions between the substrates, metal cofactors and 
products with the enzyme as well as the effects of mutations of key residues in the 
active site. Initial crystallographic studies of a tetragonal crystal form (form I) of a 
complex of a3GT with a Hg-derivative of UDP-Gal suggested the presence of a 
galactosyl moiety, covalently bound to Glu317 (Gastinel et al., 2001), consistent with 
the view that Glu317 might act as the catalytic nucleophile in a double displacement 
mechanism, the expected mechanism for a retaining glycosyltransferase (Gastinel et 
ah, 2001; Unligil et al., 2000; Zhang et al., 2004; Zhang et al., 2003; Zhang et al., 
2001). However, this observation was puzzling since the structure also contained a 
second galactose that was part of a non-covalently bound Hg-UDP-Gal, and the 
electron density for the galactose adjacent to Glu317 was weak. Subsequent kinetic, 
structural and mutational studies do not support a double-displacement mechanism 
for a3GT.
The relatively lower resolution tetragonal crystal form (form I), had a 
disordered C-terminal region (Gastinel et al., 2001) and a higher resolution monoclinic 
crystal form (form II), represented by the enzyme complex with UDP and manganese, 
was later solved in which the C-terminal region has a distinct and highly ordered 
conformation(Boix et al., 2001). Since then we have reported form II structures for 
a3GT in complexes with manganese and UDP, manganese/UDP-Galactose (UDP-Gal), 
manganese/UDP-Glucose (UDP-Glc) and with both manganese/UDP and the acceptor 
substrates lactose (LAC) and A-acetyllactosamine (Lac NAc) (Boix et al., 2002). In the 
complexes containing UDP-Gal and UDP-glc, the bond between the UDP and 
monosaccharide was cleaved, leaving a P-Galactose and a-Glucose trapped in the active 
site. Because of the relatively high level of UDP-Gal hydrolase activity of a3GT, we 
have been unable to determine the structure of an enzyme complex containing an intact 
UDP-Gal substrate. UDP-2F-Galactose (UDP-2F-Gal) (Figure 3.2) is a UDP-Gal 
analogue that is resistant to hydrolysis and monosaccharide transfer that has been shown
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to be a reversible inhibitor of a3GT (^=245pM) and other GTs (Burkart et al., 2000). 
Unlike the mercurial derivative of UDP-Gal, this derivative is closely similar in size to 
the donor substrate. We were unsuccessful in attempts to crystallize a complex of this 
inhibitor with wild-type a3GT, but have been able to crystallize and solve the structure 
of its complex with the Arg365Lys mutant. Previous studies showed that Arg365 in the 
C-terminus of a3GT interacts with the a-phosphate of UDP and that this mutation to Lys 
specifically perturbs catalytic activity but not substrate binding (Boix et a l , 2001; Zhang 
et al., 2003). The structure of the complex with UDP-2F-Gal is the first structure of a 
complex for an enzyme in this family with a donor substrate analogue inhibitor. It 
provides high resolution information about the conformation of the donor substrate 
mimetic and enzyme as well as their interactions in what is presumably an appropriate 
model for the Michaelis complex with UDP-Gal. To extend the picture, we have also 
determined the structures of the apo-forms and UDP complexes of the wild-type enzyme 
and Arg365Lys mutant. Together, these show that progressive conformational changes 
occur in two regions of a3GT during the catalytic cycle; mutational and truncation 
studies suggest that conformational changes in the C-terminal region are important for 
catalysis. This is consistent with studies with other glycosyltransferases that suggest a 
role for loop conformations in modulating the active site environment during the 
catalytic cycle (Unligil and Rini, 2000).
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Figure 3.2: Chemical structure of UDP-2F-Gal. UDP-2F-Gal is more similar in size to the 
donor substrate, UDP-Gal with the difference in substitution of a fluorine atom at the 2’ 
position of the galactose moiety (shown in green). [Chemical structure of UDP-2F-Gal 
obtained from the PDB entry: 2JCF (Jamaluddin et al., 2007)]
3.2.2 Methods 
Crystallisation
Co-crystals o f  a3GT mutants, Arg365Lys mutant and the C-terminal truncated mutant, 
CA3 in the presence o f substrates and substrate analogues were grown in conditions 
containing 5-10% PEG 6000, 0.1M Tris-HCl, pH 8 and 5-20% MPD as discussed in 
section 3.1 while crystals o f  the apo form o f wild type a3G T and the Arg365Lys 
mutant were grown in conditions containing Tris-HCl buffer pH 8.0 and 1.4M 
ammonium sulphate and 1.4M sodium acetate and 0.1M sodium cacodylate, pH 6.5 
respectively. Crystallisation techniques for the apo form o f  the enzyme are discussed 
in more detailed in subchapter 3.4.
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Data collection, Processing and Structure refinement
Datasets for the apo-form of the protein and a high resolution dataset for the 
Arg365Lys mutant to 1.8 A were collected at the Synchrotron Radiation Source 
(SRS), Daresbury, UK (station PX 9.6 and PX 14.2 respectively, using an Area 
Detector Systems Corp. detector system). Diffraction data for the Arg365Lys mutant 
in a complex with UDP-2F-Gal to 2.4 A resolution were collected at the SRS, 
Daresbury (station 14.1, with an MAR 345 image plate system). The dataset for the 
CA3 mutant in a complex with UDP-Gal was collected to 2.0 A resolution at DESY, 
EMBL outstation, Hamburg, Germany (station X I3, using a 30-cm MAR research 
image plate system). Raw data images for the wild type apo structure, Arg365Lys apo 
structure, Arg365Lys in complex with UDP and Arg365Lys in complex with UDP- 
2F-Galactose were indexed and scaled using the DENZO and SCALEPACK modules 
of the HKL suite (Otwinowski and Minor, 1997) while processing of the CA3 mutant 
dataset was carried out using MOSFLM (Leslie, 2001) and SCALA (CCP4, 1994).
All five structures were determined by the molecular replacement method 
using the native form II structure (PDB code: lK4V)(Boix et a l, 2001) as a search 
model with the program MOLREP (Vagin and Teplyakov, 1997). Crystallographic 
refinement was performed using the program package CNS (Brunger et a l , 1998) for 
the complex structures of the mutants. Several rounds of energy minimization, 
simulated annealing, B-factor refinement and model building using the program 
COOT(Emsley, 2004) were performed until the could not be improved. 
Appropriate ligand(s) were inserted into the structure as the refinement progressed. 
Residues with poor side-chain density were modelled as alanines and regions with 
very poor main chain electron density were excluded from the refinement. Water 
molecules were gradually included into the model at positions corresponding to peaks 
in the F0-Fc electron density map with heights greater than 3a and at H-bond distance 
from appropriate atoms. Occupancy for the second manganese binding site in the 
Arg365Lys mutant in the complex with UDP was determined by setting the B-factor 
of the manganese to the Wilson B-value of the data which is 17 A2 and then carrying
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out a series of short refinement runs using different occupancies for the manganese 
ion (0.2 to 1.0). Refinement was carried out using the program REFMAC (CCP4, 
1994) for the ‘apo’ form of the wild type enzyme and the Arg365Lys mutant 
structures. Data collection and refinement statistics for all 5 structures are listed in 
Table 3.1.
74
Chapter 3 Structural Studies on Bovine a-1,3 Galactosyltransferase (a3GT)
Protein WT (apo) R365K (apo) R365K-UDP R365K-UDP-2F-Galactose CA3
Substrates used in none none lOmMUDP lOmM UDP-2F-Gal lOmM UDP-Gal




Substrates observed in the none none 2 manganese 2 manganese (one/monomer) 1 manganese (one/monomer)
crystal structure 1 UDP 2 UDP-2F-Gal (UP1) 
(one/monomer)
1 UDP (one/monomer)
C-terminus Disordered Disordered Partially ordered Disordered in molecule A 
Partially ordered in molecule B
Fully ordered (residues 358-365)
Space group P4i2,2 P2.2.2, C2 PI C2
Mols/A.S.U 1 2 1 2 1
Crystal parameters
a (A) 93.57 95.93 122.82 44.74 121.76
b(A ) 93.57 103.26 68.25 64.76 68.30
c(A ) 108.42 121.49 44.73 66.47 43.96
o f ) 90.0 90.0 90.0 83.3 90.0
PC) 90.0 90.0 90.2 83.9 90.1
Y f) 90.0 90.0 90.0 70.1 90.0
Resolution (A) 50.00-2.56 50.0-3.3 50.0-1.8 50.0-2.4 50.0-2.01
R Vmm (%)‘ (outermost shell)b 7.2 (68.3) 20.1 (61.9) 10(21.0) 5.2 (12.8) 10.3 (34.1)
Completeness (%) (outermost 98.1 (84.8) 99.8 (99.9) 91.7(93.6) 89.9 (67.2) 96.4 (80.8)
shell)"
I / a l  (outermost shell)" 24.0(2.1) 7.6 (2.4) 9(5.1) 11.5(4.4) 12.4 (3.2)
Total reflections 299696 220655 155949 111638 88715
Unique reflections 15988 18881 34457 27634 23156
R*n«/RttJ (%) 26.4/32.8 20.6/28.1 19.4/20.4 18.1/22.9 18.7/20.7
Ramachandran Plot 84.6/15.4 85.3/14.7 88.8/11.2 86.6/13.4 88.6/11.4
% core/allowed
RMSD from ideal
Bond angles f ) 1.73 1.63 1.39 1.30 1.42
Bond lengths (A) 0.02 0.016 0.007 0.007 0.007
W ater molecules 23 61 395 551 204
B-factor statistics (A2)
Protein* 58.9 37.0(A), 35.0(B) 15.4 30.6 (A), 31.3(B) 16.5
Ligand in the active site* - - 13.5 (UDP) 47.7 (UP1-A), 33.8 (UP1-B) 16.8 (UDP), 33.5 (Tris)
Metal* - - 13.7 (MN1), 58.5 (MN2) 42 (MN1-A), 30.3 (MN1-B) 15.2 (MN1)
a i?.ymm=£>,E/[|//(h) -  </(h)>|/E*E///(h)], where Ii is the /th measurement and <I(h)> is the weighted mean of all measurements of 1(h).
b Outermost shell are 2.63 -  2.56 A, 3 .37-3 .30  A, 1.91 -  1.80 A, 2.55 -2.40 A and 2.07-2.01 A respectively . 
c ^ crysF E/,|F0 - Fc\/UiF0, where F0 and Fc are the observed and calculated structure factor amplitudes of reflection h. 
d Rfrcc is equal to Rayn for a randomly selected subset of reflections, not used in refinement.
* Temperature factors for individual molecules quoted
Table 3.1: Refinement statistics for the structures of the ‘apo’ form of wild type a3GT and Arg365Lys mutant, Complexes o f the 
Arg365Lys mutant with UDP and 2 manganese ions, UDP-2F-gal and the structure o f CA3 mutant in complex with UDP and Tris
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3.2.3 Results
Structures of apo- wild type a3GT and Arg365Lys mutant
The orthorhombic crystals of the apo-form of the Arg365Lys mutant with 2 
molecules per asymmetric unit diffracted to 3.3A and the structure has a higher 
average B-factor compared to the substrate bound structures (Table 3.1). In both 
molecules in the asymmetric unit, the C-terminus (residues 358-368) is disordered; in 
molecule A, there is also a high level of disorder in the Trpl95 loop between residues 
190 and 199 with the most significant differences from the UDP complex of wild- 
type a3GT (PDB code 1K4V) being in residues Trpl95 and Glnl96 (Figure 3.3). In 
molecule B, this region is more structured but residues 188 to 199 are arranged 
differently as a result of molecular contacts in the crystal. This suggests that, in the 
absence of ligands, this region is highly flexible.
Apo-wild type a3GT crystallised in the tetragonal space group with one 
molecule in the asymmetric unit, and diffracted to 2.56A resolution. In general, the 
structure is closely similar to that of the apo form of the Arg365Lys mutant. The same 
two regions in the structure are disordered, the C-terminal 11 residues and Trpl95 
loop (residues 190-199). The disorder is reflected in a distinct break in electron 
density in the region corresponding to residues Trpl95 and Gin 196. The global 
disorder in the structure is reflected in the average B-factor which is close to 60 A 2 
(Table 3.1).
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Figure 3.3: Surface representation of the wild type a3GT structure in complex with UDP 
(Boix et al; 2001, PDB code: 1K4V). The region highlighted in green represents the loop 
corresponding to residues Lysl90-Serl99. The diagram in panel A shows the different 
conformation of this loop in the enzyme’s apo form; apo wild type (blue) and apo Arg365Lys 
mutant (salmon) indicating that this region is highly flexible and is mostly disordered in the 
absence of donor ligand binding . The region highlighted in yellow shows the C-terminal 
region of the enzyme. Panel B shows the different conformation of the this region in different 
crystal structures of the mutants with different ligands bound in the active site; Arg365Lys 
mutant in complex with UDP-2F-Gal (orange), Arg365Lys mutant in complex with UDP and 
2 manganese ions (light green) and C-terminal truncated mutant (CA3) in complex with UDP 
and Tris ion (purple).
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UDP complex of Arg365Lys mutant
The crystals o f the Arg365Lys mutant in complex with UDP were grown by mixing 
1 pi o f the protein (4-8 mg/ml) in 20mM MES-NaOH, pH 6.0, 10% glycerol, 1 OmM 
M nCb and lOmM UDP with an equal volume o f  reservoir solution (Figure 3.4). 
Arg365Lys mutant crystals were also grown in conditions containing UDP-Gal 
using the same method as the co-crystallisation with UDP. These crystals diffracted 
to 1.8 A and 1.77 A respectively (Figure 3.5 & 3.6).
Crystals o f Arg365Lys mutant crystallised in the 
presence o f  UDP and manganese. Crystallisation 
condition: 10% PEG 6000 and Tris-HCl pH 8.
The crystal diffracted to 1.8 A in space group C2. 
(The longest single needle is about 0.05 mm)
Clover leaf shaped crystal o f Arg365Lys mutant 
crystallised in the presence o f UDP-Gal and 
manganese. Crystallisation condition: 12% PEG 
6000, 5% MPD, Tris pH 8. The crystal diffracted 
to 1.77 A in space group C2.
(Typical crystal dimensions: 0.1 X 0.2 X 0.2 mm)
Figure 3.4: Crystals of Arg365Lys mutant in complex with UDP and UDP-Gal in the C2 
space group.
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Figure 3.5: Diffraction image from Arg365Lys mutant crystal in complex with UDP and 2 
manganese ions that diffracted to 1.8A resolution. The inset represents a portion of the 
image zoomed in to show the high-resolution spots. The circles have been drawn to mark the 
resolution range. The data collection parameters used were: X= 0.978 A; Aq>= 1.0° and 
exposure = 15 seconds at SRS, Daresbury, UK ( Station PX 14.2), collected using an 
ADSC-CCD detector. The rings mark the resolution limits of 7 A, 3.6 A, 2.4 A and 1.8 A 
proceeding outwards from the centre. The data was processed to 1.8 A
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1.77 A
Figure 3.6: Diffraction image from Arg365Lys mutant crystal in complex with UDP-Gal 
and manganese that diffracted to 1.77A resolution. The inset represents a portion of the 
image zoomed in to show the high-resolution spots. The circles have been drawn to mark the 
resolution range. The data collection parameters used were: X= 0.978 A; Aq>= 1.0° and 
exposure = 15 seconds at SRS, Daresbury, UK (Station PX 14.2), collected using an ADSC- 
CCD detector. The rings mark the resolution limits of 6 A, 3 A, 2 A and 1.7 A proceeding 
outwards from the centre. The data was processed to 1.77 A
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The crystals of these complexes of the Arg365Lys mutant are in the centred 
monoclinic space group with one molecule per asymmetric unit. The structure shows 
UDP and a manganese ion bound in the active site as in the wild-type a3GT 
structures previously described by Boix et al (2001). However, in the 
Arg365Lys*UDP complex structure, the C-terminal region is somewhat disordered 
and, initially, it appeared that there was no electron density for residues 358-368. 
However, with subsequent rounds of refinement and improved phases, density for the 
first three residues of the C-terminus became visible, enabling the modelling of 
Thr358, Lys359 and Glu360 into the structure. Inspection of this initial structure 
suggested that Glu360 interacts with the second phosphate of the UDP, which is 
chemically anomalous, but also showed the presence of a region of electron density 
that was not accounted for in the model. This density was subsequently identified as a 
second manganese ion, bound with about 90% occupancy at a location similar to that 
of the Tris ion in the structure of the UDP complex of the CA3 mutant (vide infra). 
Based on their proximity (<4 A distance), the second manganese interacts with the 
side chains of Glu317, His280 and Gln247; the fourth ligand is a water molecule that 
bridges between the metal and the second phosphate of the UDP (Figure 3.7).
The substitution of Lys for Arg365 was not observed in the structure because 
of the disorder in residues 361-368; this may reflect the presence of the mutation, 
since Lys can form fewer H-bonds than Arg and also the presence of the second 
manganese that reduces interactions of Lys359 and Tyr361 with the second phosphate 
of the UDP.
We also crystallized the Arg365Lys mutant in the presence of UDP-Gal. The 
structure for this complex is identical to the structure of Arg365Lys in complex with 
UDP indicating that the UDP-Gal has undergone hydrolysis (unpublished results) in 
keeping with the significant UDP-Gal hydrolase activity of the Arg365Lys mutant 
(Zhang et al., 2003; Zhang et al., 2001). However, unlike the structure of the wild- 
type enzyme complex with UDP-Gal, the released galactose is not trapped in the 
active site (Boix et al., 2002); this is consistent with the more open structure of active 
site in the mutant enzyme resulting from the Arg365Lys mutation.
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Figure 3.7: Stereo diagram showing the active site environment of the Arg365Lys 
mutant in complex with UDP and 2 manganese ions shown as purple and violet spheres. The 
catalytic manganese is designated as MN1 while the second manganese is designated as 
MN2. UDP is shown in slate and the C-terminal residues are shown in light green. The water 
molecules making direct interactions with the second manganese are shown as cyan spheres. 
The red dashed line represents the distance between the catalytic manganese (MN1) and the 
second manganese (MN2) which is approximately 7.5A.
Structure of the Arg365Lys complex with UDP-2F-Gal
Crystals o f  the Arg365Lys mutant were grown in the presence o f  UDP-2F- 
Gal, manganese and GlcNAc (Table 3.1). The presence o f GlcNAc was found to be 
essential for crystallisation, but no electron density corresponding to a GlcNAc 
molecule was identified in the structure. The space group was triclinic with 2 
molecules per asymmetric unit and the structure was solved at a resolution o f  2.4A. In 
the structure, an intact UDP-2F-Gal molecule and one manganese ion are bound in 
the active site. Two regions o f structure show varying levels o f  disorder in other 
a3GT structures, residues 190-195, centred around T rpl95 and residues 358-368 at 
the C-terminus (Figure 3.3). In this complex, the T rpl95 loop is ordered and in a 
different conformation from that in apo-forms o f  wild-type and Arg365Lys a3G T 
while, also unlike the apo-enzyme structures, the C-terminus is partly ordered (Figure 
3.3B). In molecule B, residues Thr358, Lys359, Glu360, Tyr361 and Asn362 are 
ordered, Asn363 is modelled as a glycine because o f  the absence o f  any defined 
density for the side chain and residues 363-368 are disordered. In molecule A, 
residues Thr358 and Lys359 are ordered and residues 360-368 are disordered,
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suggesting that the greater order in molecule B may result from molecular contacts in 
the crystal. The partially ordered C-terminal structure appears to be stabilized by 
interactions between Lys359 and the p-phosphate of the inhibitor. It seems likely that 
two factors may prevent this region from forming the highly structured closed 
conformation observed in the UDP complex of wild-type a3GT. One is the presence 
of the 2F-Gal (2F-Gal) attached to the p-phosphate of the UDP that appears to 
displace the network of water molecules which stabilize the interactions between 
residue 365 and the p-phosphate that appear to be important in stabilizing the closed 
structure in the UDP complex (Boix et al., 2001). Secondly, the mutation of Arg365 
to Lys may compromise interactions that are required for the stabilization of the 
closed conformation. Figures 3.8 and 3.9 show the structure of the active site around 
the bound UDP-2F-Gal. The UDP moiety is bound similarly to UDP in previously 
characterized a3GT complexes, except that there are fewer interactions between 
residues in the C-terminal region and the diphosphate; most notably, there are no 
interactions involving Tyr361 and Lys365, the site of the mutation. The inhibitor is 
bound in a distorted configuration in which the 2F-galactosyl moiety is bent back 
almost parallel to the plane of the diphosphate, a conformation that is similar to that 
of UDP-2F-Gal bound to the bacterial retaining galactosyltranferase, LgtC (Persson et 
al., 2001). As shown in Figure 3.12, the structure is different from the structure of the 
Hg-UDP-Galactose in the form I structure of Gastinel and co-workers (Gastinel et al.,
2001). The pyranose ring adopts a more distorted structure than the more stable 4Ci 
chair conformation often observed in other UDP-Gal containing complexes in the 
RCSB-Protein Data Bank; the 05 of the ring puckers forward in such a way that it 
disrupts the stable chair conformation. Key residues responsible for stabilizing the 
2F-Gal in this conformation include several residues that are highly conserved in 
homologues of a3GT: Arg202, which is adjacent to the Trpl95 loop, Asp225 of the 
Asp225-Val-Asp227 motif associated with manganese binding, and His315, Asp316 
and Glu317. Also His280, which varies among a3GT homologues and corresponds to 
Leu/Met266 that has a major role in donor substrate specificity in the histo-blood 
group A and B transferases, interacts with the fluorine atom at 2' position (Table 3.2).
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Y139
VI36
Figure 3.8: Stereo diagram showing the active site environment of the Arg365Lys 
mutant in complex with the catalytic manganese and donor analogue, UDP-2F-Gal (bright 
orange). Residues from the C-terminal region are shown in orange.
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Figure 3.9: Schematic diagram showing the main contact residues including hydrogen bond 
and hydrophobic interactions calculated by the program HBPLUS(McDonald and Thornton, 
1994) between the residues of Arg365Lys mutant and the donor analogue, UDP-2F-Gal.
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Table 3.2: Close atom contacts (< 3.5 A) between the 2F-Gal moiety of UDP-2F-Gal and 
a3GT mutant Arg365Lys
Ligand atom Interacting atoms (a3GT- Arg365Lys)  Distance (A)
(UDP-2F-galactose)
F2’ NE2 280 His 3.00
0E2 317 Glu 3.20
0 3 ’ ODl 225 Asp 2.74
NH2 202 Arg 2.74
0D2 316 Asp 3.30
0 4 ’ N 317Glu 3.20
0D2 316 Asp 2.79
0 6 ’ ND1 315 His 2.83
van der Waals contacts
Residue Number of 
contacts
Residue Number oj 
contacts
Phel34 3 Val226 1
Alal35 4 Asp227 4
Vall36 4 His280 2
Tyrl39 32 Ala281 8
Trpl95 4 His315 3
Ilel98 6 Asp316 6
Seri 99 4 Glu317 3
Arg202 7 Lys359 2
Asp225 8
Contact distances are the following maximum allowed values: C-C, 4.1 A; C-N, 3.8 A; C-O, 
3.7 A; O-O, 3.3 A; O-N, 3.4 A; N-N, 3.4 A; C-S, 4.1 A; O-S, 3.7 A; N-S, 3.8 A; C-F, 3.17 A; 
N-F, 3.03 A. The contact distances were calculated using CONTACT from the CCP4 
suite(CCP4,1994).
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C-terminal truncations and Lys359 mutations
To further explore the roles of residues in the flexible C-terminus region, and 
conformational changes involving this region, we have investigated the effects of 
progressive C-terminal truncations and substitutions for Lys359 on catalytic activity. 
Lys359 was selected because, like Arg365, it is totally conserved in all known 
relatives of a3GT. Studies carried out by Tumbale and co workers (Jamaluddin et a l , 
2007) showed that the truncation of up to three amino acids from the C-terminus 
(CA3 mutant) had little effect on activity but removal of a fourth residue (Arg365) 
produced a major loss in activity arising from a 120-fold reduction in Acat and smaller 
changes in the Km and K\ for UDP-Gal. It should be noted that this result is in conflict 
with a previous report by Henion et a l who found that the removal of just three 
residues of the C-terminus resulted in a complete loss of activity (Henion et a l , 
1994).
Crystals of the CA3 mutant were grown in the presence of UDP-Gal and N- 
acetyl lactosamine (LacNAc); their space group is C2 with one molecule per 
asymmetric unit. The structure, which was solved at 2.0 A resolution, contains a 
manganese ion and UDP in the active site. An additional region of electron density 
was, on refinement, identified as a Tris ion bound in the active site. This ion appears 
to disrupt interactions of Lys359 and Arg365 with the diphosphate moiety of the UDP 
but eight C-terminal residues (residues 358-365) are highly ordered, apparently being 
stabilized in part by interactions between Glu360 and the Tris. The Tris ion is bound 
at a location similar to that of the second manganese ion in the Arg365Lys«UDP 
complex and has similar structural effects in disrupting some interactions of the C- 
terminus with the UDP and the main body of the enzyme. Both ions are located at a 
site anticipated to overlap that of the trisaccharide product. The conformation of the 
C-terminal region in CA3 is distinct from that in the form II structure of wild-type 
a3GT (Figure 3.3B and 3.10). It is possible that the absence of the last three residues, 
in particular Asn367 and Val368, which interact with the Trpl95 loop in the wild- 
type enzyme, may contribute to the change in structure in this mutant. However, the 
components of the binding site for the acceptor substrate (Boix et a l , 2002) are intact
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and the functional properties o f  the truncated enzyme show only minor changes 
(Jamaluddin et a l., 2007).
V226i Y139
V I 36
Figure 3.10: Stereo diagram showing the active site environment of the CA3 mutant 
in complex with UDP (slate) and Tris ion (forest green). C-terminal residues are represented 
in purple while the catalytic manganese is shown as a purpleviolet sphere. Interatomic 
distances between 2.5A -  3.5A are shown as black clashed lines while the black solid lines 
represent the metal coordinating interactions.
The flexible C-terminal region includes two basic amino acids that are totally 
conserved in all known members o f the a3GT family, Lys359 and Arg365. In 
previous structures, both Lys359 and Arg365 have been observed to interact directly 
with phosphates o f the bound UDP and acceptor substrates (Boix e t al., 2002; Boix et 
al., 2001) and the role o f  Arg365 has previously been investigated through the 
properties o f the Lys mutant (Zhang et al., 2003). a3G T variants with conservative 
(Arg) and side chain truncated (Ala) substitutions for Lys359 were therefore 
expressed to investigate the role o f  this residue. Studies by Tumbale and co workers 
also showed that the principal effects o f  both o f  these changes were to reduce kcat : 
34-fold for the Arg substitution and 350-fold for the Ala substitution (Jamaluddin et 
al., 2007). Substitutions for both Arg365 and Lys359, like the deletion o f Arg365, 
therefore lower transition state stability. This is consistent with their conservation in 
the related enzymes which differ in specificity for donor and acceptor substrates, 
suggesting that they are important for catalysis and/or structure rather than substrate 
specificity. It is interesting to note that attempts at co-crystallising the Lys359Arg 
mutant with UDP-Gal resulted in a structure o f  the mutant in complex with just UDP,
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manganese and glycerol bound in the active site. Although the mutant was 
crystallised in the presence o f  UDP-Gal, only the UDP moiety is seen to be bound in 
the active site. The cell dimensions o f the crystal and overall structure o f the mutant is 
similar to that o f  previous structures o f  Arg365Lys mutant in complex with UDP and 
2 manganese ions and the structure o f the CA3 in complex with UDP and Tris ion. 
The Lys359Arg mutant showed a glycerol molecule bound in a similar position to the 
second manganese ion and the tris molecule found in the Arg365Lys*UDP and 
CA3*UDP complexes (Figure 3.11). The mutation o f  Lys359 to Arg could not be 
observed as the C-terminal region is disordered. Refinement statistics for the structure 
o f  Lys359Arg mutant in complex with UDP and glycerol are listed in table 3.3.
Figure 3.11: Stereo diagram showing the active site environment of the Lys359Arg 
mutant in complex with UDP (slate), glycerol (green) and catalytic manganese is shown as a 
purpleviolet sphere (MN1). Interatomic distances between 2.5A -  3.5A are shown as black 
dashed lines while the black solid lines represent the metal coordinating interactions.
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Table 3.3: Data collection and refinement statistics for Lys359Arg-UDP complex 
structure
Substrates observed in the crystal Manganese
structure UDP moiety
Glycerol molecule











R ^ / R t J  (%) 18.7/22.6
Ramachandran Plot
% core/allowed 89.9 /10.1
R-factor statistics (A2)
Protein* 12.08 (A)
Ligand in the active site* 10.3 (UDP), 41.4 (GOL)
Metal 11.7 (MN1)
a /2Symm=£/iEj[|/l(h) -  </(h)>|/EAI*/,{h)], where Ii is the ith measurement and <I(hy> is the weighted 
mean of all measurements of 1(h).
£ Outermost shell are 2.15-2.10 A .
c R c r y s t -  £a|F0 - Fc\rLhF0, where Fa and Fc are the observed and calculated structure factor amplitudes 
of reflection h.
d  Rfce is equal to t for a randomly selected 5.1% subset of reflections, not used in refinement.
e Temperature factors for individual molecules quoted
Discussion
The structure of the UDP-2F-Gal complex shows a conformation for the 
donor substrate analogue that contrasts with the configuration of UDP-Gal in the 
earlier structure of Gastinel et al. (2001) of a complex containing Hg-UDP-Gal. The 
UDP moiety interacts with a3GT similarly to the UDP in this and other previously- 
described structures, while the 2F-Gal is bound in a bent, apparently strained 
configuration similar to that of the Hg-UDP-Gal structure (Gastinel et al., 2001). An
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interesting feature o f this structure is the deformation o f  the pyranose ring o f  2F-Gal 
which could be a result o f  the substitution o f oxygen for fluorine at the 2' position. 
Fluorine is much more electronegative than a hydroxyl group and therefore would 
produce much stronger electrostatic interactions with both NE2 o f His280 and OE2 o f 
Glu317 which results in a change in the overall puckering o f  the ring. The hydroxyl 
groups circling the 2F-Gal pyranose ring coordinate interactions with the surrounding 
amino acid residues hence giving insight into key residues that may play a crucial role 
in catalysis and substrate specificity. The residues that make close contacts (< 3.5A) 
with the 2F-Gal ring include Glu317, Asp316, Asp225, His280, His315 and Arg202 
with the last two residues making direct hydrogen bond interactions with the sugar 
ring. Interestingly the orientation o f  the UDP moiety o f  Hg-UDP-Gal in the wild type 
structure (Gastinel et al., 2001) is different from that o f  UDP-2F-Gal in the 
Arg365Lys mutant structure, with the biggest difference observed in the position o f 
the uracil ring o f UDP (Figure 3.12). The orientation o f  UDP from the Hg-UDP-Gal 
is influenced by the binding o f  the mercury (Hg2*) ion close to the uracil ring thereby 
shifting its position to minimise steric hindrance.
•  •
Figure 3.12: Stereo view representation of the Hg-UDP-Gal from the form I structure 
(Gastinel et al, 2001; PDB code: 1G93) shown in light cyan, superimposed on top of the 
UDP-2F-Gal from the Arg365Lys mutant structure shown in bright orange. Manganese ion is 
shown as a purple violet sphere.
Furthermore, the presence o f  the mercury ion might contribute to the disorder 
o f  the C-terminal region observed in the wild type structure. The Arg365Lys*UDP-
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2F-gal complex is a plausible structure for a donor substrate-enzyme complex that 
suggests a role for ground-state destabilization of the UDP-Gal in the catalysis of 
galactose transfer to disaccharide acceptors and other molecules including water 
(Zhang et al., 2001) and azide (Monegal and Planas, 2006). Interestingly the low 
catalytic activity of a3GT for galactose transfer to water or azide is an inverting 
reaction, producing [3-Galactose and (3-azido galactose in contrast to the retaining 
reaction for transfer to larger oligosaccharide substrates (Boix et al., 2002; Monegal 
and Planas, 2006). We have used the structures of the UDP-2F-Gal complex and UDP 
plus lactose complex to model a ternary complex containing both UDP-2F-Gal and 
lactose. This suggests that there is no steric clash when both substrates bind to the 
enzyme which is consistent with kinetic studies that show a3GT utilizes a sequential 
mechanism in which UDP is not released prior to acceptor substrate binding (Boix et 
al., 2002). The interactions between the 2F-Gal and enzyme are summarized in Table 
3.2; they are different from those between the wild-type enzyme and [3-Galactose in 
the structure of the complex containing hydrolyzed UDP-Gal complex (Boix et a l,
2002) (Figure 3.13). The Arg365Lys mutant retains significant catalytic activity, it is 
reasonable to suggest that the complex of UDP-2F-Gal complex with this mutant 
provides a suitable model for the a3GT*UDP-Gal complex. Consequently, residues 
making H-bond interactions with the 2F-Gal are likely to play important roles in 
specificity for the UDP-Gal relative to other UDP-sugars. It is interesting that in the 
histo-blood group A and B synthases, a A-acetylgalactosaminyl-transferase and a 
galactosyltransferase, respectively, that differ in sequence at only 4 sites, a key 
residue that contributes to their difference in specificity is Leu266 or Met266, of the 
A and B transferases, respectively, which corresponds to His280 of a3GT (Patenaude 
et a l, 2002). The presence of this residue may be a key to the high specificity of 
a3GT for UDP-Gal vs UDP-GalNAc since the imidazole ring appears to block the 
accommodation of the more bulky acetamido group on C2 of the galactose ring. The 
fact that mutation of His280 to Ala produces an enzyme with a low but significant 
level of UDP-GalNAc transferase activity is consistent with this view (Zhang et a l,
2003). Interactions of UDP-2F-Gal with Trpl95 and Lys359 can account for the 
stabilization of the Trpl95 loop and the C-terminus in the complex as compared with
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the apo-enzyme. We suggest that in the complex o f  wild-type a3GT with UDP-2F- 
Gal, the presence o f  Arg, as opposed to Lys at position 365 may result in stronger 
interactions between ligand and the C-terminal region producing increased order in 
this region than in the Arg365Lys mutant. A conformational difference between the 
complexes o f wild-type a3GT and the Arg365Lys mutant with the inhibitor may help 
to explain our ability to obtain crystals o f  the complex o f  UDP-2F-Gal with only the 
Arg365Lys mutant. In the UDP complex o f wild-type a3GT, the C-terminus is highly 
ordered as compared with the UDP-2F-Gal complex o f  the Arg365Lys mutant. There 
Arg365Lys mutant complex with UDP is also somewhat more ordered than the UDP- 
2F-Gal complex; however, this structure is complicated by the presence o f  a second 
manganese ion.
Figure 3.13: Stereo view of the UDP and galactose from the wild type a3GT 
structure (Boix et al, 2001; PDB code: 1GX0) shown in slate and green colour respectively, 
superimposed on top of UDP-2F-Gal from the Arg365Lys mutant structure shown in bright 
orange. Manganese ion is shown as a purple violet sphere.
In the histo-blood group A and B glycosyltransferases, there are flexible loops 
corresponding to those in a3G T. Unlike a3G T, these loops are disordered in enzyme 
complexes containing UDP and acceptor substrates as well as in the apo-enzymes 
(Patenaude et al., 2002). However naturally-occurring mutations in both loops have 
been shown to affect enzyme activity. Interestingly, the mutations in the large 
(Trpl95) loop specifically affect B-transferase activity while mutations in the C-
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terminal region affecting the Lys and Arg corresponding to Lys359 and Arg365 of 
a3GT affect the activities of both A and B transferases (Yazer and Palcic, 2005). 
Therefore, although the two loops in the A and B transferases do not become 
stabilized in the presence of UDP, with or without acceptor substrate, in contrast to 
a3GT, the effects of mutations suggest that these flexible regions play a significant 
role in the enzyme mechanism. This may reflect interactions between Trpl95 and the 
Gal or GalNAc of the donor substrate that do not occur in the UDP complex. 
Structural changes may occur in these regions only in the presence of the intact donor 
substrate, or in a ternary complex.
No structures are available for complexes containing both a UDP- 
Gal analogue and acceptor substrate or the UDP and trisaccharide product. However, 
as discussed previously, we have determined the structure of complexes containing a 
cleaved UDP-Gal, i.e. the products of galactose transfer to water, and of UDP plus 
acceptor substrates. The latter are dead-end inhibitory complexes while the former 
can be viewed as an enzyme»product complex of the UDP-Gal hydrolase activity. In 
all of these complexes, the C-terminus is highly structured, as in the UDP complex, 
being stabilized by interactions between Tyr361 and the p-phosphate and by direct 
and solvent mediated interactions between Arg365 (Lys in the Arg365Lys mutant) 
and both phosphates. A significant distinct feature of the closed conformation is a 
network of solvent molecules that is conserved between the various complexes that 
have this type of structure; these solvent molecules mediate interactions that stabilize 
the C-terminus. The presence of the 2F-Gal blocks the formation of this network, 
maintaining a more open conformation. Catalysis appears to be linked to a transition 
between this open conformation in which the C-terminus is partially ordered and the 
closed conformation present in the previously described structure of wild-type 
enzyme containing UDP plus galactose. The selective reduction in A^at arising from 
Lys359 and Arg365 mutations and the deletion of residues 365-368 are consistent 
with this being important for catalysis.
There is growing interest in the role of protein dynamics in protein functions 
including catalysis (Daniel et a l , 2003; Hammes-Schiffer and Benkovic, 2006). GTs
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can be divided into 65 or more families based on functional properties and sequence 
inter-relationships, but a limited array of them have been structurally characterized. 
The presence of one or two loops that are disordered in the absence of ligands but 
develop distinct ordered structures on substrate binding appears to be a widespread 
feature of these enzymes (Unligil and Rini, 2000). a3GT complexes containing UDP 
or UDP-2F-Gal show increased order in these loops relative to apo-enzyme structures 
but also much lower global temperature factors (17 A 2 vs 60 A 2) .  This may arise, in 
part, due to differences in molecular contacts in the different crystal forms but also 
appears to reflect the conformational flexibility of the ligand-free form.
The presence of a second manganese in the active site in the UDP complex of 
the Arg365Lys mutant, as well as the more open conformation, distinguishes its 
structure from that of the previously characterized complex with UDP (Boix et al., 
2001). The second manganese, like the Tris in the similar CA3 mutant structure, 
interacts with residues involved in binding acceptor substrates (Glu317, Gln247) and 
the galactose moiety of UDP-Gal (His280). The binding of a second cation in the 
active site has not been previously observed in complexes of the wild-type enzyme 
and it is possible that they could be artefacts linked to the mutations which perturb 
interactions between the C-terminus, ligands and active site. However, previous 
kinetic studies have shown that the activity of a3GT is modulated by the binding of 
manganese ions to two sites, a high affinity site with a Ad of 80 pM whose occupancy 
is essential for activity and a second, weaker site (Ad of 2 mM), that increases Vm 
about 3-fold (Zhang et al., 2001). It is possible that the weaker binding site is that 
occupied by the second manganese in the Arg365Lys complex with UDP (and is also 
mimicked by the Tris in the CA3 complex with UDP). The structure indicates that the 
second manganese can only bind after galactose has been transferred to the acceptor 
substrate and the trisaccharide product has dissociated from the enzyme. A plausible 
explanation of the effects of the two manganese ions is that the tight binding 
manganese is directly involved in UDP-Gal binding and catalysis, the second ion 
increases Acat by facilitating the disruption of interactions between the C-terminal loop 
and UDP product, facilitating the dissociation of UDP, the final step in the catalytic 
cycle.
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Conclusion
The results presented here show that the binding of a donor substrate analogue 
induces conformational changes in both the ligand and enzyme. Two loops of a3GT 
are stabilized in the complex of which the C-terminal region, in particular, is highly 
flexible. Structural transitions in this region are connected with donor substrate 
binding and distortion (ground state destabilization), cleavage of the UDP to 
galactose bond, formation of a binding site for acceptor substrate and UDP release. 
Both mutational and structural studies accentuate the key roles of two highly 
conserved basic residues, Lys359 and Arg365 in both C-terminal structural changes 
and catalysis.
Publication:
Five of the structures presented in this chapter have been published in the 
Journal of Molecular Biology. The coordinates of all five structures have been 
deposited to the Protein Data Bank (PDB) and their codes can be obtained from the 
reference below:
Jamaluddin, H., Tumbale, P., Withers, S.G., Acharya, K.R. and Brew, K. 
(2007) Conformational Changes Induced by Binding UDP-2F-Galactose to alpha-1,3 
Galactosyltransferase- Implications for Catalysis. J. Mol. Biol. 369: 1270-1281.
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3.3 In search for the catalytic nucleophile of a-1,3 Galactosyltransferase 
(a3GT)
3.3.1 Introduction
One of the main aims of this project was to shed light into the structural basis 
of a3GT catalytic mechanism. In particular to try to search for the ever elusive 
catalytic nucleophile which was implicated in a double displacement mechanism first, 
proposed by Gastinel and co-workers in 2001. Based on the form I structure (Gastinel 
et al., 2001), Glu317 was purported to be the catalytic nucleophile, however, the low 
resolution of the structure and high 5-factors have cast doubts on this conclusion. In 
2003, Zhang and co-workers reported that mutation of Glu317 to Gin affected the rate 
of galactosyltransfer however, the magnitude of this change does not support the 
proposal that Glu317 is the catalytic nucleophile in a double displacement mechanism 
(Zhang et al., 2003). We have carried out crystallisation attempts of the Glu317Gln 
mutant in complex with substrates in order to obtain conclusive evidence in support 
of the double displacement mechanism. Therefore, this chapter describes the 
crystallisation, structure determination, refinement and analysis of the first structure 
of a mutant of a3GT with an intact active donor substrate bound in the active site. 
This chapter will also discuss how this Glu317Gln-UDP-Gal complex structure has 
led to further mutational and structural studies and the implications that these mutant 
structures have towards the understanding of catalysis and specificity of a3GT.
3.3.2 Glu317Gln mutant in complex with UDP-Gal 
Crystallisation
We sought to obtain the crystal structure of the Glu317Gln mutant in complex with 
UDP-Gal. The protein was prepared as previously described in subchapter 3.1. 
lOmM MnCh and lOmM UDP-Gal were then added to the protein sample and 
incubated on ice for about 1 hour prior to crystallisation. Initial crystallisation 
attempts were carried out based on the published crystallisation condition which 
consisted of 5-10% PEG 6000 and 0.1M Tris-HCl pH 8 (Boix et al., 2002; Boix et
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al., 2001; Zhang et al., 2004; Zhang et a l, 2003). However, this condition did not 
produce any co-crystals but instead caused thick precipitation. An additive screen 
based on the original crystallisation condition was then carried out as described in 
subchapter 3.1. Among all the additives tested, the addition o f MPD was observed to 
facilitate solubility o f the protein and promote the formation o f  crystals (Table 3.0). 
Crystals o f  the Glu317Gln mutant in complex with UDP-Gal were grown at 16°C by 
vapour diffusion, by the hanging drop method by mixing 1 pi o f the protein at 
5mg/ml in 20mM MES-NaOH buffer, pH 6.0, 10% glycerol, containing 10 mM 
M nCh and 10 mM UDP-Gal, with an equal volume o f reservoir solution containing 
10% PEG 6000, 0.1M Tris-HCl, pH 8.0 and 8% MPD. Single crystals grew to a 
relatively large size (Figure 3.14) and diffracted up to 1.82 A (Figure 3.15). 
Crystallisation for the rest o f  a3GT mutants were carried out using this condition 
(PEG 6000 varying between 5-15% and MPD concentration varies between 2-20%) 
unless otherwise stated.
Figure 3.14: Crystals of Glu317Gln mutant in complex with UDP-Gal grew within 3-7 days 
at 19°C using the hanging drop technique at a protein concentration of 5 mg/ml. 1 pi of 
Glu317Gln mutant in 20mM MES-NaOH pH 6.0, 10% glycerol, lOmM MnCl2 and 5mM 
UDP-Gal was mixed with 1 pi well solution containing 10% PEG 6000, 8% MPD and 0.1M 
Tris-HCl, pH 8. (crystal size: 0.5 X 0.2 X 0.1 mm)
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Figure 3.15: Diffraction image for the Glu317Gln mutant in complex with UDP-Gal. 
Collected on station 14.2 at the SRS, Daresbury, UK. The rings mark the resolution limits of 
6 A, 3 A, 2 A and 1.6 A proceeding outwards from the centre. The data was processed to
1.82 A
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Data collection, Processing and Structure refinement
High resolution datasets were collected at the Synchrotron Radiation Source (SRS), 
Daresbury, UK for the Glu317Gln mutant in complex with UDP-Gal to 1.82 A 
resolution at station PX 14.2, using an Area Detector Systems Corp. detector system. 
The data were collected at cryogenic temperature of 100K using a cryoprotectant of 
25% glycerol. Raw data images were indexed and scaled using MOSFLM (Leslie, 
2001) and SC ALA (CCP4, 1994) respectively. The data were processed and scaled 
in the orthorhombic space group P222 to 1.82 A. The cell dimensions were a=87.03 
A, b= 91.38 A, c= 94.63 A and a=p=y=90°. The Glu317Gln co-crystal with UDP- 
Gal was highly mosaic but the high symmetry of the space group meant that 
relatively high completeness of 97.6% was still achieved (Table 3.4). The solvent 
content for the crystal was calculated using the CCP4 supported program, 
matthews_coeff. This helped to determine the number of molecules in the 
asymmetric unit. Calculations showed that for 2 molecules (molecular weight of 
-34000 Da per molecule) of Glu317Gln mutant in the asymmetric unit, the 
Matthews coefficient was 2.77A3/Da with the solvent content of around 56%.
Although the crystal lattice was determined as primitive orthorhombic 
(P222), it still remained to be determined which of the subgroups the crystal 
belonged to. This was confirmed by looking at the systemic absences in each of the 
sub-space groups. Two criteria were chosen for a reflection to be deemed as present. 
Reflections that hold true to the general as well as special conditions specified for a 
particular sub-group should be present and the I/oI value for each reflection that 
conforms to the former criterion should be greater than 2. The dataset was processed 
in the space group P222 and molecular replacement was carried out for all possible 
sub-groups in P222 using the wild type form I structure, PDB code: 1K4V (Boix et 
a l , 2001) as a search model. Finding a correct solution by molecular replacement is 
usually indicative that the space group used is correct. Structure solution was carried 
out by molecular replacement using the program MOLREP (CCP4, 1994) to find 2 
molecules in the asymmetric unit. The best solution was found in P2i2i2j space 
group with R-factor of 45.7% and correlation score of 63.8%. The dataset was also
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checked against the space group determination program, POINTLESS (CCP4,1994) 
and this program also picked up space group P2i2i2i. Analysis of the crystal packing 
of the structure solution in P2i2i2i space group did not show any clashes between 
the dimer and also the symmetry related molecules which is indicative that the 
solution obtained was correct.
Crystallographic refinement was performed using the program package CNS 
(Brunger et a l, 1998) and model building was carried out using the program COOT 
(Emsley, 2004). Procedures carried out with CNS included the slowcool protocol of 
simulated annealing at 2500K using a maximum likelihood target function, 
restrained individual B-factor refinement, conjugate gradient minimisation, and bulk 
solvent correction. The behaviour of the Rfree value [using a test set comprising of 
1069 (1.6%) reflections] was monitored throughout refinement. Iterative cycles of 
refinement alternated with model building in COOT improved the quality of the 
structure and brought down the conventional (Kcryst) as well as the Rfree values. Water 
molecules were gradually included into the model at positions corresponding to 
peaks in the |F0| -  |FC| electron density map with heights greater than 3a and at FI- 
bond distance from appropriate atoms. Residues with poor side-chain density were 
modelled as alanines and regions with very poor main chain electron density were 
excluded from refinement as not to bias the model. One bound MPD molecule from 
the crystallisation medium was identified and was included in the final stages of 
refinement. The final R ^  and Rfree for this structure are 18.7% and 20.1% 
respectively (Table 4). The program PROCHECK (Laskowski et a l, 1993) was used 
to assess the quality of the final structure. Analysis of the Ramachandran plot 
showed all the residues to be within allowed region of the plot (Figure 3.16).
101
Chapter 3 Structural Studies of Bovine a-1,3 Galactosyltransferase (a3GT)
Table 3.4: Data collection and refinement statistics for Glu317Gln-UDP-Gal complex 
structure
Substrates observed in the crystal structure Manganese
Intact UDP-Gal











Rtymm (%)* (outermost shell)b 10.1 (51.7)
Completeness (%) (outermost shell)b 97.9 (97.9)





% core/allowed 89.5 /10.5
RMSD from ideal
Bond angles (°) 1.481
Bond lengths (A) 0.015
Number of water molecules 723
B-factor statistics (A2)
Protein*
Ligand in the active site* 18.5(A), 18.0 (B)
Metal* 22.0 (GDU-A), 17.0 (GDU-B)
23.8 (MN1-A), 18.4 (MN1-B)
a Rsym„rI,fiLi[\Ilih) -  </(h)>|/5^^-(h)], where Ii is the rth measurement and </(/»)> is the weighted 
mean of all measurements of 1(h). 
b Outermost shell are 1.89-1.82 A .
c i?cryst= I.h\F0 - Fc\/UiF0, where F0 and Fc are the observed and calculated structure factor amplitudes 
of reflection h.
d  Rfree is equal to y« for a randomly selected 1.6% subset of reflections, not used in refinement. 
e Temperature factors for individual molecules quoted
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Figure 3.16: Ramachandran plot for the refined structure of Glu317Gln mutant of a3GT in 
complex with UDP-Gal at 1.82 A resolution. The red coloured region of the plot (A, B, L) 
represents the residues in the most favoured regions; yellow regions (a,b,l,p) represents 
residues in the additional allowed regions; grey/buff coloured regions (~a,~b,~l,~p) 
represents residues in generously allowed regions and white areas of the plot represents the 
sterically disallowed regions. The glycine residues are represented by triangles; AJaJ~a 
represent alpha helices; B/b/~b represent beta strands, L,l,~l represent left-handed helices; 
p/~p represent epsilon.
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Results
The structure showed that the mutation produced no overall changes in the structure 
of the mutant as compared to the wild type structure. After the first round of 
refinement, the electron density showed unambiguous difference density 
corresponding to the manganese ion and full-length UDP-Gal in the active site. The 
subtle mutation from glutamate to glutamine could not be observed clearly from the 
electron density as the mutation is structurally conserved. The electron density for 
the overall protein was ordered and well defined however, electron density for 
residues that correspond to the c-terminal region (residues 358 to 368) was observed 
to be very disordered except for the side chain density of residue Arg365.
The previous structure of the wild type a3GT in complex with UDP-Gal 
showed that the galactose moiety was cleaved off and is situated a distance away 
(approximately 4 A) from the p-phosphate of UDP, suggesting that hydrolysis of 
UDP-gal had taken place (Boix et al., 2002). In this Glu317Gln mutant structure, a 
full length UDP-Gal is bound in the active site of each of the 2 molecules (Figure 
3.17A) and this is consistent with kinetic studies which showed that this mutant has 
a markedly reduced hydrolase activity as compared to the wild type enzyme (Zhang 
et al., 2003). The UDP-Gal is bound to the enzyme in a distorted conformation as 
opposed to a fully extended conformation observed for UDP-sugars in other proteins 
(Thoden and Holden, 1998). In this structure, the galactose moiety is bent almost 
perpendicular to the plane of the diphosphate region of UDP, suggesting a role for 
ground state destabilization in catalysis. The UDP moiety binds essentially in the 
same manner as in previous structures of the wild type and mutant a3GT bound with 
UDP (Boix et al., 2002; Boix et al., 2001; Zhang et al., 2004; Zhang et al., 2003). 
With the exception of C-terminal residues contacts, all other protein contacts with 
the UDP moiety are the same between the complexes. The galactosyl moiety of 
UDP-Gal is highly ordered within the active site of the Glu317Gln mutant as shown 
in the well-defined electron density for the intact UDP-Gal as shown in figure 3.17. 
The ring adopts the stable 4Ci chair conformation and forms hydrogen bonds with 
the side chain atoms of residues Asp316, Asp225, His315, His280 and Arg202. Both 
0 2 ’ and 0 3 ’ hydrogen bond with the side chain carboxylate of the Asp225 while
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both 0 3 ’ and 0 4 ’ make hydrogen bonds with the carboxylate of Asp316 (Table 3.5), 
and this indicates that both these residues might play an important role in donor 
substrate binding and catalysis. Interestingly, Asp225 is invariant in the al,3- 
glycosyltransferase family whilst Asp316 is conserved in all a3GalT orthologs 
(Gastinel et a l, 2001). Similar bidentate hydrogen bonding has also been observed 
in structures of other glycosyltransferases such as the retaining galactosyltransferase 
LgtC from Neisseria meningitides (Persson et al., 2001), cyclodextrin 
glycosyltransferases and a-amylases (Brayer et a l , 2000). The main chain nitrogen 
atom of the mutated residue, 317 is at a close interacting distance (3.3 A )  with 0 4 ’of 
the galactose moiety. However, the side chain of the mutated residue does not make 
any direct interaction with the UDP-Gal as it is positioned as if it is stacking with the 
galactosyl ring of UDP-Gal (Figure 3.17A). A single water molecule is observed to 
interact directly with the galactosyl moiety of UDP-Gal in which it makes bidentate 
interaction with both 0 6 ’ and 0 5 ’ of galactose and a single interaction with OIB on 
the P-phosphate region of UDP (Figure 3.17A).
Table 3.5: Hydrogen bond interactions between UDP-Gal and a3GTmutant 
Glu317Gln
Ligand atom Interacting atoms Distance ( A )
(UDP-Gal) (a3GT- GIu317GIn )
0 2 ’ OD2 225 Asp 2.58
NE2 280 His 3.05
0 3 ’ OD1 225 Asp 2.97
NH2 202 Arg 2.86
0 4 ’ OD2 316 Asp 2.78
0 6 ’ ND1 315 His 2.77
Ligand atom Interacting atom Distance ( A )
(UDP-Gal)
0 5 ’ WAT 3.01
0 6 ’ 2.59
OIB 2.65
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Figure 3.17: A- Close-up view of the active site interactions between the galactose moiety of 
UDP-Gal with the surrounding residues. Also shown are the manganese ion and a water 
molecule which interacts directly with the sugar. The UDP-Gal molecule is depicted in 
yellow, manganese ion (MN) as a purpleviolet sphere and water molecule as a blue sphere. 
Residues from the active site cleft are represented in lightcyan while the residue from the C- 
terminus is represented in salmon. Close interactions are represented as black dashed lines. 
B- The electron density in grey represents the Fc-Fc map, contoured at 3 a, calculated from 
the final model, with UDP-Gal molecule omitted.
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When this structure is compared to the structure o f  Arg365Lys mutant in 
complex with UDP-2F-Gal (Jamaluddin et a l., 2007), it is observed that this single 
water molecule hydrogen bonds with 0 5 ’ o f  the galactose hence maintaining the 
stable 4Ci chair conformation. It is reasonable to assume that the absence o f  a water 
molecule to interact with the galactosyl moiety o f  UDP-2F-gal results in a distorted 
chair conformation o f the ring structure which along with the presence o f a fluorine 
atom at position 2 ’ o f  the ring, might contribute to the inhibitory nature o f  UDP-2F- 
Gal towards a3GT (Figure 3.18).
WAT
Figure 3.18: UDP-Gal from the Glu317Gln structure superposed with UDP-2F-Gal from the 
Arg365Lys structure (PDB code: 2JCF) (Jamaluddin etal., 2007). The UDP-Gal is shown in 
yellow sticks while UDP-2F-Gal is shown in pink sticks. Manganese ion is shown in purple 
sphere while the water molecule which interacts directly UDP-Gal is shown in cyan. Close 
contacts are shown as black dashed lines.
Another interesting feature o f  this structure is that the C-terminus is mostly 
disordered except for the conserved residue Arg365. The side chain electron density 
for residue 365 is quite defined although the main chain density is virtually absent 
(Figure 3.19). The side chain o f Arg365 interacts directly with the a-phosphate o f 
the UDP moiety similar to the interactions observed in the wild type-UDP complex
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structure. The difference in the interactions observed between Arg365 o f this 
complex with the wild type-UDP complex is that it lacks the interaction with the 
network o f  water molecules surrounding the p-phosphate region o f  UDP. This lack 
o f  interaction is due to the presence o f  the galactose moiety which displaced the 
network o f  water molecules. It is predicted that interactions between Arg365 with 
these water molecules along with a-phosphate o f  UDP and Tyrl39  function to 
stabilize the closed conformation o f  the C-terminus over the active site. The fact that 
only the side chain o f Arg365 is observed to interact with the intact UDP-Gal while 
other residues on the C-terminus are disordered is indicative that Arg365 plays an 
important role in catalysis.
Figure 3.19: Shown is the C-terminal region (highlighted in salmon) of the Glu317Gln 
mutant in complex with UDP-Gal. Shown is the disordered and broken electron density for 
the C-terminus region compared to the rest of the enzyme (highlighted in lightcyan). The 
electron density in light blue represents the 2F0-FC map, contoured at 1.0 o, calculated from 
the first model after molecular replacement. Defined electron density is only observed for 
the side chain of residue Arg365.
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We have also crystallised the Glu317Gln mutant in the presence of UDP-glucose in 
an attempt to obtain a complex structure of a3GT with an intact donor substrate 
(data not shown). However, in this structure, only the electron density for UDP 
moiety is visible while the glucose moiety is absent in the structure indicating that 
either the glucose moiety has been hydrolysed or that the glucose moiety is 
disordered due to the change in the vicinal hydroxyl chemistry at position 4’. If the 
former is true, our result would reflect another interesting finding on a mutant of 
bovine p4Gal-Tl. In this study, mutation of residue 228, a residue in the vicinity of 
Glu317, from Arg to Lys increased the glucosyltransferase activity of p4Gal-Tl 
(Ramakrishnan et a l , 2005). It is thought that residue Glu317 in p4Gal-Tl 
(equivalent to Asp316 in bovine a3GT) is important in determining the low 
glucosyltransferase activity of the enzyme (Ramakrishnan et a l , 2005). Glu317 of 
a3GT is in close proximity to Asp316 hence mutation of this residue might explain 
the increased activity for UDP-glucose. However, detailed kinetic study on the 
Glu317Gln mutant of a3GT with UDP-glucose has yet to be carried out therefore, 
any conclusion on the effect of the mutation on glucosyltransferase activity could 
not be drawn out as yet.
Further structural studies on a3GT mutants based on the Glu317Gln complex 
structure
To further elucidate the catalytic mechanism of a3GT, several mutations were 
carried out in order to understand the role of the residues surrounding the active site 
in catalysis. The crystal structure of the Glu317Gln mutant allowed us to identify the 
residues which make direct interactions with the galactose moiety of UDP-Gal prior 
to hydrolysis and enabled further mutational studies to be carried out on these active 
site residues. Described here are the crystal structures of a3GT with Asp316 mutated 
to Asn and Glu in complex with UDP and LacNAc, His280Arg mutant, the AGGL 
mutant which has 4 mutations in residues which are predicted to be important in 
donor substrate specificity: His280Ala, Ala281Gly, Ala282Gly and Ile22Leu as well 
as the 5 site mutant which has mutations on 5 residues encompassing both the donor
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substrate binding site as well as the acceptor substrate binding site; His280Gly, 
Cys338Leu, Gln247His, Ala248Pro and Trp249Gly.
3.3.3 Asp316 mutants in complex with UDP and N-acetyllactosamine 
(LacNAc)
Methods
In the crystal structure of the a3GT Glu317Gln, Asp316 is observed to interact 
directly with the 0 4 ’ atom of the galactose moiety hence constructs of a3GT with 
Asp316 mutated to Asn and Glu were created in order to study die role of this 
residue in substrate binding and catalysis. Crystallisation of both these mutants was 
carried out in the presence of UDP-Gal and LacNAc using the same crystallisation 
methods described previously for the Glu317Gln mutant. The structures of both 
mutants were determined by the molecular replacement method using the native 
form II structure (PDB code: 1K4V (Boix et al., 2001), as a search model with the 
program Molrep (Vagin and Teplyakov, 1997). Crystallographic refinement was 
performed using the program package CNS (Brunger et al., 1998) for the 
Asp316Glu while crystallographic refinement was carried out using the program 
REFMAC for the Asp316Asn mutant structures. After the initial refinement, the 
difference electron density maps revealed the presence of all the mutated residues at 
their respective positions and UDP, manganese ion and LacNAc bound in the active 
sites of the Asp316Glu and Asp316Asn mutants. Several rounds of refinement and 
model building using the program COOT (Emsley, 2004) were performed until the 
Rfree could not be improved. Water molecules were gradually included into the 
model at positions corresponding to peaks in the |F0| -  |FC| electron density map with 
heights greater than 3a and at H-bond distance from appropriate atoms. Data 
collection and refinement statistics are shown in table 6. The program PROCHECK 
(Laskowski et al., 1993) was used to assess the quality of the final structure. 
Analysis of the Ramachandran plot showed all the residues for the Asp316Glu and 
Asp316Asn complex structures to be within allowed region of the plot (Figure 3.20 
and Figure 3.21 respectively).
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"TableS. 6: Data collection and refinement statistics for Asp316Glu and Asp316Gln
complexes
Asp316Glu Asp316Asn






























Resolution (A) 50.0-1.76 50.0-2.2
R*jmm (%)* (outermost shell)b 7.9 (22.6) 12.0 (30.6)
Completeness (%) (outermost 93.1 (87.5) 94.9 (86.2)
shell)b
I/oI (outermost shell)b 20.36 (3.57) 9.74 (2.50)
Total reflections 412471 353562
Unique reflections 76955 39855
(%) 18.3/21.0 18.3/22.7
Ramachandran Plot 87.8/12.2 90.5/9.5
% core/allowed
RMSD from ideal






Number of water molecules 1256 426
Ligand B-factor statistics (A2) 
Protein* in the active site* 
Metal*
19.0 (A), 18.7 (B)
15.6 (UDP-A), 15.0 (UDP-B)
17.1 (MN1-A), 16.7 (MN1-B) 
25.0 (NAL-A), 25.6 (NAL-B)
22.0 (A), 21.8 (B)
17.6 (UDP-A), 16.9 (UDP-B) 
19.2 (MN1-A), 19.4 (MN1-B)
a  /^mn=£A£/[|/j(h) -  </(h)>|/S*Z;*/i(h)3, where I i  is the ith measurement and </(/»)> is the weighted mean o f  all measurements o f
m.
b  Outermost shell are 2.26-2.2 respectively.
c  R ay,t= I/,[F0 - F cY D iF 0, where F 0 and F c are the observed and calculated structure factor amplitudes o f  reflection h . 
d  Rfoc is equal to R ay*  for a randomly selected are 1.3% and 3% subset o f  reflections respectively, not used in refinement 
e  Temperature factors for individual molecules quoted.
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Phi (degrees)
Figure 3.20: Ramachandran plot for the refined structure of Asp316Glu mutant of a3GT in 
complex with UDP and LacNAc at 1.76 A resolution. The red coloured region of the plot 
(A, B, L) represents the residues in the most favoured regions; yellow regions (a,b,l,p) 
represents residues in the additional allowed regions; grey/buff coloured regions 
(~a,~b,~l,~p) represents residues in generously allowed regions and white areas of the plot 
represents the sterically disallowed regions. The glycine residues are represented by 
triangles; A/a/~a represent alpha helices; B/b/~b represent beta strands, L,l,~l represent left- 
handed helices; p/~p represent epsilon.
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Figure 3.21: Ramachandran plot for the refined structure of Asp316Asn mutant of a3GT in 
complex with UDP and LacNAc at 2.2 A resolution. The red coloured regions of the plot (A, 
B, L) represents the residues in the most favoured regions; yellow region (a,b,l,p) represents 
residues in the additional allowed regions; grey/buff coloured regions (~a,~b,~l,~p) 
represents residues in generously allowed regions and white areas of the plot represents the 
sterically disallowed regions. The glycine residues are represented by triangles; A/a/~a 
represent alpha helices; B/b/~~b represent beta strands, L,l,~l represent left-handed helices; 
p/~p represent epsilon.
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Results
Monoclinic crystals with 2 molecules per asymmetric unit were grown in the 
presence of UDP-Gal, manganese ion and LacNAc. Eventhough the mutants were 
crystallized in the presence of UDP-Gal, manganese and LacNAc, ordered electron 
density is only evident for the UDP moiety of UDP-Gal suggesting that either the 
Gal moiety was lost through hydrolysis during the experiment or the sugar moiety is 
disordered due to the mutation. The binding of UDP in both these structures is 
almost identical to the wild type enzyme in complex with UDP (Boix et a l, 2001). 
The binding of the acceptor substrate, LacNAc is essentially the same as in the wild 
type complex with a slight perturbation in the orientation of the GlcNAc moiety of 
the acceptor substrate. The area around the active site is similar to that of the wild 
type enzyme structure with the only difference observed at the site of the respective 
mutation. The orientation of Glu316 in the Asp316Glu mutant is essentially the 
same as the Asp316 in the wild type structure however residue Asn316 of the 
Asp316Asn showed a dramatic change in orientation. The position of Asn316 is 
almost a 180° turn from the position of Asp316 in the wild type enzyme (Figure 
3.22). This might explain the extremely low activity of this mutant compared to that 
of Asp316Glu and Glu317Gln mutant. Mutation to Asn completely abolished the 
carboxylic nature of the residue, hence, compromising its stabilising interactions 
with UDP-Gal. The absence of any major structural change in the enzyme indicates 
that the reduction in catalytic activity is a direct result of the change of the residues’ 
side chains chemistry in residue 316.
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D /E /N 3 1 6
Figure 3.22: Superposition of the Glu317Gln mutant structure in complex with UDP-Gal 
with the Asp316Glu and Asp316Asn structures. Residue 316 in the Glu317Gln, Asp316Glu 
and Asp316Asn mutant structures are shown in lightcyan, limegreen and chartreuse 
respectively.
3.3.4 His315Arg mutant in the presence of UDP.
Methods
His315 o f  a3GT which is observed to interact directly with the 0 6 ’ atom o f 
galactose moiety in the Glu317Gln mutant structure corresponds to the inactivating 
residue in Forssman synthase (FS) enzyme. Two His315 mutant constructs to Arg 
which corresponds to a substitution in inactive human FS and, mutation to Gin 
which corresponds to a residue present in the active canine FS were created and 
studied (Tumbale et a l., data not published). Mutational studies showed that the 
mutation o f  His315 to Arg reduced the kcat o f  the enzyme significantly whilst the 
mutation to Gin weakens UDP-Gal binding (Tumbale e t al., data not published). 
Crystals o f  His315Arg were grown in the presence o f  UDP-Gal were obtained 
although attempts to crystallise the His315Gln mutant were unsuccessful. 
Crystallisation o f  His315Arg mutant was carried out in the presence o f  UDP-Gal
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using the same crystallisation methods described previously for the Glu317Gln and 
the Asp316 mutants. The dataset was scaled and processed to 2.4 A resolution. 
Because the cell dimensions for the His315Arg dataset were isomorphous with the 
previously determined wild type structure [form II , PDB code: 1K4V (Boix et a l ,
2001)], these coordinates were used as a starting model. Crystallographic refinement 
was performed using the program REFMAC (CCP4, 1994). After the initial 
refinement, the difference electron density maps revealed the presence of the 
mutated residue at position 315 and unambiguous electron density corresponding to 
the UDP moiety of UDP-Gal and manganese ion bound in the active site. Water 
molecules were gradually included into the model at positions corresponding to 
peaks in the |F0| -  |FC| electron density map with heights greater than 3o and at FI- 
bond distance from appropriate atoms. The data collection and final refmement 
statistics are listed in Table 3.7. Data collection and refinement statistics are shown 
in Table 3.7. The program PROCHECK (Laskowski et al., 1993) was used to assess 
the quality of the final structure. Analysis of the Ramachandran plot showed all the 
residues for the His315Arg complex structure to be within the allowed region of the 
plot (Figure 3.23).
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Table 3.7: Data collection and refinement statistics for His315Arg-UDP complex structure













R,ymm (%)* (outermost shell)b 9.3 (15.3)
Completeness (%) (outermost shell)b 90.9 (74.1)





%  core/allowed 89.5 /10.5
RMSD from ideal
Bond angles (°) 1.113
Bond lengths (A) 0.008
Number of water molecules 434
B-factor statistics (A2)
Protein* 25.1 (A), 27.8 (B)
Ligand in the active site* 21.4 (UDP-A), 22.6 (UDP-B)
Metal* 19.5 (MN1-A), 25.2 (MN1-B)
a  /?«ymm=£fr£i[l//(h) -  </(h)>|/I*£i//(h)], where l i  is the rth measurement and </(/»)> is the weighted mean o f  all measurements o f  
1(h ).
b  Outermost shell are 2.06-2.40 A .
c  R c ,y tt- Z»\F0 -  F tfZ k F 0, where F a and F c are die observed and calculated structure factor amplitudes o f  reflection h . 
d  R f„ t is equal to R ^  for a randomly selected 3.5% subset o f  reflections, not used in refinement 
e  Temperature factors for individual molecules quoted
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Phi (degrees)
Figure 3.23: Ramachandran plot for the refined structure of the His315Arg mutant of a3GT 
in complex with UDP and manganese ion at 2.4 A resolution. The red coloured region of the 
plot (A, B, L) represents the residues in the most favoured regions; yellow regions (a,b,l,p) 
represents residues in the additional allowed regions; grey/buff coloured regions 
(~a,~b,~l,~p) represents residues in generously allowed regions and white areas of the plot 
represents the sterically disallowed regions. The glycine residues are represented by 
triangles; A/a/~a represent alpha helices; B/b/~b represent beta strands, L,l,~l represent left- 
handed helices; p/~p represent epsilon.
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Results
The crystal structure o f  the His315Arg mutant showed binding o f only the UDP 
moiety despite the fact that crystallisation was carried out in the presence o f  UDP- 
Gal, indicating that hydrolysis o f  UDP had occurred. Crystallisation was carried out 
in the absence o f acceptor substrate however, galactose can still be transferred to 
water albeit at a much slower rate. The structure o f this mutant is exactly the same as 
previous structures o f the wild type mutant and the Asp316 mutant complexes 
indicating that the crystallisation process is promoted after cleavage o f UDP-Gal and 
that the formation o f the dead-end UDP*enzyme complex optimises crystal 
formation in the ?2\ space group. The position o f  the side chain o f  mutant residue 
Arg315 is approximately 5 A away from the bound UDP however superposition of 
the Glu317Gln*UDP-Gal structure with the His315Arg structure showed that the 
longer side chain o f Arginine might interfere with the binding o f UDP-Gal or at the 
very least hinder the stabilisation o f  the folded conformation o f UDP-Gal (Figure 
3.24).
Figure 3.24: Superposition of UDP-Gal from the Glu317Gln mutant structure with the 
His315Arg mutant structure shows that the 0 6 ’ of the galactose moiety would be too close 
to the NH2 atom of the mutated Arg315 residue. Residues His315 from the Glu317Gln 
structure and Arg315 in the His315Arg mutant are shown as palecyan and palegreen sticks 
respectively while UDP-Gal is shown as yellow sticks. The close interactions between the 
315 residues and UDP-Gal are shown as black dashed lines.
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3.3.5 Discussion
It has been proposed that the catalytic reaction for retaining glycosytransferases 
proceeds through a mechanism involving a covalently bound glycosyl-enzyme 
intermediate (Breton et al., 2006; Lairson and Withers, 2004; Unligil and Rini, 
2000). If this scheme is to be followed, a suitable nucleophile should be located 
close to the anomeric carbon (Cl) of the UDP-Gal and on the correct (P) face to 
allow the displacement of the UDP leaving group. Previous structural studies on 
a3GT had identified residue Glu317 as a possible candidate for this role (Gastinel et 
al., 2001) however subsequent mutational and structural studies failed to support 
this theory (Boix et al., 2002; Boix et al., 2001; Zhang et al., 2003), hence casting 
the role of Glu317 as a catalytic nucleophile in the proposed double displacement 
mechanism in doubt. In recent years, a number of crystal structures representing 
several families of retaining transferases have been solved however due to the high 
hydrolase activity, only a fraction of these structures have intact donor substrates 
bound in the active site hence limiting the identification of possible catalytic 
nucleophiles for modeling attempts. Therefore, the determination of crystal 
structures with uncleaved donor substrates in the active site is highly anticipated. 
The crystal structure of the Glu317Gln mutant in the presence of the active substrate, 
UDP-Gal showed the intact substrate bound in the active site, providing insight into 
the interactions which occur between the active site residues and the donor substrate 
prior to hydrolysis of the sugar. The distorted conformation of the UDP-sugar is 
reflective of donor-enzyme complex structures of other glycosyltransferases and this 
suggests that this distorted conformation might play a role in the catalytic 
mechanism of glycosyltransferases. However this structure does not provide great 
support for the double displacement mechanism but instead tends to strengthen the 
S>ji type mechanism hypothesis which was previously proposed based on modeling 
studies (Boix et al., 2002). In this mechanism, it is proposed that 03 of the acceptor 
displaces the UDP on the same side of the galactose ring to produce an a-galactosyl 
product without formation of a P-galactosyl-enzyme intermediate. At the same time, 
02  of the p-phosphate of the UDP is positioned to deprotonate the acceptor 03
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deprotonate the acceptor 0 3  (Boix et a l , 2002).Although we currently do not have a 
crystal structure o f the enzyme in complex with both the intact donor and acceptor 
substrate, superposition o f the G lu317Gln-UDP-Gal complex structure with that o f 
the wild type enzyme in complex with UDP and lactose (PDB code: 1GX4) suggests 
that this might be a plausible mechanism for a3GT. The hydroxyl 0 3  atom from the 
galactose moiety o f  N-acetyllactosamine is 2.5 A away from the anomeric carbon 
C l ’ o f  UDP-Gal and the lack o f  any other polar atoms within 4 A o f the reactive 
center C l ’ suggests that the acceptor substrate might be a viable candidate for a 
nucleophile (Figure 3.31).




Figure 3.31: Structure of the wild type a3GT in complex with GalNAc (PDB code: 
lGX4(Boix et al., 2002)) modeled with UDP-Gal from the Glu317Gln structure. The red 
dashed line shows the distance between LacNAc and C l’ of UDP-Gal which is 
approximately 2.53 A.
A water molecule which forms direct hydrogen bonds with 0 6 ’ and 0 5 ’ o f the 
galactose moiety as well as O IB  on the p-phosphate o f  UDP is also in close 
proximity to the C l ’ carbon (3.87 A). The critical residue, 317 is positioned on the 
P-face o f  the galactose moiety however, it is too far from the C l ’ carbon (4.8 A ) to 
effectively act as a nucleophile in support o f the double displacement mechanism but 
on the other hand, the possibility o f structural changes occurring to allow a close
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approach of residue 317 to C l’ in the ternary enzyme complex cannot be totally 
precluded. The kinetic data showed that the mutation to Gin does cause a significant 
decrease in the catalytic activity of the enzyme however, the magnitude of this 
change does not lend support to the proposal that Glu317 is the catalytic nucleophile 
but instead suggests that Glu317 plays a role in acceptor substrate binding and in 
stabilizing a cationic transition state for galactose hydrolysis (Zhang et a l , 2003). 
The structure of the Glu317Gln mutant in complex with UDP-Gal also showed 
disorder of the C-terminus with the exception of residue 365 which shows obvious 
side chain density for the Arg residue. The Arg side chain is shown to interact 
directly with the 02A atom of the a-phosphate of UDP in a similar way as in the 
closed C-terminus structure (Form II) indicating that this residue might play a role in 
catalysis. The disorder of the C-terminus in the absence of acceptor probably 
indicates that binding of the acceptor and cleavage of the UDP-Gal bond might 
occur concurrently with the structural change of the C-terminus to the conformation 
which folds over to form the full active site. This structural change leads to the 
formation of the active site pocket which serves to provide an ideal environment for 
the binding of the acceptor molecule in the correct orientation for catalysis. The 
occlusive nature of the active site pocket facilitates efficient catalysis by ensuring 
that water molecules are excluded from the active site, or at least controlled within 
it. The bent conformation of the bound donor, UDP-Gal besides ensuring optimal 
binding by minimizing steric hindrance also acts to present the C l’ carbon for 
nucleophilic attack by the approaching acceptor molecule. It is possible that upon 
binding of the acceptor substrate the galactose ring of UDP-Gal is bent further 
underneath the diphosphate plane of UDP making the C l’ carbon more vulnerable to 
nucleophilic attack from 013 atom of the acceptor.
Residue Asp316 is predicted to play a role in stabilizing and controlling the 
folded conformation of the galactose ring in order for hydrolysis to occur. The 
kinetic data shows that mutation of this residue to glutamate decreased the Acat to 
31% of the wild type activity and this decrease in catalytic activity maybe attributed 
to the change in side change structure. Although we only managed to obtain the 
structure of Asp316Glu mutant in complex with a hydrolysed UDP-Gal (UDP) and
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N-acetyllactosamine, when this structure is superimposed with the structure of the 
Glu317Gln in complex with UDP-Gal it is obvious that the longer side chain of Glu 
would have made a much closer and stronger hydrogen bonding interaction with the 
0 4 ’ atom of galactose. This might have compromised the ability of the sugar moiety 
to be transferred to the acceptor molecule, furthermore, the longer side chain may 
have served as a barrier for the galactose ring to fold further underneath the 
diphosphate. Mutation of residue Asp316 to Asn renders the protein inactive and this 
could be due to the change in side chain chemistry which could have compromised 
the hydrogen bond interaction with the 0 4 ’ atom of galactose. Modelling of UDP- 
Gal in the crystal structure of the Asp316Asn mutant showed that the Asn residue 
faced away from the galactose moiety and would not have made any direct 
interactions with the galactose. Asp316 is expected to function in stabilizing the 
conformation of the sugar in the correct orientation for hydrolytic attack by the 
acceptor molecule.
3.4 Structural basis for substrate specificity of o3GT
3.4.1 Structure of AGGL (His280Ala-Ala281Gly-Ala282Gly-Ile283Leu) 
mutant in the presence of UDP-Gal
Introduction
His280 has been predicted to be responsible for conferring substrate specificity in 
a3GT (Gastinel et al., 2001). Several mutant constructs with substitutions of Gin, 
Asn, Thr, Arg, Ala, Gly, Leu, and Pro for His280 based on the variability of the 
residue corresponding to His280 in different relatives of a3GT were generated by 
Zhang and co-workers and studied (Zhang et al., 2003). These mutants were shown 
to have very low enzymatic activity with only the mutation to Gin displaying 
activity greater than 1% of the wild-type enzyme (Zhang et a l , 2003). Attempts to 
co-crystallise the His280 mutants with donor UDP-Gal were carried out in the hope 
of obtaining a structure of the mutant in complex with the un-cleaved donor 
substrate and to shed light on how His280 can structurally confer substrate
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specificity of a3GT towards UDP-Gal. All of the His280 mutants were less soluble 
than the wild type enzyme and tend to precipitate on addition of the donor substrate, 
UDP-Gal. This made characterisation and crystallisation of the mutants in the 
presence of substrates almost impossible. Due to this factor, the AGGL mutant was 
constructed based on the structure of the Glu317Gln»UDP-Gal complex in order to 
study the donor substrate specificity of the enzyme. In the Glu317Gln complex 
structure, it is observed that the 0 2 ’ atom of the galactose moiety interacts directly 
with His280 which has been previously implicated in the substrate recognition and 
specificity of a3GT. Previous mutational studies of His280 showed that mutations to 
smaller side chains, Alanine and Glycine showed low levels of GalNAc transferase 
activity while mutation to a larger side chain, Arginine rendered the enzyme 
completely inactive (Zhang et al., 2003) which contradicted previous studies on 
porcine a3GT by Lazarus and co workers which stated that mutation of His271 
(porcine equivalent to bovine His280), a residue critical for donor substrate 
recognition to smaller side chain residues such as Ala, Leu and Gly caused complete 
loss of activity whilst mutation to Arg retained the enzyme’s activity. (Lazarus et al.,
2002). Characterisation of the mutant showed that the donor substrate specificity 
was altered from UDP-Gal to UDP-GalNAc. It displayed a marked increase in UDP- 
GalNAc hydrolysis and a lower activity for Gal transfer (Tumbale et. al, 
unpublished results).
Methods
Crystallisation of this mutant in the presence of UDP-GalNAc was sought in order to 
observe the interactions of the GalNAc moiety with residues of the AGGL mutant 
and shed light into how changes in the side chain chemistry of the respective 
residues affect substrate binding and specificity. This mutant was relatively easy to 
crystallise compared to the other His280 mutants described previously. Crystals of 
the AGGL mutant grew in the presence of UDP-GalNAc and in conditions 
containing 10-15% PEG 6000, 15-25% MPD and 0.1M Tris-HCl, pH 8. No 
additional cryoprotectant was used during data collection as the high concentration 
of MPD in the crystallisation condition could sufficiently serve as cryoprotectant. A
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dataset was collected, processed and scaled to 2.7 A in P3j21 space group with one 
molecule in the asymmetric unit. The structure was solved by the molecular 
replacement method using the native form II structure (PDB code: 1K4V (Boix et 
a l , 2001) as a search model with the program Molrep (Vagin and Teplyakov, 1997). 
Crystallographic refinement was performed using the program package REFMAC 
(CCP4, 1994). Residues with poor side-chain density were modelled as alanines and 
regions with very poor main chain electron density were excluded from refinement 
as not to bias the model. Water molecules were gradually included into the model at 
positions corresponding to peaks in the |F0| -  |FC| electron density map with heights 
greater than 3a and at H-bond distance from appropriate atoms. Refinement was 
carried out until the ^ryst and could not be improved. The data collection 
statistics and the final refinement statistics are listed in Table 8. The program 
PROCHECK (Laskowski et al., 1993) was used to assess the quality of the final 
structure. Analysis of the Ramachandran plot showed all the residues for the 
His280Arg structure to be within allowed region of the plot (Figure 3.26).
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Table 3.9: Data collection and refinement statistics fo r  the AGGL mutant structure















Rtymm (%)* (OUteiTOOSt Shell)b 13.7 (30.3)
Completeness (%) (outermost shell)b 99.7 (98.3)







Bond angles (°) 0.010
Bond lengths (A) 1.199
Number of water molecules 44
B-factor statistics (A2)
Protein* 24.4
Ligand in the active site* 20.6 (UDP)
Metal* 20.8 (MN1)
a /2>yinil=£A£l[|/i(h) -  </(h)>|/£*£i/i(h)], where li  is the rth measurement and <I(hy> is the weighted mean of all measurements of
m
b Outermost shell are 2.77-2.7 A.
c Ray«= £a|F0 - F f^UiF0, where F„ and Fc are the observed and calculated structure factor amplitudes o f reflection h. 
dRtec is equal to for a randomly selected 8% subset of reflections, not used in refinement 
e Temperature factors for individual molecules quoted
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Figure 3.26: Ramachandran plot for the refined structure of the AGGL mutant of a3GT in 
complex with UDP at 2.7 A resolution. The red coloured region of the plot (A, B, L) 
represents the residues in the most favoured regions; yellow regions (a,b,l,p) represents 
residues in the additional allowed regions; grey/buff coloured regions (~a,~b,~l,~p) 
represents residues in generously allowed regions and white areas of the plot represents the 
sterically disallowed regions. The glycine residues are represented by triangles; A/a/~a 
represent alpha helices; B/b/~b represent beta strands, L,l,~l represent left-handed helices; 
p/~-p represent epsilon.
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Results
The AGGL mutant crystallised in the trigonal space group with one molecule per 
asymmetric unit. The crystal structure o f the mutant showed binding o f  the 
manganese ion and UDP without the GalNAc moiety even though it was crystallised 
with UDP-GalNAc indicating that hydrolysis might have take place. The mutations 
for the respective residues His280 to Ile283 were also observed in the structure 
clearly. The mutations left a pocket in the donor substrate recognition site that would 
accommodate the bulky 2-acetamido group o f GalNAc (Figure 3.27) hence, 
explaining the relatively higher activity that this mutant has towards GalNAc as 
compared to Gal (Tumbale et al., unpublished data). This indicates that the mutation 






Figure 3.27: AGGL mutant structure modeled with UDP-GalNAc. Residues from the AGGL 
mutant are shown in violet while the modeled UDP-GalNAc is shown in limegree
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3.4.2 Structure of the 5 site (His280Gly-Cys338Leu-Gln247His-Ala248Pro- 
Trp249GIy) mutant in the presence of donor substrates
Methods
The 5 site mutant was constructed in order to study the effects of mutating residues 
identified as important for donor and acceptor binding on the catalytic efficiency of 
the enzyme. Crystallisation of the 5 site mutant in the presence of both donor and 
acceptor substrates was carried out in the hope of obtaining a crystal structure of 
a3GT with both the intact UDP-Gal and LacNAc bound in the active site. Crystals 
of the 5 site mutant were grown in the presence of 10 mM MnCb, lOmM UDP and 
UDP-gal respectively in crystallisation condition containing 10-15% PEG 4000, 0.1 
M Tris-HCl, pH 8.0 and 0.2 M sodium acetate. Before data collection the crystals 
were flash-cooled at 100K in a cryoprotectant containing the reservoir solution and 
25% glycerol. 5 site mutant datasets to 2.1 A and 1.88 A resolution respectively 
(station PX 14.2, SRS Daresbury, using an Area Detector Systems Corp. detector 
system) were collected. Raw data images were indexed and scaled using the 
DENZO and SCALEPACK modules of the HKL suite (Otwinowski and Minor, 
1997). The structures of the 5 site mutants were determined by the molecular 
replacement method using the native form II structure [PDB code: 1K4V (Boix et 
a l , 2001)], as a search model with the program MOLREP (Vagin and Teplyakov, 
1997). Crystallographic refinement was performed using the program REFMAC. 
After the initial refinement, the difference electron density maps revealed the 
presence of all 5 mutated residues at their respective positions. Water molecules 
were gradually included into the model at positions corresponding to peaks in the 
|F0| -  |FC| electron density map with heights greater than 3a and at H-bond distance 
from appropriate atoms. Residues with poor side-chain density were modelled as 
alanines and regions with very poor main chain electron density were excluded from 
refinement so as not to bias the model. Refinement was carried out until the Royst and 
Rfree could not be improved. The data collection statistics and the final refinement 
statistics are listed in Table 3.10. The program PROCHECK (Laskowski et a l, 
1993) was used to assess the quality of the final structure. Analysis of the
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Ramachandran plot showed all the residues for the 5 site mutant structures to be 
within the allowed regions of the plot (Figure 3.28 and 3.29 respectively).
Table 3.10: Data collection and refinement statistics for the 5 site mutant grown in the 
presence of UDP and UDP-Gal respectively
5 site mutant (His280Gly-Cys338Leu-Gln247His-Ala248Pro- 
Trp249Gly)______________
Substrates used in lOmMUDP lOmMUDP-Gal
crystallisation lOmM Manganese lOmM Manganese
Substrates observed in the none none
crystal structure
Disordered regions 191-198 343-368
342-368
Space group P32 P32
Mols/A.S.U 2 2
Crystal parameters




P O 90.0 90.0
y O 120.0 120.0
Resolution (A) 50.0-2.1 50-1.88
Rfymm (%)* (outermost shell)b 6.4 (34.9) 7.3 (46.0)
Completeness (%) (outermost 98.0 (80.7) 95.6 (87.5)
shell)b
I/a l (outermost shell)b 28.33 (3.79) 17.19(2.66)
Total reflections 565302 609673
Unique reflections 39902 52337
22.2/25.19 19.9/24.4
Ramachandran Plot 88.7/11.3 92.0/8.0
%  core/allowed
RMSD from ideal
Bond angles (°) 1.256 1.132
Bond lengths (A) 0.009 0.009
Number of water molecules 328 408
B-factor statistics (A2)
Protein® 27.2 (A), 27.3 (B) 25.0 (A), 25.0 (B)
Ligand in the active site® - -
Metal® - -
a ,^ynmi=£/,I,[|//(h) -  </(h)>|/EAZ;*/<(h)], where Ii is the rth measurement and </(A)> is the weighted mean o f all measurements of
m.
b Outermost shell are 2.16-2.11 and 1.93-1.88 respectively.
c Jieryst= Ia|F„ - FJ/DiFo, where Fa and Fc are die observed and calculated structure factor amplitudes of reflection h. 
d  is equal to Ray* for a randomly selected are 2.8% and 2.1% subset of reflections respectively, not used in refinement 
e Temperature factors for individual molecules quoted
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Figure 3.28: Ramachandran plot for the refined structure of the 5 site mutant of a3GT in the 
presence of UDP at 2.1 A resolution. The red coloured regions of the plot (A, B, L) 
represents the residues in the most favoured regions; yellow regions (a,b,l,p) represents 
residues in the additional allowed regions; grey/buff coloured regions 
represents residues in generously allowed region and white areas of the plot represents the 
sterically disallowed regions. The glycine residues are represented by triangles; A/a/~a 
represent alpha helices; B/b/~b represent beta strands, L,l,~l represent left-handed helices; 
p/~p represent epsilon.
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Figure 3.29: Ramachandran plot for the refined structure of the 5 site mutant of a3GT in the 
presence of UDP-Gal at 1.88 A resolution. The red coloured regions of the plot (A, B, L) 
represents the residues in the most favoured regions; yellow region (a,b,l,p) represents 
residues in the additional allowed regions; grey/buff coloured regions (~a,~b,~l,~p) 
represents residues in generously allowed regions and white areas of the plot represents the 
sterically disallowed regions. The glycine residues are represented by triangles; A/a/~a 
represent alpha helices; B/b/~b represent beta strands, L,l,~l represent left-handed helices; 
p/~p represent epsilon.
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Results
The crystal structures of the 5 site mutant in the presence of UDP and UDP-Gal are 
in the trigonal space group with 2 molecules in the asymmetric unit. This structure 
did not show any ligand binding even though the crystallisation was carried out in 
the presence of donor substrates and manganese ions. Interestingly this structure 
showed significant amounts of disorder and rearrangement in several regions of the 
enzyme. The disorder and rearrangement is thought to be mostly attributed to the 
respective mutations which had been carried out. Although electron density for most 
of the polypeptide chain of this mutant is very well defined, there are several regions 
which exhibit very poor electron density. Exclusion of these regions from refinement 
showed almost complete absence of electron density for region 192-198 and region 
342-368 (Figure 3.30A) for the 5 site mutant structure in the presence of UDP whilst 
the 5 site mutant in the presence of UDP-Gal only showed disorder in region 
between residues 343-368. The disorder for region 192-198 is similar to the structure 
of the ‘apo’ wild type enzyme in previous studies (Jamaluddin et a l, 2007). This 
seems to suggest that the 192-198 region is highly flexible and undergoes a 
conformational change on binding of the donor substrate (Jamaluddin et al., 2007). 
The rearrangement and disorder in the region 342-368 is observed to be attributed to 
the mutation of residue Trp249 to glycine. In the wild type enzyme structure Trp249 
is observed to make a direct interaction with Asp340 (Figure 3.30B). We believe 
that this interaction is important in maintaining the structural integrity of the 
enzyme, therefore mutation to glycine in the 5 site mutant would disrupt this crucial 
interaction hence destabilising the region corresponding to residues 342 to residue 
368. The large structural changes that are observed in this mutant may be one of the 
reasons why this mutant displayed very low activity and why we fail to observe 
binding for the donor substrate despite being crystallised in the presence of UDP and 
UDP-Gal respectively. Interestingly the disorder and rearrangement observed in 
these structures are similar to that of the His280Arg mutant structure.
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Figure 3.30- A: Ca trace of the wild type a3GT structure (green) with the structure of the 5- 
site mutant in the presence of UDP (magenta). The region highlighted by a red circle shows 
the region of the mutation. B: 5 mutated residues and the effect of the mutation has on the 
structural integrity of the enzyme. Mutation of Trp249 to glycine disrupted the interaction 
with Asp340 hence causing disorder in the region beyond Asp340.
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3.43 Discussion
The AGGL mutant showed remarkably low galactosyltransferase activity but 
increased GalNAc transferase activity indicating that the quadruple mutation has 
altered the specificity of the enzyme. Although we could not obtain a structure of the 
AGGL mutant in complex with an intact UDP-GalNAc, modeling of GalNac in the 
active site of the mutant suggests that there is enough space to accommodate the 2- 
acetamido group of GalNAc at the substrate recognition pocket. Changes in donor 
substrate specificity due to mutagenesis have been reported for other 
glycosyltransferases with the most recent being of the human blood group B 
galactosyltransferase in which mutation of a residue adjacent to the metal binding 
motif changed the specificity of the enzyme from UDP-Gal to UDP-GalNAc 
(Persson et al., 2007). Other reported studies include mutants of bovine 4-P- 
galactosyltransferase which displayed increased glucosyltransferase activity upon 
mutation of a single residue, Arg228Lys (Ramakrishnan et al., 2005) and increased 
GalNAc transferase activity with a Tyr289Leu mutation (Ramakrishnan and Qasba, 
2002). The donor specificity of toxin B glucosyltransferase from C. difficile altered 
to UDP-GalNAc upon a double mutation (Jank et al., 2005). A plant anthocyanin 
galactosyltransferase altered its specificity to glucosyltransferase with a Gln382His 
mutation (Kubo et al., 2004). This shows how altering the size and shape of the 
substrate recognition pocket in glycosyltransferase via mutation can change the 
specificity of the enzyme hence, offering a promising scheme for structure based 
protein engineering to generate glycosyltransferases of desired specificity.
The 5 site mutant has mutations on residue His280 and Trp249 indicating 
that the disorder which is observed in both structures might be due to the structural 
change of the side chain residue. In the wild type enzyme structure, His280 is 
observed to interact with residue Trp356 via a water molecule and residue Trp249 is 
observed to interact directly with Asp340. In the 5 site mutant, His280 and Trp249 
are mutated to glycines, totally eliminating the side chain structures that coordinate 
these interactions and in effect compromising the structural integrity of the enzyme 
hence, causing rearrangement and disorder of the region beyond residue 337. This
135
Chapter 3 Structural Studies of Bovine a -1,3 Galactosyltransferase (a3GT)
result is indicative of how mutations can compromise the structural integrity of a 
protein.
3.5 Conclusions
The results presented here serve to highlight the role of the residues lining the active 
site in particular residue Glu317 which previously has been implicated as the 
catalytic nucleophile for a proposed double displacement mechanism. Structural and 
mutational studies that we have carried out however, points to a possibility of a 
different mode of mechanism in which the acceptor molecule itself acts as the 
catalytic nucleophile. We predict that Glu317 acts to facilitate acceptor substrate 
binding and stabilize a cationic transition state for galactose cleavage. The formation 
of the ternary complex for catalysis is inherently linked to the conformational 
change of the C-terminus which provides an enclosed environment for efficient 
catalysis by minimizing unwanted hydrolysis. His280 plays an important role in 
catalysis by conferring the donor substrate specificity of the enzyme. There is 
potential for structure based rational design of a3GT with differing donor substrate 
specificity.
3.4.4 Crystal structure of a3GT in complex with /?-Nitrophenyl galactoside 
(pNPGal) and modeling studies of a3GT with the inhibitor U66.
Introduction
Enzymes are nature’s very own catalyst and they exhibit unparalleled catalytic 
prowess and environmental compatibility. Despite these attractive attributes 
enzymes have yet to witness widespread application in synthetic chemistry. The 
under use of their enormous potential stems not only from the reluctance of synthetic 
chemists to deviate from their conventional chemical methods but also from the 
general limitations on enzyme applicability that arise from the high degree of 
substrate specificity displayed by most enzymes. However, concerted efforts by 
means of rational protein engineering and directed evolution methods to alter 
substrate specificity are successfully challenging the perceived latter limitation.
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Another alternative strategy for the expansion of an enzyme’s substrate specificity 
hence, its synthetic application is through ‘substrate engineering’. The attachment of 
a readily removable functional group to an alternative glycosyltransferase substrate 
induces a productive binding mode, facilitating rational control of substrate 
specificity and regioselectivity using wild-type enzymes (Lairson et al., 2006). 
Furthermore recent studies in the use of glycosyltransferase to synthesise 
glycoconjugates for therapeutic use has sparked interest in the application of 
alternative donor and acceptor substrates for the assembly of variable forms of 
glycoconjugates. Here we present the crystal structure of the wild type a3GT in 
complex with UDP and an alternative acceptor molecule p-Nitrophenyl galactoside 
(pNPGal). This chapter will also discuss modeling studies of an inhibitor of a3GT 
which is designated as U66. This chapter will also move on to describe soaking and 
co-crystallisations attempts which have been carried out in order to obtain the crystal 
structure of a3GT in complex with the inhibitor U66.
3.4.4.1 Crystal structure of wild type a3GT in complex with p-Nitrophenyl 
galactoside (pNPG).
Methods
Preparation of the wild type a3GT sample was carried out as previously described. 
Wild type complex crystals were grown in 5% PEG 6000 and 0.1M Tris-HCl, pH 8 
in the presence of lOmM MnCfe and lOmM UDP. The wild type crystals (Figure 
3.32) were then subjected to soaks in total of 50 mM pNPGal with gradual 
increment in concentration of 10 mM over a period of 5 days prior to X-ray 
exposure.
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Figure 3.32: Typical crystal of wild type a3GT in a 2pl drop grown in 5-10% PEG 6000 and 
0.1M Tris-HCl, pH 8; in the presence of lOmM MnCl2 and lOmM UDP. These crystals will 
usually diffract to better than 2 A resolution (maximum crystal size: 0.7 X 0.4 X 0.3 mm)
As the cell dimensions were isomorphous with the wild type structure, the 
published structure o f  the form II wild type enzyme [PDB code: 1K4V (Boix et al., 
2001)] was used directly in refinement. Crystallographic refinement was performed 
using the program REFMAC (CCP4, 1994). After the initial refinement, the 
difference electron density maps revealed unambiguous density corresponding to 
pNPGal bound at the acceptor binding site o f  the enzyme. Defined and ordered 
electron density is also observed for the UDP molecule and the manganese ion. 
Several rounds o f refinement and model building using the program COOT (Emsley, 
2004) were performed until the R free could not be improved. Water molecules were 
gradually included into the model at positions corresponding to peaks in the |F0| -  
|FC| electron density map with heights greater than 3a and at H-bond distance from 
appropriate atoms. Data collection and refinement statistics are shown in table 3.11. 
The program PROCHECK (Laskowski e t a l., 1993) was used to assess the quality o f 
the final structure. Analysis o f  the Ramachandran plot showed all the residues for
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the wild type a3GT complex with UDP and pNPGal to be within the allowed 
regions of the plot (Figure 3.33).
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Table 3.11: Data collection and refinement statistics for WT a3GT-p-Nitrophenyl- 
Galactoside complex structure
Substrates observed in the crystal structure Manganese
UDP












Rtymm (%)* (outermost shell)b 8.6 (22.2)
Completeness (%) (outermost shell)b 94.4 (80.7)





% core/allowed 91.3 /8.7
RMSD from ideal
Bond angles Q 1.481
Bond lengths (A) 0.015
Number of water molecules 552
B-factor statistics (A2)
Protein* 18.2(A), 18.0 (B)
Ligand in the active site* 13.0 (UDP-A), 33.1 (pNPGal), 13.7 (UDP-B) 
35.8 (pNPGal)
Metal* 14.9 (MN1-A), 15.0 (MN1-B)
a .Rqanr^AZ/d/^) -  </(h)>|/£fr£j/j(h)], where //  is the /th measurement and <l(hy> is the weighted mean o f all measurements o f
m.
b Outermost shell are 2.17-2.12 A .
c Rcy,t= Z*[F0 - FtfZhFo, where F0 and Fc are the observed and calculated structure factor amplitudes o f  reflection h. 
d is equal to for a randomly selected 2.6% subset of reflections, not used in refinement.
e Temperature factors for individual molecules quoted
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Figure 3.33: Ramachandran plot for the refined structure of wild type a3GT in complex with 
P-nitrophenyl galactoside (pNPGal) at 2.12 A resolution. The red coloured regions of the 
plot (A, B, L) represents the residues in the most favoured regions; yellow region (a,b,l,p) 
represents residues in the additional allowed regions; grey/buff coloured regions 
(~a,~b,~l,~p) represents residues in generously allowed regions and white areas of the plot 
represents the sterically disallowed regions. The glycine residues are represented by 
triangles; A/a/~a represent alpha helices; B/b/~b represent beta strands, L,l,~l represent left- 
handed helices; p/~p represent epsilon.
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Results
/j-Nitrophenyl galactoside (pNPGal) binds at the acceptor binding site of a3GT in 
which the galactose moiety binds similarly to the galactose moiety of the enzyme’s 
natural acceptor substrate N-acetyllactosamine (LacNAc). However binding of the 
nitrophenyl moiety differs slightly from the binding of the GlcNAc moiety of 
LacNAc in which the position of the nitrophenyl ring is slightly perturbed compared 
to the GlcNAc ring of LacNAc (Figure 3.34 and 3.35). The perturbation in the 
orientation is due to the absence of vicinal hydroxyl groups on the nitrophenyl ring 
of pNPGal. These vicinal hydroxyl groups on LacNAc make more hydrogen bond 
interactions with water molecules. In LacNAc, the vicinal hydroxyl, 03 of the 
GlcNAc moiety interacts directly with NE1 of Trp250. This interaction as well as 
hydrogen bond interactions with water molecules and the hydrophobic interactions 
which exist between the rings, facilitate in stabilizing the position of the GlcNAc 
ring in its parallel stacking orientation to the ring of Trp249 (Figure 3.35 and Figure 
3.36). This might explain the higher binding affinity that a3GT has towards its 
natural acceptor substrate, LacNAc compared to pNPGal. Based on hydrogen 
bonding calculation of HBPLUS (McDonald and Thornton, 1994), LacNAc has 
more hydrogen bonding interactions with the surrounding residues compared to 
pNPGal while pNPGal makes more hydrophobic interactions with the surrounding 
residues (Figure 3.36). The higher number of hydrogen bonding formation between 
LacNAc and the binding site residue again is reflected in stronger binding of 
LacNAc at the active site.
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Figure 3.34: Diagram o f the Fo-Fc electron density contoured at 3.0 o level, o f pNPGal. Diagram B shows the interactions o f a3GT 
with pNPGal. The protein residues are drawn as ball-and-stick m odels, water molecules appear as cyan spheres , and the pNPGal is 
shown in orange. The manganese ion (MN) is shown as a purple sphere. H-bonds are indicated by dashed  lines. The figures were 
created with pymol.
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Figure 3.35: Diagram o f the Fo-Fc electron density contoured at 3.0 o level, o f  LacNAc in a3GT. Diagram B shows the interactions 
o f a3G T with LacNAc. The protein residues are drawn as ball-and-stick m odels , water molecules appear as cyan spheres, and the 
LacNAc is shown in teal. The manganese ion (MN) is shown as a purple sphere. H-bonds are indicated by d ashed  lines. The figures 
were created with pymol.
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Table 3.12: Comparison of the close interactions (between 2.5A and 3.5A) between the natural acceptor 
substrate LacNAc and the alternative acceptor substrate p-Nitrophenyl galactoside (pNPGal) with wild type 
a3GT
Wild type a3GT«LacNAc complex [PDB code: 
1GX4 (7)]





[C5 0 1 3
.Cl 2








LacNAc Distance (A) Residue or 
ligand/Atom
pNPGal Distance (A)
Glu317/OEl 014 2.83 Glu317/OEl 0 4 2.75
Glu317/OE2 014 3.29 Gln247/NE2 0 4 2.85
Gln247/NE2 014 3.18 Gln247/NE2 05 2.90
Thr259/OG 1 016 2.85 Gln247/NE2 0 1 ’ 3.39
Trp250/NE1 03 3.21 Thr259/OGl 06 2.68
Glu317/OE2 014 3.29 Glu317/OE2 0 4 3.28
Gln247/NE2 015 2.99 Glu317/OEl 0 4 2.73
UDP/01B 013 3.31 Trp250/NE1 0 6 3.28
UDP/02B 013 2.67 UDP/02B 0 3 2.54
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— •  LacNAc Non-ligand residues involved in hydrophobic contact(s)
— #  R esidues of alpha-GT
0  Hydrogen bond and its length 0  Corresponding atom s involved in hydrophobic contact(s)
Figure 3.36: Comparison of hydrogen bond interactions and hydrophobic interactions 
calculated by the program HBPLUS (McDonald and Thornton, 1994).
146
Chapter 4 Crystallisation of Canine Forssman Synthase
Discussion
Glycoconjugates which are bound to proteins or lipids play an essential role in many 
biological processes. Glycoconjugates play an important role in cell signaling and 
recognition and have been implicated in related processes such as cellular 
differentiation and immune response. The varied role that glycoconjugates have 
suggests the power of carbohydrates in therapeutic approaches. For example, the a-1 
acid glycoprotein and the IgG molecule both display variations in glycan structure in 
disease when compared to those on healthy references cells during acute phase 
response and rheumatoid arthritis respectively (Dwek, 1996; Mackiewicz et al., 
1991; Varki, 1993). The tetrasaccharide sialyl Lewis X and related structures are key 
determinants in the recruitment of lymphocytes during inflammation (Springer, 
1990) and furthermore, it has long been known that glycoconjugates on protein 
carriers are able to induce an antibody response that might protect an organism from 
infection. a3GT in particular has the potential to be used in cancer therapeutics as 
the product of the enzyme the a-Gal epitope has been shown to elicit strong immune 
response in humans. Theoretically, a rationally designed conjugate with a specific 
ligand at one end that specifically binds cancer cells and an a-Gal epitope at the 
other end will coat the cancer cells with a-Gal epitopes, and induce anti-Gal 
mediated immune response. For this reason there is an increased interest in the use 
of a-Gal epitopes for the treatment of prostate or breast cancer cells. Hence, the 
study on the enzymatic synthesis of the a-Gal epitope by the enzyme a3GT is an 
important tool in glycodiversification. Understanding the catalytic mechanism of 
a3GT by means of structural studies can assist in structure based protein engineering 
to generate a3GT with new substrate specificity hence able to synthesise novel 
glycoconjugates for therapeutic use.
Some glycosyltransferases such as a-l-4-galactosyltransferase from 
Neisseria meningitidis LgtC, which transfer galactose from a uridine 5’- 
diphosphogalactose (UDP-Gal) donor substrate to the axial 4’-OH of terminal 
lactose containing acceptor substrate has been shown to display acceptor substrate 
promiscuity. Aside from lactose, LgtC also has also been shown to transfer to a D- 
galactose, albeit with a markedly reduced efficiency and also to a range of D-aldose
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sugars and wyo-inositol of which some of these sugars possess equatorial hydroxyl 
groups (Lairson et al., 2006). Further studies showed that LgtC can use p- 
nitrophenyl p-D-glucopyranoside (pNPGlc), which has an equatorial hydroxyl as an 
acceptor to form a Gal-a-(l-4)-Glc linkage, indicating that pNPGlc adopts the same 
basic binding mode as lactose (Lairson et a l , 2006). This result indicates the 
possibility that some wild type glycosyltransferases that display a relatively broad 
specificity can be used as catalysts in a range of useful galactosylation reactions. The 
use of pNPGlc as an acceptor produced a single regioisomer further suggesting that 
a strategy whereby appending a conveniently installed and removed substituent onto 
the acceptor might control its active site binding orientation in a useful manner.
Further studies by Lairson and associates showed that a3GT can utilize both 
D-galactose and pNPGal as acceptor substrates. The use of D-galactose as an 
acceptor produced a mixture of regioisomers of disaccharide products whereas the 
use of pNPGal resulted in exclusive formation of a pure a-(l-3)-linked product 
(Lairson et al., 2006). This result showed that wild type a3GT has some degree of 
acceptor substrate promiscuity and has the potential to be used in the assembly of 
different glycoforms by altering the attachment of activated sugar substrates to 
variable acceptor substrates. The crystal structure of wild type a3GT in complex 
with UDP and pNPGal showed that the mode of binding for pNPGal is similar to 
that of the natural acceptor substrate, LacNAc. a3GT possesses an aromatic side 
chain (Trp249) that serves as a platform for the binding of the GlcNAc moiety of the 
LacNAc acceptor. In fact, three dimensional structures of sugar binding sites often 
show aromatic residues that function to provide a hydrophobic platform onto which 
a sugar ring face can stack. As with a3GT, LgtC also possesses an aromatic side 
chain Phel32, positioned to function in such a role, providing a platform on which 
the sugar ring of the acceptor may bind. The galactose moiety of pNPGal binds in a 
similar fashion as the galactose moiety of LacNAc. The nitrophenyl group binds 
differently from the GlcNAc moiety of LacNAc however it still mimicks the 
stacking interaction of GlcNAc with residue Trp249. Conventional attempts to 
broaden the substrate specificity of enzymes often involve the modification of both 
the substrates and the enzyme (Carter and Wells, 1987). Studies carried out by
148
Chapter 4 Crystallisation of Canine Forssman Synthase
Lairson and associates showed that by the simple expedient of transiently attaching 
alkyl or aryl substituent to the acceptor sugar they were able to broaden the substrate 
specificity of wild type LgtC to allow exclusive formation of single regioisomer 
products at synthetically useful rates (Lairson et al., 2006). The results presented by 
Lairson and associates along with the structure of wild type a3GT in complex with 
UDP and pNPGal presented here highlighted that the acceptor substrate specificity 
of glycosyltransferases is not quite as rigid as previously believed and this 
observation has direct implications for their synthetic utility. These results also 
showed that this substrate promiscuity can be harnessed by modification of the 
acceptor sugar with a readily removable aromatic substituent that can facilitate a 
productive and predictable binding mode providing both control of regioselectivity 
and an increase in catalytic rates (Lairson et al., 2006). The possibility of substrate 
engineering of glycosyltransferases can provide access to novel glycosidic linkages 
which may be used for therapeutic purposes.
3.4.4.2 Modelling of the inhibitor U66 with a3GT
During the initial part of my research, one of the main aims was to carry out docking 
studies of the ligand U66 which was shown to have a high inhibitory activity 
towards a3GT. Our collaborator, Dr Keith Brew from Florida Atlantic University, 
Boca Raton (USA) has screened 86 different potential inhibitors which were 
designed based on the structure of a3GT’s natural donor substrate, uridine 
diphosphate (UDP) (Table 3.13). From the screening studies, they have found that 
the ligand designated as U66 has the most potent inhibitory activity, with an 
inhibitory activity within a range of 24 ± 40 pM (Figure 3.37). Docking studies were 
carried out with U66 and the crystal structure of a3GT (PDB code: 1K4V).
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Figure 3.37: Diagram showing the 86 different inhibitors which were screened for 
inhibitory activity towards a3GT. Inhibitors U66 and U67 (represented in red box) were 
found to have the most potent inhibitory activity towards a3GT (Brew, K., unpublished 
results).
Methods
As kinetic studies showed that U66 is close to being a competitive inhibitor with 
respect to UDP-Gal and LacNAc (data not shown), U66 were built manually in the 
UDP binding site and LacNAc binding sites. The anthraquinone like residues (Three 
rings) are predicted to form stacking interactions with tryptophans in the tryptophan 
pocket and protrude out into solution. The molecular structure o f  U66 was built 
using the program ‘0 ’(Jones et al., 1991). The residues used to build U66 were 
obtained from the HIC-Up server (Kleywegt and Jones, 
1998)(http://alpha2.bmc.uu.se/hicup/) and the Cambridge Crystallographic Data 
Centre (CCDC) (http://cds.dl.ac.uk/cds). Residues that make up the structure o f the 
U66 are as follows (Figure 3.37).
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Figure 3.37: structure of U66
1. UDP- derived from the crystal structure o f  a3G T  (PDB code: lK4V)(Boix et 
a l, 2001).
The rest o f  the residues were built around the UDP from the a3G T  crystal structure 
(PDB code: 1K4V). Some editing was carried out in order to obtain the correct 
atoms for the inhibitor:
2. Triazole ring (Mangani and Liljas, 1993): HIC-Up server
3. Pentanal (Nevskaya et al., 2000): HIC-Up server
4. Anthraquinone (Henry and Lonsdale, 1952): Crystal web (CCDC)
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24 ± 4 0
U66
Table 3.13: Some of the ligands that have been screened for inhibitory activity towards 
a3GT. The common structure for all 86 inhibitors is shown in the red box.
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Step 1: Manually build inhibitor
The modelled complexes were refined using the program CNS (Brunger et a l,
1998) and the topology and parameter files for refinement were obtained from the 
HIC-Up server (Kleywegt and Jones, 1998).
Step 2: Docking studies to verify manually built model 
Autodock (Goodsell and Olson, 1990):
Docking studies were carried out using the program AUTODOCK 3.0. Autodock 
carries out Grid-based empirical flexible docking via Monte Carlo search and 
incremental construction (www.scripps.edu/pub/olson-web/download.html). 
Autodock uses a kinematic model for the ligand similar to the one illustrated in 
figure below. The ligand begins the search process randomly outside the binding site 
and by exploring the values for translations, rotations and its internal degrees o f 
freedom, it will eventually reach the bound conformation. Distinction between good 
and bad docked conformations was carried out by the scoring function (Teodoro et 
a l, 2003).
Figure 3.38: A drug molecule. Spheres represent atoms and bonds connecting them are 
represented by sticks. Curved arrows represent the rotatable degrees of freedom around 
bonds (Teodoro etal., 2003).
Partial atomic charges were assigned to a3G T  and U66 using the program 
SYBYL 6.8 (Ryckaert et a l, 1997). For a3G T, all water molecules were removed 
and the atomic solvation parameters were assigned to the a3G T  atoms using the 
ADDSOL utility. The grid maps around the protein binding site were calculated 
using AUTOGRID 3.0 with 80 x 80 x 80 points, and a grid spacing o f  the default
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0.375 A  (roughly a quarter of the length of a carbon-carbon single bond). The grid 
centre used was initially 6.122, 13.016, -4.651 based on the manual-docking model. 
The grid centre is usually set by default based on the coordinates for the center of the 
ligand. Torsion angles that were to be explored during the docking were defined 
using ‘deftors’ (a program which assigns root atoms and torsions to a molecule). The 
UDP moiety of the inhibitor was set as the root or fixed reference point from which 
the rest of the atoms will flex. This is because it is believed that if the inhibitor was 
to bind at the predicted binding site, the UDP moiety would fit into the binding site 
in the same conformation as it is in the crystal structure. Torsions angles were 
mainly centered around the short hydrocarbon chain connecting the triazole ring 
with the anthraquinone-like residue. The Autodock run were not successful and did 
not place the inhibitor in the manually docked site. Changing the docking parameters 
such as the number of runs, the grid center, root residues and torsion angles were 
still not successful in placing U66 at the expected binding site. At this point it was 
decided to move to another docking program namely Hex.
Hex (Ritchie and Kemp, 2000)
Hex (http://www.csd.abdn.ac.uk/hex/) is an interactive molecular graphics program 
for calculating and displaying feasible docking modes of pairs of protein and DNA 
molecules. Hex can also calculate small-ligand/protein docking (provided the ligand 
is rigid), and it can superpose pairs of molecules using only knowledge of their 3D 
shapes. The main thing, which distinguishes Hex from other macromolecular 
docking programs and molecular graphics packages is its use of spherical polar 
Fourier correlations to accelerate the docking and superposition calculations. An 
important difference between Hex and Autodock is that Hex is much more user 
friendly as it uses a graphics interface. Another difference is that in Autodock, the 
docking determination takes into account the flexibility of the ligand through the 
calculation of torsion angles within the ligand molecule whilst Hex is based on the 
principle that the ligand is rigid. Initial runs to dock the inhibitors to a3GT using the 
Hex default parameters were not successful. Consequently, U66 was manoeuvred in
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close proximity to the predicted binding site (i.e: close to the tryptophan pocket). 
The Euler angles for the orientation were as follows: a- 97, p- 36, y- 63° and an 
intermolecular separation of 26.4 A. Only chain B of the a3GT molecule was used. 
Prior to docking, as with Autodock, the water molecules in a3GT were all removed. 
The default mode, which is full rotation, was used as the docking search mode. In 
this mode, the receptor is held fixed and the ligand is translated about the receptor 
using the Ligand Range and Samples angular parameters and the Distance Range 
and Step parameters to generate different ligand poses about the receptor. The 
resolution was specified at the default settings of an initial Steric Scan at N=16, 
followed by a Final Search at N=25, using just the steric contribution to the docking 
energy. In this mode, about all but the top 20,000 orientations are discarded after the 
Steric Scan. The docking was performed using the angular search of 180° angular 
cones centred on the intermolecular axis. Using all these parameters, the inhibitor 
was placed into the predicted binding site and gave the first docking solution with 
the lowest free energy value of -390.48 (Figure 3.39). Subsequent docking trials 
showed that the U66 would be docked in the predicted binding site if the inhibitors 
were oriented in close proximity to the tryptophan pocket prior to docking.
Although the Hex solutions are in agreement with the manually docked 
model, the model should be viewed with some trepidation as the results were only 
obtained when the inhibitor was placed in very close proximity to the predicted 
binding site. This could reflect a bias in the search towards a pre selected binding 
site, therefore compromising the validity of the results.
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Results
H ex d o c k in g  
M anua l d o c k in g
Figure 3.39: Diagram showing the manually docked U66 and the result obtained via
docking using the Hex program. The manual docking position is represented in red while 
Hex docking is in green. The Hex docking result is in good agreement with the manually 
docked position and gave a low free energy value of -390.48.
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Figure 3.40: Potential inter-atomic interactions between the docked ligand, U66
(represented in yellow) with the active site residues of a3GT (represented in magenta). The 
black dashed line represents hydrogen bonds. Stacking interactions between the 
anthraquinone-like tail of U66 with the tryptophan rings (residues 249 and 250) are 
predicted to stabilise the conformation of U66.
U66 a3GT Distance (A)
O lA Asp225-OD2 3.22
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Attempts to obtain crystal structure of a3GT in complex with U66
One of the main objectives of this research initially was to co-crystallise wild type 
a3GT with the inhibitor U66, however, initial attempts to co-crystallize wild type 
a3GT with the inhibitor U66 were unsuccessful (data not shown). On addition of 
U66, a3GT precipitated and it was concluded that the best way to overcome this 
problem was to grow a3GT crystals without substrates or co-factor (apo) and then 
carry out soaking experiments with U66. Initial soaking experiments of wild type 
a3GT -UDP co-crystals with U66 had shown that U66 was not able to displace 
UDP from the active site (data not shown). At this point we abandoned further 
efforts to co-crystallise U66 with a3GT and sought to obtain apo crystals of the 
enzyme for use in soaking experiments with U66. We attempted to obtain 
crystallisation conditions for the apo forms of the wild type enzyme and the 
Arg365Lys mutant. Apo wild type a3GT was successfully crystallised in the 
tetragonal form previously reported by Zhang and co-workers (Zhang et al., 2003) 
Crystallisation of a3GT mutants was carried out using the vapour diffusion method. 
Initially, crystallisation screens of the Arg365Lys mutant in its ‘apo’ form did not 
produce any viable results. The crystallisations results for the screens were mostly 
bleak with the results mainly being clear drops and heavy precipitation, with the 
latter predominating. It was observed that condition number 12 from Structure 
screen I consistently produced phase separation (Figure 3.41) for the Arg365Lys 
mutant. Phase separation or also known as protein droplets can be a positive 
indicator of a potential crystallisation condition and it is sometimes likely that 
crystals would grow from phase separation (Bergfors, 1999). Based on this 
knowledge, streak seeding was carried out. The same condition was repeated and the 
new drops containing the Arg365Lys mutant were streak seeded from the phase 
separation. Crystalloids appeared after a week of incubation and streak seeding was 
carried out subsequently until the crystal size and morphology improved (Figure 
3.41). The condition for crystallisation was also refined and the most optimum 
condition was established to be in the presence of 2M sodium acetate and 0.3M 
sodium cacodylate pH 6.5.
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Phase separation. A similar phenomena 
occurred when Arg365Lys variant (apo) was 
crystallised in Structure Screen 1 condition 
number 12: 1.4M sodium acetate, 0.1M 
sodium cacodylate, pH 6.5
Crystalloid o f Arg365Lys variant formed a 
week after streak seeding from phase 
separation. The crystalloids grew in the form 
o f dense clusters and are not useful for data 
collection
After subsequent streak seeding from 
crystalloids and refinement o f crystallisation 
condition, Arg365Lys variant crystal 
morphology and size improved significantly. 
Crystallisation condition: 2M sodium
acetate, 0.3M sodium cacodylate, pH 6.5
Figure 3.41: Diagram showing gradual improvement of mutant Arg365Lys ‘apo’ crystal 
morphology via streak seeding. This crystal diffracted to 3.3 A and crystallised in 
orthorhombic space group P2i2i2i.
The same condition was used to co-crystallise Arg365Lys mutant with UDP- 
Gal and manganese. These attempts produced small crystals o f bipyramidal 
morphology (Figure 3.42).
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Figure 3.42: Crystal of Arg365Lys variant grown in the presence of UDP-Gal and 
manganese Crystallisation condition: 2M sodum acetate and 0.3M Na sodium cacodylate, 
pH 6.5. The crystal diffracted to 3.7 A in tetragonal space group (Typical crystal size: 
0 .0 6 X 0 .0 7 X 0 .1 8  mm).
These apo crystals however did not diffract well hence are not ideal crystals to be 
used for soaking experiments. Initial attempts to soak these crystals in U66 were 
unsuccessful and due to time constraints further attempts at obtaining a crystal 
structure o f  a3GT in complex with U66 were stopped so that the research could 
move on to other areas o f study
Discussion:
Selective glycosyltransferase inhibitors would be valuable tools for probing the 
functions o f glycosyltransferases and their products. With few exceptions, however, 
selective glycosyltransferase inhibitors do not exist. The design o f inhibitors for 
a3GT is important in the relation to the problems o f  xenotransplant rejection caused 
by the recipient’s anti-Gal antibody reaction to the donor’s a-Gal epitope. Several 
inhibitors o f a3GT have been reported and some o f  them is an 1-AMminosugar based 
UDP-galactose analogue which was found to be a potent and selective inhibitor o f 
a3GT but not o f the (3-1,4 galactosyltransferase. Azasugars have also been designed 
to inhibit the enzyme activity by forming a strongly associated complex in the active 
site via favourable electrostatic interaction (hydrogen-bonded ion pair) in a manner 
similar to inhibitors o f retaining glycosidases (Compain and Martin, 2001). Studies 
by Takayama and associates showed that 1-deoxygalactonojirimycin which is a 
potent inhibitor o f ceramide glucosyltransferase showed no inhibition towards a3GT
160
Chapter 4 Crystallisation of Canine Forssman Synthase
nor towards p-1,4 galactosyltransferase (Takayama et al., 1999). These results 
indicate clearly that the position of the imino-group is crucial for the recognition of 
the piperidinols by the enzyme. The design of inhibitors of a3GT is still at an early 
stage but even though we did not manage to obtain a crystal structure of the enzyme 
in complex with U66, the modeling and docking studies seem to suggest that U66 
binding spans both the donor substrate and the acceptor substrate site. The inhibitory 
nature of the compound may be attributed to this mode of binding as it obstructs 
both substrate binding sites hence preventing the natural substrates from binding at 
the active site. Designing a selective inhibitor of a3GT will require greater 
understanding of the catalytic activity of the enzyme as well as attempts to obtain 
crystal structures of a3GT in complex with inhibitors in order to have a detailed 
understanding of their binding mode. The information acquired would make it 
possible to prepare a focused library of compounds to identify better and more 
potent inhibitors.
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CHAPTER 4
Crystallisation of Canine 
Forssman Synthase (FS)
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4.1 Introduction
Glycolipids are carbohydrate-attached lipids. Their role is to provide energy and also 
serve as markers for cellular recognition. They occur where a carbohydrate chain is 
associated with phospholipids on the cell membrane surface. The carbohydrates are 
found on the outer surface of all eukaryotic cell membranes. They extend from the 
phospholipid bilayer into the aqueous environment outside the cell where they act as 
a recognition site for specific chemicals as well as helping to maintain the stability 
of the membrane and attaching cells to one another to form tissues.
Microbial pathogens have long co-evolved with their eukaryotic hosts and 
this has resulted in a remarkable specificity in their interactions. As a consequence 
of this, pathogenic organisms have a restricted ability to cause disease to a limited 
number of species. The early stage in the development of pathogenesis of most 
infectious diseases is microbial adherence to the host cells (Xu et a l , 1999). As a 
result, the capacity for adherence has become a major determinant of the host range 
available to a given pathogen. Due to their role in cell recognition, glycolipids are 
usually the initial attachment site for several pathogenic agents such as bacteria, 
viruses and bacterial toxins. These pathogens are known to recognize host 
glycolipids as their initial attachment site (Hansson et a l , 1985; Hansson et a l , 
1984; Karlsson and Stromberg, 1987; Svanborg Eden et a l , 1983). Hence, the 
susceptibility to infectious diseases is impacted greatly by factors regulating 
glycolipid synthesis.
Glycolipids are composed of a variable carbohydrate moiety attached to a 
ceramide backbone and can be found in almost all eukaryotic cells. Hundreds of 
distinct glycolipids have thus far been described (Basu et a l , 1987). The variability 
in glycolipid structures takes place primarily in the carbohydrate moiety due to 
differences in the number, type, or anomeric linkage between sugar residues (Stults 
et a l , 1989; Xu et a l , 1999). However, each cell type will only express glycolipids 
which contain a limited combination of all possible carbohydrate structures. This 
cell lineage-specific pattern of glycolipid expression is tightly regulated during
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cellular differentiation and development and also varies between species (Hakomori, 
1986; Monner and Muhlradt, 1993; Sadahira et al., 1991; Sandhoff and van Echten, 
1993).
The enzyme globoside a-N-acetylgalactosaminyltransferase (EC-Number 
2.4.1.88 ) or also known as Forssman synthetase (FS) is responsible for the synthesis 
of Forssman glycolipid (FG; Forssman antigen) which is a member of the 
globoseries glycolipid family, all of which have in common a core galactosyl- 
(al,3)galactose moiety (Xu et al., 1999). FS catalyzes the transfer of N- 
acetylgalactosamine from its nucleotide donor, UDP-JV-acetyl-D-galactosamine to 
the acceptor, JV-acetyl-D-galactosaminyl-1,3-D-galactosyl-1,4-D-galactosyl-1,4-D- 
glucosylceramide to form its product the Forssman glycolipid (FG), A-acetyl-D- 
galactosaminyl-a-1,3 -N-acety 1-D-galactosam inyl-a-1,3-D-galactosyl-a-1,4-D- 
galactosyl-a-1,4-D-glucosylceramide. An interesting feature of FG is that unlike 
many other mammalian species, human cells do not normally produce it but instead 
produce the precursor glycolipids globotriosylceramide and globoside (Gb04). In 
humans and some species, these precursors serve as attachment site for pathogenic 
agents. In other species, it is likely that the modification of these glycolipids, such as 
the addition of iV-acetylgalactosamine to create FG, alters the adherence of 
pathogenic organisms hence modifying host susceptibility to infectious diseases. A 
study by Elliot and co-workers (2003) described a molecular and genetic 
relationship between FG expression and Shiga toxin (Stx) susceptibility. In this 
study, they isolated the FS cDNA from human, canine, and murine cells and found 
that whereas the murine and canine FS genes express a functional enzyme, the 
human FS cDNA was found to express a protein that lacks FS activity, despite a 
high degree of sequence identity with the enzymatically active murine and canine FS 
genes. In order to examine the relationship between FG expression and Stx 
susceptibility, Vero cells were transfected with the three FS orthologues or a vector 
control. Complementation with the human FS cDNA had no effect on Stx 
susceptibility, whereas stable expression of the canine and murine FS resulted in 
markedly decreased susceptibility to toxin. Among individual cells, an inverse 
correlation between FG expression and Stx binding was demonstrated. Moreover,
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only strongly FG-reactive cells were capable of growing in the presence of Stx. 
These cells were found to have high levels of FG expression and a correspondingly 
diminished Gb03 content. Based on these results, Elliot and co-workers concluded 
that expression of a functionally active FS modifies Stx receptor glycolipids to FG 
and results in markedly decreased susceptibility to toxin. They further speculated 
that inactivation of the FS gene during primate evolution may account for the 
marked susceptibility of human cells to Stx (Elliott et al., 2003). Studies by Xu and 
co-workers showed that the inability to produce FG results from mutations within 
the putative FS catalytic domain. However, widespread tissue expression of the FS 
mRNA seems to suggest that although the human FS is not active it may still retain 
some biological function and the inactivity of the enzyme in humans may be due to 
2 possible reasons. The first reason might be due to FS acquiring a novel enzymatic 
activity or it may be because the remaining biological functions in humans do not 
require glycosyltransferases activity. Xu and co-workers moved on to compare the 
human orthologue of FS with that of a3GT. a3GT is similar to FS in that the a3GT 
gene is expressed in many mammalian species however it lost the ability to encode 
glycosyltransferase activity only recently during primate evolution. Interestingly, 
whereas the human FS retains 83% amino acid identity with the canine orthologue 
and is expressed widely in human tissues, the a3GT is not expressed in human cells, 
and the processed pseudogene contains multiple frameshift mutations (Galili et al., 
1988; Xu etal., 1999).
The study reported in this thesis concentrated on the structural studies of these 2 
family 6 glycosyltransferase with the bulk of the study concentrated on structural 
studies of several a3GT mutants in order to further understand the catalytic activity 
and specificity of this enzyme. The important role that FG plays in host-pathogen 
interactions and by implication, the important role that FS has to play in synthesizing 
FG makes it crucial for us to understand the structural basis for the catalytic activity 
of FS. It is in this context that we also sought to elucidate the crystal structure of FS 
in the hope of understanding structurally its catalytic mechanism.
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Methods
Forssman synthase (FS) enzyme was cloned, expressed and purified by Percy 
Tumbale in our collaborator Professor Keith Brew’s laboratory, Florida Atlantic 
University, USA. The pure enzyme was supplied to us in buffer containing 20mM 
Mes-NaOH, pH 6.5 and 50% Glycerol at a concentration of 0.48 mg/ml. The protein 
needed to be buffer exchanged into a buffer containing 20mM Mes-NaOH, pH 6.5 
and 10% glycerol and then concentrated to 5-8mg/ml (Abss62 between 0.12-0.22) 
prior to crystallisation set ups. The method used for this step is as described 
previously in Chapter 3. During the buffer exchange and concentration process, 
quite a large amount of protein was lost and due to the small amount of protein 
available, this has put a limitation on the number of crystallisation screens that could 
be carried out. Described here are the optimisation attempts which had been carried 
out in light of the limited resources that were available.
Crystallisation was carried out using the hanging drop vapour diffusion 
method by mixing lpl protein in the presence of lOmM UDP-GalNAc and lOmM 
MnCh with lpl of well solution and suspended above 0.5-0.8 ml reservoir. 
Crystallisation screens were also carried out in the absence of UDP-GalNAc. The 
drops were incubated at 4°C, 16°C or 22°C and the well solution to protein ratio was 
also varied in hope of obtaining diffraction quality crystals. Crystallisation trials 
were initially carried out using published conditions for the human ABO blood 
group enzymes however, this condition resulted in protein precipitation hence, the 
focus moved on to commercial crystallisation screens such as the Hampton 
PEG/ION screen, Hampton Malonate Screen, Hampton Ammonium sulphate screen, 
Molecular Dimensions Structure Screen I and II, Hampton Crystal Screen Lite, 
Memstart Kit Screen and Memsys Screen.
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4 3  Results
Initial screening was carried out with the commercially available screens at the 
maximum concentration of protein (8 mg/ml) and incubated at 16°C. These screens 
represent a hundred conditions which have commonly given crystals in previous 
experiments. These commercial screens produced many drops with heavy 
amorphous precipitate suggesting that either the protein or the precipitant 
concentration was too high in most cases. The screens were carried out a second 
time with a lower protein concentration of 5 mg/ml and subsequent screens were 
carried out using this protein concentration. Initial screens at this concentration using 
the PEG/Ion Screen showed precipitation in all the conditions hence a second 
crystallisation set up was carried out by halving the precipitant concentration of all 
the conditions from the PEG/Ion screen. This resulted in most drops having a small 
amount of precipitates, some of which were more crystalline in nature. Several other 
screens such as the Molecular Dimensions Structure Screens and Hampton Crystal 
Screen Lite gave promising results with several conditions producing crystalloids 
and microcrystals (Table 4.0). However the morphology of these crystalloids and 
microcrystals were the same in which they produce very fine needle crystals 
growing in clumps (Figure 4.0 ). Several optimisation screens based on these initial 
hits were carried out along with streak, macro and micro seeding in the hope of 
improving the crystal morphology. The optimisation screens involved varying the 
protein concentration, precipitant, pH range and also the addition of additives as 
shown in Table 4.0. Variations on these conditions did not produce crystals with 
improved crystal morphology. The needle crystals improved tremendously in length 
(there were several instances in which the needles grew to span the whole length of 
the drop) however they were still very thin and were still growing in clumps hence 
were not suitable for data collection. At this point the aim of the optimisation trials 
was to produce a single needle crystal which could be fished out of the drop easily 
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Figure 4.0: A: initial crystalloids obtained from structure screen I/II, PEG/Ion screen and 
crystal screen lite. B: slight improvement in size of the crystal after optimisation however, 
the crystals are still very fine needles growing in clumps resembling sea urchins hence, are 
not suitable for data collection.
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Following the lack of success with the optimisation trials to produce 
diffraction quality crystals, membrane protein screens from Molecular Dimensions 
were tried: Memsys Kit and Memstart Kit. Interestingly, several conditions (Table 
4.0) from these screens produced crystalloids within 2 hours of incubation which is 
much faster than conditions from the structure screens and Hampton Research 
screens which normally would take between 2-4 weeks. These crystallisation 
conditions interestingly reflected the crystallisation condition of human ABO blood 
group enzymes which had been previously tried for FS crystallisation without much 
success. Both the human ABO blood group enzyme and the conditions from the 
Memstart Kit Screen (conditions number 2 and 8 ) use ADA/NaOH as a buffer and 
contain the salt Ammonium sulphate albeit at different concentrations. Although the 
conditions from the Memstart Kit Screen looked promising, the morphology of the 
crystalloids were still similar to that of previous conditions and the challenge is to 
improve the conditions in order to obtain a single diffraction quality crystal. As the 
major difference between the conditions of the human ABO blood group enzyme 
and the conditions from the Memstart Kit Screen is the pH of the buffer, preliminary 
optimisation trials were carried out by varying the pH of the ADA buffer in order to 
find out the pH boundary of FS. This was important as it would give a clearer idea of 
which pH range to pursue for crystallisation. Crystallisation set ups were carried out 
using condition number 2 from the Memstart Kit Screen but with two different pH, 
6.5 (original pH from Memstart Kit) and 7.5 (pH for the crystallisation condition of 
human ABO blood group enzyme). The concentration of the precipitant which is 
ammonium sulphate was also varied between the ranges of 0.8M to 1.5M. Results 
from this optimisation trial showed that FS is more stable at pH 6.5 and tends to 
form amorphous precipitates at pH 7.5 which explains why repeating the condition 
of the human ABO blood group enzyme for FS crystallisation met with failure. The 
results also showed that an ammonium sulphate concentrations of less than 1.2M 
showed the best crystal improvement while concentration above 1.2M produced 
amorphous precipitates. These results provided a clear and defined route for 
subsequent optimisation trials. As the results from the membrane protein screens 
were obtained at the time of writing, further optimisation trials were put on hold.
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0.1M Sodium citrate, pH 5.6
0.2M Ammonium acetate
Fine needles growing in clusters
Number 12:
1.4M sodium acetate trihydrate 
0.1M sodium cacodylate, pH 6.5
Fine needles growing in clusters
Number 19:
19% PEG 8000
0.1M sodium cacodylate, pH 6.5 
0.2M zinc acetate







Fine needles growing in clusters
Molecular Dimensions Memstart 
Kit
Number 2:
0.1M ADA/NaOH, pH 6.5 
1M Ammonium sulphate
To be optimised further
Number 8:
0.1M lithium sulphate hydrate 
0.1M ADA/NaOH, pH 6.5 
1M Magnesium sulphate hydrate





0.1M sodium chloride 
0.1M lithium sulphate 
30% PEG 400




0.2M lithium citrate tribasic
tetrahydrate
20% PEG 3350
Fine needles growing in clusters
Number 46:
0.2M sodium citrate tribasic
dehydrate
20% PEG 3350
Fine needles growing in clusters
Hampton Research Crystal Screen 
Lite
Number 39:
0.1M HEPES sodium, pH 7.5 
2% v/v PEG 400 
1M Ammonium sulphate
Fine needles growing in clusters
Hampton Research Crystal Screen 
Lite
Number 39:
0.1M HEPES sodium, pH 7.5 
2% v/v PEG 400 
1M Ammonium sulphate
Fine needles growing in clusters
Hampton Research Malonate 
Screen






Table 4.0: Conditions from commercial screens which produced crystalloids or 
microcrystals and the outcome of optimisation trials of these respective conditions.
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Discussion
Crystallisation of proteins requires obtaining the right set of conditions to 
supersaturate the protein solution in the most favourable way for crystallisation. The 
challenge in crystallisation is to identify these sets of conditions in order to obtain a 
diffraction quality crystal as there are numerous factors which can influence the 
crystallisation ability of a particular protein. Some of the factors that affect the 
solubility of the protein, and therefore its saturation level are protein concentration, 
precipitant concentration and type, pH and temperature. These conditions are the 
easiest to vary in crystallisation experiments hence would usually serve as the 
variable factors of most optimisation trials. In designing crystallisation trials, it is 
often hoped that the preliminary commercial screens will produce some form of 
preliminary crystals that can be optimised by adjusting the aforementioned 
parameters. From the commercial screens that were tested on FS, there were 10 
conditions which showed promising results. However optimisation of 7 of these 
conditions from the commercial screens of Molecular Dimensions and Hampton 
Research did not result in any marked improvement of the crystal size but 
interestingly these conditions showed that FS seemed to crystallise in conditions 
containing acetate ions and/or citrate ions (Table 15) indicating that these ions can 
be favourable additives for FS crystallisation.
Subsequent crystallisation trials using the membrane protein screens from 
Molecular Dimensions resulted in three conditions which produced more promising 
looking crystalloids and microcrystals. Interestingly enough two of these conditions 
contain ADA buffer which also contains an acetate component. Preliminary 
optimisation trials indicated that pH 6.5 and an ammonium sulphate concentration of 
below 1.2M are most favourable for FS crystallisation. Hence, future optimisation 
trials may involve fine grid screens of the pH and also concentration of the 
ammonium sulphate precipitant. Apart from that, seeding techniques should also be 
applied in the crystallisation experiments especially using the streak seeding and 
microseeding techniques. Additives (Chapter 3, Table 3) should also be included in 
the crystallisation trials paying particular attention to the incorporation of acetate
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and citrate ions. Another way to explore the crystallisation space more effectively is 
to set up more screens however, as FS was supplied at low concentration (0.48 
mg/ml) and in 50% glycerol this may be difficult. Buffer exchange and 
concentration of FS prior to setting up crystallisation means that a considerable 
amount of protein is lost before hand hence this limited amount of protein may 
hinder larger scale crystallisation trials. If the expression and purification step for 
producing FS can be improved to produce FS protein at higher concentration, this 
can minimise the loss of protein as it will shorten the length of the buffer exchange 
and concentration process. With larger amounts of available protein, more 
crystallisation trials can be carried out.The use of robots for setting up large trials, 
and the improvement of computerised crystal identification techniques to observe 
these trials can also improve the chances of finding suitable conditions. In the 
absence of a robot, experiments must be designed as well as possible to sample the 
crystallisation space whilst conserving protein and time required to set up the 
experiments. The strategies used in these experiments became more effective 
throughout the trials as experience was gained in designing trials and scoring drops 
for their precipitate quality. However, due to time constraints there is still a large 
proportion of the crystallisation space left unexplored. Although these experiments 
have yet to result in the production of a diffraction quality crystal, they have gone 
some way towards identifying several leads which can be used for future screens.
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The reported structures of the C-terminal mutants of a3GT have identified key 
regions which undergo conformational changes on binding of substrates. From the 
structures it is evident that the loops encompassing the substrate binding sites are 
important in catalysis, providing an ideal environment for optimal binding of both 
the donor and acceptor substrates. These studies also identified a second manganese 
bound in the active site of the enzyme. This is in correlation with the kinetics studies 
which indicated that there are two binding sites for the manganese ion (Brew, K et 
al., unpublished results). The second and weaker binding site for the manganese ion 
is in close proximity to the Glu317 residue and overlaps with the putative position of 
the trisaccharride product. As the binding of this second manganese occurs only 
after the release of the product, it is postulated that this second manganese functions 
to displace the UDP group after trisaccharide product release in order to allow a new 
UDP-Gal to bind at the donor site hence maintaining a continuation of the catalytic 
cycle. It is expected that the second manganese facilitates the release of UDP by 
disrupting the interactions of the C-terminal residues with UDP leading to the open 
conformation of the C-terminus.
Although these results gave insight into what actually happens during the 
catalytic cycle of the enzyme, they do not provide any conclusive evidence about the 
mechanism of a3GT. The work thus far did not provide any strong evidence for the 
previously proposed double displacement mechanism (Gastinel et al., 2001) 
although subsequent structural and mutational studies on the Glu317Gln mutant did 
show that residue Glu317 is important in catalysis and the conserved mutation to 
Gin has reduced both the hydrolase and transferase activity of the enzyme (Zhang et 
al., 2003). However the magnitude of reduction in activity does not support a double 
displacement mechanism instead it seems to suggest that Glu317 might play a role in 
stabilising the cationic transition state for the cleavage of the bond between UDP 
and Cl of the galactose. This might explain why in the crystal structure of the 
Glu317Gln mutant in complex with UDP-Gal, a full length UDP-Gal is observed 
bound in the active site. This complex structure is one of the few crystal structures of 
glycosyltransferase with an intact active donor substrate bound in the active site. The 
hydrolysis rate of UDP-Gal by a3GT is very fast and it is notoriously difficult to
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obtain a crystal structure of the enzyme in complex with an intact active donor 
substrate. The mutation to Gin has reduced the hydrolysis and transferase activity to 
an extent that a complex of the mutant with UDP-Gal managed to be trapped in the 
crystal structure.
Due to the lack of direct evidence for the double displacement mechanism 
and the failure to observe any glycosyl-enzyme covalent intermediate in the crystal 
structures of the active site mutants discussed in section 3.2, it looks that it is highly 
likely that a3GT might utilise an alternative mechanism. Another detailed work 
carried out thus far on retaining galactosyltransferases is the characterisation of the 
structure of Neisseria meningitides a-galactosyltransferase LgtC with stable donor 
and acceptor substrate analogues bound. This study revealed an active site in which 
the only functional group appropriately positioned to act as a nucleophile was that of 
the side chain amide of Gin 189 (Persson et al., 2001). Replacement of this residue 
with alanine however, yielded an enzyme that retained sufficient activity (~3%) to 
shed considerable doubt on its role as a nucleophile (Persson et a l , 2001). The 
authors of this paper went on to suggest that a SNi-like mechanism involving a direct 
attack on the Cl atom of UDP-Gal by the acceptor molecule itself concurrent with 
cleavage of the glycosidic bond and direct transfer of the Gal moiety to the 
disaccharide acceptor without the formation of a glycosyl enzyme intermediate. In 
such a mechanism, the enzyme acts as a scaffold that precisely orients substrates in 
close proximity, decreasing the energy of the transition state by stabilising the 
oxocarbenium ion-like species and activating the leaving group (Lairson et a l, 2004; 
Persson et al., 2001). It is postulated that a3GT, a retaining enzyme as well, might 
carry out a similar catalytic mechanism.
However the evidence to date does not totally support either the double 
displacement mechanism or the SNi-like mechanism and more experimental 
evidence is clearly needed before a lucid understanding of the mechanism of 
retaining glycosyltransferase will be obtained. As attempts to obtain a crystal 
structure of a3GT in complex with both donor and acceptor substrates has yet to be 
carried out, this could be the next step in trying to understand the catalytic 
mechanism of the enzyme.
175
Conclusions and Future Work
The structure of the wild type a3GT in complex with pNPGal showed the 
enzyme exhibits some degree of substrate promiscuity. This promiscuity can be 
useful in utilising a3GT for the synthesis of novel glycoconjugates for therapeutic 
use. The promiscuity displayed by a3GT is yet unclear and not well characterised. 
Questions remain on how far this promiscuity can be utilised for synthetic use and 
this phenomenon coupled with a better catalytic understanding of <x3GT needs to be 
more widely studied in order to harness its synthetic usefulness. There is plenty of 
scope for further investigation of the use of alternative substrates especially acceptor 
substrates. The general ease of producing good quality diffracting crystals of a3GT 
would enable soaking studies with potential acceptor substrates to be carried out. 
High resolution data is needed in order to clearly observe the mode of binding for 
these new acceptor molecules and these information can then be subsequently used 
for the design of novel glycoconjugates or inhibitors.
Crystallisation of Forssman synthase (FS) enzyme is still at an early stage 
however recent results obtained gave good indications for subsequent crystallisation 
experiments. The challenge is to produce large diffracting crystals, only showers of 
needles have thus far resulted from all the conditions that have been identified. More 
optimisation trials should be carried out by varying the concentration of the protein 
used, the precipitant concentration and varying the pH of the buffer. Addition of 
additives should also be carried out and subsequently seeding of the needles into 
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